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Abstract
Ribonucleic acid (RNA) is a biological molecule that exists in the cell of virtually all kinds
of known living organisms. Although its significance in fundamental cellular processes such
as protein synthesis has been known for decades, an increasing number of novel species and
functions of RNA have been discovered recently, and a complete picture of RNA functions
in the cell is still elusive. One of the major challenges in RNA studies is that there had
been no efficient method to quantify RNA with spatial and temporal information in vivo. In
my doctoral studies, I developed a novel RNA sequencing method that metabolically labels
RNA in a cell- and time-specific manner in mice and applied this method to solve biological
problems that had been difficult to tackle.
First, the robustness of the newly developed in vivo RNA labelling method was assessed.
To confirm the sensitivity and specificity of RNA labelling, multiple transgenic mice that
label RNA in different cell types were generated. By comparing the data obtained from
each transgenic strain to previously generated transcriptomic datasets, I confirmed that RNA
labelling in a specific cell type was achieved in all the strains analysed. This method would
be useful to study cell-type-specific transcriptomics rather than the commonly used laborious
and time-intensive cell isolation method often used, and might provide data that closely
reflect the native transcriptional state in vivo.
Next, using the same RNA labelling method, I tested if there is any RNA that is mobile
between different cell types in mice. Intercellular mobility of RNA has been shown in
nematodes and plants, but whether there is any RNA that is mobile between different
mammalian cells in vivo is still unclear. The cell-specific RNA labelling method allowed
us to assess the mobility of RNA directly for the first time. Based on previous publications,
three different cell types were chosen as potential “donor” cells, and transgenic mice that
label RNA in these cells were generated. The donor cell-derived labelled RNA was sought in
“recipient” tissues that are not capable of labelling RNA. However, although RNA labelling
was achieved in the donor tissues, no labelled RNA was found in the recipient tissues in any
of the animals tested. This experiment presents a novel methodology to assess the mobility
of RNA in living mice, and the obtained data suggest that only minor intercellular transfer of
RNA, at best, is happening in the tested pairs of tissues.
xIn the final part of my thesis, I applied the metabolic RNA labelling method to study the
transcriptional dynamics in the early preimplantation mouse embryos. Unlike conventional
RNA sequencing methods that can only quantify RNA abundance in each stage of the
embryos, metabolic RNA sequencing can directly interrogate the transcriptional activity of
each gene. This method is particularly powerful in studying the transcriptional network in the
early preimplantation embryo, where embryo-derived RNA needs to be distinguished from
maternally-deposited RNA. By exposing the mouse embryos to a nucleotide analogue in a
stage-specific manner, I identified genes that are actively transcribed in the 2-cell embryos.
This method would be useful in studying the transcriptional cascade in the early mammalian
preimplantation embryos.
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UTP urdine triphosphate
UTR untranslated region
U uracil
UV-Vis ultraviolet-visible
WAT white adipose tissue
WT wild-type
ZGA zygotic genome activation
Chapter 1
Introduction
1.1 Ribonucleic acid
Existence of nucleic acid was first reported by a Swiss chemist, Friedrich Miescher, in 1871.
It was named “nuclein” because it was discovered in nuclei of leucocytes isolated from the
pus on surgical bandages (Dahm, 2005). Later, studies on different tissues from various
organisms revealed that there are two kinds of nucleic acids, which were initially called
thymus nucleic acid and yeast nucleic acid, based on what these molecules are extracted
from. This was, based on our current knowledge, because these tissues have a different ratio
of deoxyribonucleic acid (DNA) to ribonucleic acid (RNA).
The contribution of RNA in protein synthesis process was predicted by its existence in the
cytoplasm, where protein synthesis also takes place. Also, metabolic labelling experiments
revealed a correlation between the protein and RNA synthesis rate (Gorman and Halvorson,
1959). Although scientists discovered RNA-rich particles called “microsomal particles”,
which we now know as ribosome, and speculated its significance in protein synthesis as
early as the mid 1950s (Littlefield et al., 1955), understanding how exactly the genetic
code is translated through RNA had been challenging. This is partly due to the extensive
disproportion of RNA species; while ribosomal RNA (rRNA) and transfer RNA (tRNA)
account for 85% and 10% of cellular RNA, respectively, messenger RNA (mRNA) only
accounts for 5%. Also, mRNA has a much shorter half-life and is quite unstable compared
with the rest of the RNA species. Thus, scientists at the time only focused on the “soluble
RNA”, or tRNA, and “stable RNA”, which is rRNA residing in microsomal particles, and
thought that the stable RNA was the template for protein synthesis (Fig. 1.2).
mRNA was first observed as a distinct class of molecules from the other RNA by Al
Hershey’s group in 1953 and also by Volkin and Astrachan in 1958 (Astrachan and Volkin,
1958; Hershey et al., 1953). Both groups exposed bacteria to radiolabelled nucleic acid
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precursors followed by a phage infection, and observed short-lived RNA that was clearly
distinct from tRNA and rRNA. However, at this point, its link to protein synthesis remained
obscure.
A conceptual result that suggests the existence of a messenger molecule was shown by
the experiments performed by Pardee et al. (1959), which is better known as the PaJaMa
experiment named after the authors’ surnames (Pardee, Jacob, and Monod). This experiment
is primarily important in discovering the concept of gene regulation. They used Escherichia
coli (E. coli) with two alleles: β -galactosidase Repressor mutant (i-) and β -galactosidase
mutant (z-) (Fig. 1.1). They showed that E. coli (i- z-) started synthesising β -galactosidase
after being crossed with wild-type E. coli (i+ z+) within a minute (Pardee, 2002). This
experiment suggested that there is a system that works as “a messenger” from a gene to
the host cell protein synthesis system. Three hypotheses were presented to explain the
phenomenon (Fig. 1.2) and were elegantly tested in back-to-back papers published in Nature
in 1961. Two groups showed that the previously observed transient RNA synthesised
in response to the phage infection is the messenger that conveys the genetic information
for protein synthesis (Brenner et al., 1961; Crick et al., 1961). Brenner et al. exposed
bacteria to different radiolabelling agents before and after an infection, and showed that the
newly synthesised RNA after infection indeed interacted with ribosomes. Also, no newly
synthesised ribosomes were detected, while newly transcribed RNA had the similar base
composition to that of the phage DNA. These results collectively suggest that the model III
is the most plausible model (Fig. 1.2).
1.2 Regulatory RNA
It was not too long after the discovery of mRNA before people noticed that there were classes
of RNA that are not translated into protein. Notably, most of the abundant classes of RNA
in a cell are non-protein-coding but play important roles in protein synthesis. For instance,
ribosomal RNA (rRNA), together with ribosomal proteins, join amino acids based on the
mRNA sequence to synthesise proteins, and, importantly, rRNA itself is the key component
that has peptidyl transferase activity to join the amino acids (Noller et al., 1992). Hoagland
and Zamecnik successfully identified the soluble RNA, tRNA, as a transporter of amino
acids to ribosome (Hoagland et al., 1958). Also, small nuclear RNAs (snRNAs), which
function as core components of RNA splicing machinery was also discovered (Lerner et al.,
1980; Zhuang and Weiner, 1986). This series of discoveries clearly proved that some RNA
species act as functional molecules in essential biological systems without being translated
into proteins.
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β-galactosidase-positive donor, and only
measuring activity in the recipient cells. 
To Monod’s delight, I solved this problem in
a few days by adding streptomycin. The
drug was chosen to kill the streptomycin-
sensitive donor cells, but not the drug-
resistant recipients in mating experiments.
I also showed that it  immediately blocked
the donor ’s β-galactosidase synthesis, 
while leaving enzyme production by the
drug-resistant mated cells unaffected.
The mating procedure presented
another problem. We needed to mix and
aerate the bacteria, but we did not want 
to separate mated pairs by excessive
agitation. So, I devised a method where 
I mixed the cells in a thin layer of medium
in a very large flask, with very gentle
swirling. But when J acob joined me to work
on a crucial experiment, his pipet was too
short to reach the sample in my big flasks.
There was a momentary crisis with a burst
of rapid French swearing before we
changed to a smaller flask. The atmosphere
was tense because we knew by then that we
were onto something important, and we
wanted to get it  published quickly.
We were all very excited to discover that
the bacteria  started to produce enzyme
activity within about a  minute after  the
gene’s transfer  by mating, demonstrat ing
that  the transfer  of molecular  information
from gene to protein is very rapid. Init ially,
the enzyme production was constitut ive,
because condit ions within the recipient
bacteria  were sufficient  for  its production.
But the most  remarkable discovery was
the requirement for  a  galactoside inducer
for production of the enzyme to continue.
Basically, these experiments provided the
first  understanding of the mechanisms 
for control of gene expression, and 
showed that  production of an enzyme is
primarily regulated at  the level of gene
expression rather than act ivation of a
preformed enzyme.
Social life at the Pasteur Institute
The atmosphere in  the Inst itute was
congenial. The lunchroom was used for
seminars, and was where we all met  and
had lively discussions. There were usually
a couple of dozen scient ists a t  lunch,
almost  a ll were French. The only other
American at  the laboratory was the
eminent  biochemist  Bernard Horecker,
and we became good fr iends. I was a lso
fr iendly with younger  French scient ists
including Elie Wollman, Francois and
Francoise Gros, Ben Nisman,
The PaJaMa experiment [a] is named after its investigators, myself (Arthur Pardee),
Francois Jacob and Jacques Monod, and because it involves mating. This research is among the
best known in the 20th century, and it contributed to award of the Nobel Prize in Physiology or
Medicine (1965) to Jacob, Monod and André Lwoff, the Director of the Pasteur Institute [b,c]. 
I have summarized my experiences previously [d,e], and for a fascinating historical account see
The Eighth Day of Creation [f]. 
The studies followed on from Francois Jacob and Elie Wollman’s important work on bacterial
conjugation. They had discovered the oriented transfer of the chromosome and knew the exact
time of transfer of the region containing the lac genes from the donor to the recipient cell. The
production of β-galactosidase is induced by galactosides in wild-type E. coli (i +z +). Jacob and
Monod isolated z − mutants that cannot produce the enzyme, and others (i −) that constitutively
produce the enzyme in absence of inducer [b]. The general plan was, by mating, to transfer (z +i +)
genes into (z −i −) bacteria, and to determine whether (i +) or (i −) wins.
We found that the bacteria started to produce β-galactosidase within about a minute after the
gene’s transfer by mating. Initially, the enzyme production was constitutive, but it dropped off
quickly, requiring addition of the inducer to continue. The interpretation developed by us, with
suggestions from Leo Szilard, was that the inducible cells make a repressor molecule that blocks
enzyme synthesis. This repressor has to be neutralized by an added inducer. It is not made by the
constitutive mutant (i −) cells, which therefore do not need inducer (Fig. I). This conclusion is
opposite to Monod’s hypothesis that an inducer is produced by the constitutive cells, which
predicted that mated cells should continue to produce the enzyme constitutively, a concept
consistent with Roger Stanier’s discovery of sequential induction of the series of enzymes that
catalyze a sequence of degradative reactions. Jacob initially had the opposite opinion, that
inducibility would be dominant, because of his and Elie Wollman’s mating studies that
concluded that λ phage lysogeny is blocked by an endogenous inhibitor [b].
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Box 1: The PaJaMa experiment
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Fig. I. Control of β-galactosidase induction and the PaJaMa experiment. (a) In the wild-type bacteria (i + z +), the
Repressor is produced from the i gene. This blocks transcriptional production of β-galactosidase. The Inducer
(galactoside) binds to the Repressor and releases repression, allowing further production. Streptomycin (Sm) is
also inhibitory (grey). (b) The PaJaMa experiment. Genes from the donor (i + z +) are introduced into an i − z −
recipient. Initially β-galactosidase is produced because the recipient cannot make Repressor. Then, production
of Repressor from the donor i gene is switched on and Repressor accumulates, gradually switching off
production of β-galactosidase. The Inducer is then required to restart production of β-galactosidase. Choosing
streptomycin-sensitive donor cells and streptomycin-resistant recipient cells makes the mated bacteria
resistant to streptomycin; thus β-galactosidase is only produced by the mated cells.
Fig. 1.1 PaJaMa experiment
Schematic of experimental syst m utilised by Pardee, Jacob, and Monod (taken from Pardee
(2002)). (a) In wild-type E. coli, Repressor transcribed fr i gene in ibits the transcripti
of β -galactosidase from z gene. Repressor production is inhibited by Inducer (galactosidase)
and z starts to synthesise β -galactosidase. (b) In the PaJaMa experiment, genes from wild-
type (i+ z+) were transferred to mutant bacteria (i- z-). Since there is no Repressor present
in the recipient ba teria, β -galactosidase was initially synthesised. However, as Repressor
accumulates in the cell, β -galactosidase gradually diminished.
A large non-coding RNA class that does not synthesise mRNA but contributes to regul te
the abundance of RNA by controlling the synthesis or degradation of RNA is called regulatory
RNA. It is interesting to note that Jacob and Monod had initially speculated that the primary
product of Repressor of β -galactosidase “may be a polyribonucleotide”, although this turned
out to be incorrect, as the functional Repressor synthesised is a polypeptide. One of the first
discoveries of RNA-mediated gene expression control dates back to 1983. In E. coli, Simons
and Kleckner discovered that RNA transcribed from the antisense strand of IS10, a Tn10
transposon, inhibits the translation of the transposase encoded in IS10 (Simons and Kleckner,
1983).
The first regulatory RNA discovered in eukaryotes was Xist RNA in the mammalian
cell. Mammalian female cells possess two X chromosomes, and one of them is randomly
inactivated in a process called X chromosome inactivation. The Xist gene was identified as a
key factor that regulates this phenomenon, but, surprisingly, it has no open reading frame
(ORF), suggesting that the Xist gene does not code for a protein, and that the RNA transcript
itself has regulatory functions (Brockdorff et al., 1992).
In the following year, 1993, Ambros and Ruvkun groups discovered that the lin-4 gene C.
elegans encodes a small RNA that binds to the 3′ untranslated region (UTR) of lin-14 mRNA
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Fig. 1.2 Models of protein synthesis proposed by 1961
Diagrams represent three different protein synthesis models in bacteria in response to phage
infection proposed by 1961 (taken from Brenner et al. (1961)). Three models were proposed
to explain the fact that after phage infection bacterial cells stop synthesising bacterial proteins,
and, instead, phage proteins are synthesised. (I) A specialised ribosome is formed for each
gene, and, upon phage infection, phage gene-specific ribosomes are synthesised and bacterial
ribosome is somehow inhibited. (II) Some phage-derived RNA binds to the specialised host
ribosomes and stalls host protein synthesis. Phage proteins are synthesised on phage DNA.
(III) Only non-specialised ribosomes exist in the cell and “messenger RNA” is synthesised
from DNA and used as a template for protein synthesis as ribosome. A phage infection
inhibits the synthesis of host mRNA, and phage mRNA instead “hijacks” host ribosomes to
synthesise phage proteins.
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and inhibits the translation of it (Lee et al., 1993; Wightman et al., 1993). This is the first
discovery of regulatory small RNA that is later named as microRNA (miRNA).
Since then, numerous research projects have been conducted to explore the biological
functions of two major classes of regulatory RNA: long non-coding RNA (lncRNA) and
small RNA. Although there is no concrete definition for each term, the former generally
refers to RNA longer than 200 nucleotides (nt) and the latter indicates ones that are shorter
than this. Some major non-coding RNAs in mammals are summarised in Table 1.1 (Cech
and Steitz, 2014; Kim et al., 2009).
Table 1.1 Major mammalian non-coding RNA species
Functional category Name Length (nt)
Translation
rRNA (ribosomal RNA) 20-5,000
tRNA (transfer RNA) 70-90
RNA processing
snRNA (small nuclear RNA) 100-300
snoRNA (small nucleolar RNA) 70
Gene regulation
siRNA (small interfering RNA) 18-22
miRNA (microRNA) 21-24
piRNA (PIWI-interacting RNA) 23-29
Xist 17,000
Tsix 40,000
Hotair 2,000
1.2.1 Small RNA
Small RNA-induced gene regulation is now known as RNA interference (RNAi), and the
detailed mechanisms have first been described by Fire et al. (1998). Decades of studies have
now revealed complex biogenesis pathways of various small RNAs (Fig. 1.3). In addition to
endogenous small RNA such as miRNA, RNAi can also be induced by introducing exogenous
double-stranded RNA (dsRNA). This dsRNA can be further processed in the host cells and
generate small interfering RNA (siRNA) that induces RNAi on target mRNAs.
Since the development of high-throughput RNA sequencing methods, an increasing
number of small RNA species have been discovered. Here, I summarise the details of three
major classes of small RNA species: miRNA and piRNA as most well-studied examples, and
tRNA-derived fragments as one of the novel small RNAs.
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complex (piRISC) that can recognize and silence com-
plementary RNA targets. Indeed, genetic evidence has 
shown that, in addition to piRNAs, PIWI proteins are 
necessary for TE silencing and have crucial roles in 
gonadal development.
Silencing of transposable elements. In D. melanogaster, 
mutations in each of the three members of the PIWI 
family — PIWI, Aubergine (AUB) and AGO3 — lead 
to transposon derepression in the germ line, indicating 
that they act non-redundantly during TE silencing16–19. 
Figure 1 | Biogenesis of small RNAs in mammals. a | Small interfering RNA (siRNA) biogenesis. Transcripts that are  
able to form double-stranded RNA (dsRNA) or long stem–loop structures serve as endogenous siRNA (endo-siRNA) 
precursors. Pseudogenes transcribed in an antisense orientation produce RNA that pairs with cognate gene mRNAs  
as well as with transcripts that are derived from intergenic repetitive sequences on the genome, including transposons. 
The processing of endo-siRNA requires Dicer, whereas the role of Dicer-binding proteins — such as TAR RNA-binding 
protein (TRBP; also known as TARBP2) and PACT (also known as PRKRA) — remains undetermined. After maturation, 
endo-siRNAs (which are ~21 nucleotides (nt) in length) are loaded onto Argonaute 2 (AGO2). Whether endo-siRNAs are 
loaded onto other AGO members, such as AGO1, AGO3 and AGO4, remains to be determined. Exogenous siRNAs 
(exo-siRNAs) are derived from exogenous dsRNAs by Dicer–TRBP (or Dicer–PACT). exo-siRNAs are loaded onto AGO1, 
AGO2, AGO3 and AGO4; however, only the AGO2–siRNA complex functions in RNA interference, as other AGO 
members lack Slicer activity. b | MicroRNA (miRNA) biogenesis. The primary transcripts of miRNAs (pri-miRNAs) are 
transcribed by RNA polymerase II from miRNA genes on the genome. pri-miRNAs form hairpin structures and are 
processed to ~60–70 nt miRNA precursors (pre-miRNAs) by the microprocessor Drosha–DGCR8 (DiGeorge syndrome 
critical region 8) complex in the nucleus. After being exported by exportin 5 and RanGTP, pre-miRNAs are further 
processed to ~22 nt miRNA–miRNA* duplexes (in which miRNA* is the passenger strand that is degraded) by the 
Dicer–TRBP (or Dicer–PACT) complex. Mature miRNAs are then loaded onto AGO1, AGO2, AGO3 and AGO4.  
c | PIWI-interacting RNA (piRNA) biogenesis. piRNAs (which are 24–32 nt in length) are processed from single-stranded 
RNA precursors that are transcribed largely from particular intergenic repetitive elements known as piRNA clusters. 
Unlike miRNAs and siRNAs, piRNAs do not require Dicer for their processing. The requirement for Drosha has not been 
formally tested. First, primary piRNAs are produced through the primary processing pathway and are amplified through 
the ping-pong pathway, which requires Slicer activity of PIWI proteins. Primary piRNA processing and loading onto 
mouse PIWI proteins might occur in the cytoplasm. MIWI2 (also known as PIWI-like protein 4) specifically associates with 
secondary piRNAs that are processed through the amplification loop, and is localized in the nucleus to exert its silencing 
function. (A)
n
 indicates the poly(A) tail formed during translation, and m7G indicates the 5′-terminal cap of the mRNA.
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Fig. 1.3 Biogenesis pathways of small RNA species in mice
Schematic representation of the biogenesis pathways of known small RNA species (taken
from Siomi et al. (2011)). (a) dsRNA precursors for siRNA can b produced ithe from endo-
siRNA-encoding loci in the geno e or exogenously introduced dsRNA. The dsRNA is then
diced by Dicer and generates mature siRNA. The siRNA is then bound by an AGO protein to
target mRNAs. (b) Pri-miRNA transcribed is bound by Drosha and DGC 8, and proc ssed
into pre-miRNA. Pre-miRNA is then xported to the cytoplasm by Exportin-5. Similar to
siRNA, pre-miRNA is further cleaved by Dicer to generate mature miRNA and loaded onto
an AGO. (c) piRNA precursors are generated as single-stranded RNA and exported to the
cytoplasm. The precu sors undergo primary processing, followed by second ry processing
called “ping-pong cycle” to amplify the piRNAs. The processed piRNAs are imported back
to the nucleus and suppress targets with MIWI2. Other organisms such as C. elegans possess
completely different biogenesis pathways.
1.2 Regulatory RNA 7
microRNA
microRNA (miRNA) is a class of regulatory RNA that is 18-22 nt long and widely con-
served from plants to humans. From miRNA genes, long primary miRNA (pri-miRNA) are
transcribed by RNA polymerase II (Pol II). Since a miRNA gene normally contains a pair
of complementary sequences, pri-miRNA forms a hairpin structure, which is subsequently
cleaved off by an enzyme, Drosha. This cleaved-off hairpin, which is 60-70 nt long, is
now called precursor miRNA (pre-miRNA). Pre-miRNA is then transferred to the cytoplasm
by a protein Exportin and further cleaved by Dicer to generate mature miRNA. One of the
strands is loaded on an Argonaute (Ago) complex, which is the effector complex that binds
to mRNAs to inhibit their translation or to degrade them.
The targeting mechanism of miRNA has also been investigated extensively. One of the
canonical miRNA targeting systems is that a 7-8 nt long sequence at the miRNA’s 5′ end (2nd
to 7th nucleotides from its 5′ end) called “seed” base-pairs with the 3′ end of mRNA that
contains one or more complementary sequences to the seed sequence (Lewis et al., 2005).
Although some experiments that identify direct interactions between mRNA and miRNA
revealed that there are non-canonical binding independent of seed matchings, follow-up
analyses found that miRNA-mediated gene silencing is only induced with canonical pairs.
This indicates that seed sequence-mediated targeting is the core targeting mechanism of
miRNAs.
Based on the targeting mechanisms of miRNAs through their seed sequence, a number of
bioinformatic software have been developed to computationally predict which mRNAs are
targeted by a given miRNA (Agarwal et al., 2015; van Dongen et al., 2008). Although multiple
aspects, such as the conservation level of the seed region, are taken into consideration in these
software, they still yield false-positives and false-negatives when validated experimentally,
suggesting that the prediction models still have room for improvements.
piRNA
While miRNAs are expressed ubiquitously, some small RNA species are expressed only in
specific cell types. PIWI-interacting RNA (piRNA) is the most well-known such small RNA,
and it is believed to be expressed mainly in germ cells. piwi (P-element induced wimpy testis)
gene was discovered in Drosophila through a screen using a transposon called P-element. This
assay revealed that piwi mutation induces male and female sterility (Lin and Spradling, 1997).
The subsequent analyses discovered that piwi homologues in various animals are essential for
viable germ cells, and that piwi proteins are homologues of Argonaute proteins (Batista et al.,
2008; Kuramochi-Miyagawa et al., 2004). An immunoprecipitation (IP) assay of mouse
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PIWI protein called MIWI revealed that small RNAs that are 26-31 nt in length, which are
distinct from previously known small RNAs, are bound by MIWI. Genome-wide sequence
analysis, as well as PIWI knock down experiments, revealed that its primary function is to
silence transposons to maintain genome integrity (Aravin et al., 2007). However, there are
also some piRNAs that regulate host transcripts, suggesting that the functions of piRNA are
not limited to transposon silencing.
Different species have completely different piRNA biogenesis pathways. While mammals
and Drosophila amplify piRNAs using a mechanism called the “ping-pong cycle”, in which
precursor RNA is cleaved using mature piRNAs as a template (Brennecke et al., 2007;
De Fazio et al., 2011), C. elegans use RNA-dependent RNA polymerase (RdRP) to achieve
piRNA amplification (Das et al., 2008; Lee et al., 2012).
Although piRNAs target mRNAs that contain homologous sequences to them, it is known
that the target sequence with a few mismatches can still be targeted by piRNAs (Bagijn et al.,
2012). This targeting mechanism makes in silico piRNA target prediction challenging and
thus requires experimental validations.
tRNA-derived fragment (tRF)
In small RNA-seq data analysis, reads mapping to tRNA or rRNA had been thought to be
random fragments from mature tRNA or rRNA and have no gene regulatory roles. However,
when a group looked into small RNA-seq reads in human prostate cancer cell lines carefully
while maintaining tRNA-mapping reads, they found out that the number of reads mapping
to tRNA-coding regions is the second largest after miRNA (Lee et al., 2009). Surprisingly,
unlike what normally happens with degraded RNA, the small RNA reads are derived from
specific loci of tRNA coding regions, either from 5′ or 3′ end, which suggests the presence
of an active molecular machinery that breaks tRNA into tRNA-derived small RNA, or tRNA-
derived fragment (tRF). Inhibition of tRF by antisense oligos resulted in transcriptional
alteration of multiple genes and affected cell viability, suggesting their regulatory potential.
Since then, tRF has been discovered in various cell types, and a growing number of
studies have been conducted to explore the link between tRF and gene expression. It started
to attract more attention in 2016 when two papers were published in Science, both of which
reported that tRFs derived from epididymis are transferred to sperm and affect the phenotype
of offspring intergenerationally (Chen et al., 2016; Sharma et al., 2016). They reported
that dietary alteration affects the repertoire of tRFs in sperm, which is transferred from the
epididymal epithelium. This, in turn, alters the transcriptional dynamics in embryos, leading
to phenotypic differences in offspring. However, the mobility of tRF was only suggested
by showing the correlation between tRFs expressed in different parts of epididymis and in
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sperm collected from the corresponding parts of the epididymis. Deeper investigations are
needed to clearly prove their intercellular mobility. tRFs as well as these tRF-related reports
are further discussed in Chapter 4.
1.2.2 Long non-coding RNA
High-throughput RNA analyses also identified numerous lncRNA genes across the genome in
different organisms. lncRNAs can arise from intergenic regions, or intronic or exonic regions
of another gene. Some are conserved across organisms and others are species-specific. Some
are polyadenylated and others are not. Unlike small RNA species, there is no known common
features among lncRNAs. Although the first regulatory RNA, Xist RNA, showed a very clear
molecular phenotype involved in X inactivation, studies on functions of lncRNAs have not
always yielded clear insights into their biological roles. Recent large-scale knock-out (KO)
experiments on zebrafish and C. elegans showed that many lncRNA KO animals are viable
and show no clear phenotypes (Akay et al., 2019; Goudarzi et al., 2019). Below, some of the
well documented regulatory lncRNAs are summarised.
Xist RNA
One of the most studied and characterised lncRNA is Xist, which is encoded on the X
chromosome of eutherian mammals. In female cells, where two X chromosomes are present,
it is known that one of the X chromosomes is silenced for dosage compensation. Studies
have identified that Xist RNA synthesised from the Xist gene on the X chromosome spreads
across one of the X chromosomes through 3D chromatin architecture (Engreitz et al., 2013)
and silences it by recruiting repressive chromatin modifiers such as the Polycomb complex
through a repeat region called RepA (Chu et al., 2015; Zhao et al., 2008).
HOTAIR RNA
The Hox clusters are important for development, and a non-coding gene named Hotair (Hox
transcript antisense RNA) was discovered in the HoxC cluster in mice. A paper reported
that a deletion of Hotair induced transcriptional changes in trans and mouse Hotair KO
mice showed skeletal malformations (Rinn et al., 2007). Hotair RNA was later shown to be
associated with the Polycomb repressive complex 2 (PRC2) and to recruit it to the genomic
target regions (Li et al., 2013).
These results, however, have been controversial. Reanalysis of the same mouse Hotair
KO showed little phenotypic changes in another group (Amândio et al., 2016). Also, the
Hotair-binding regions in the genome identified by Li et al. do not significantly overlap
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with the previously reported PRC2-binding regions. This controversy is further discussed
elsewhere (Selleri et al., 2016), but no clear conclusion has been reached yet.
1.3 RNA biogenesis
1.3.1 Biosynthesis
RNA consists of a ribose sugar chain and bases. There are four bases in RNA: adenine (A),
uracil (U), cytosine (C), and guanine (G). The purines (A and G) and the pyrimidines (U and
C) have different biosynthetic pathways, but both require the same molecule, phosphoribosyl
pyrophosphate (PRPP), which is a derivative from ribose-5-phosphate produced from the
pentose phosphate pathway.
For purine synthesis, PRPP is converted to inosine monophosphate (IMP). Adenine
monophosphate is synthesised directly from IMP, while guanine monophosphate (GMP) is
synthesised through an intermediate, xanthosine monophosphate (XMP) (Fig. 1.4). CHAPTER 33 Metabolism of Purine & Pyrimidine Nucleotides 295
reaction is cytosolic carbamoyl phosphate synthase II, a dif-
ferent enzyme from the mitochondrial carbamoyl phosphate 
synthase I of urea synthesis (Figure 28–12). Compartmenta-
tion thus provides two independent pools of carbamoyl phos-
phate. PRPP, an early participant in purine nucleotide synthe-
sis (Figure 33–2), is a much later participant in pyrimidine 
biosynthesis.
Multifunctional Proteins Catalyze the 
Early Reactions of Pyrimidine Biosynthesis
Five of the first six enzyme activities of pyrimidine biosynthesis 
reside on multifunctional polypeptides. One such polypeptide 
catalyzes the first three reactions of Figure 33–9 and ensures 
efficient channeling of carbamoyl phosphate to pyrimidine 
biosynthesis. A second bifunctional enzyme catalyzes reac-
tions 4 and 5 of Figure 33–9.
THE DEOXYRIBONUCLEOSIDES OF 
URACIL & CYTOSINE ARE SALVAGED
While mammalian cells reutilize few free pyrimidines, “salvage 
reactions” convert the pyrimidine ribonucleosides uridine and 
cytidine and the pyrimidine deoxyribonucleosides thymidine 
and deoxycytidine to their respective nucleotides. ATP-depen-
dent phosphoryltransferases (kinases) catalyze the phosphory-
lation of the diphosphates of 2`-deoxycytidine, 2`-deoxyguanos-
ine, and 2`-deoxyadenosine to their corresponding nucleoside 
triphosphates. In addition, orotate phosphoribosyltransferase 
there is a deficiency of the other nucleotide. AMP and GMP 
also inhibit hypoxanthine-guanine phosphoribosyltransferase, 
which converts hypoxanthine and guanine to IMP and GMP 
(Figure 33–4), and GMP feedback inhibits PRPP glutamyl 
amidotransferase (reaction 2, Figure 33–2).
REDUCTION OF RIBONUCLEOSIDE 
DIPHOSPHATES FORMS 
DEOXYRIBONUCLEOSIDE 
DIPHOSPHATES
Reduction of the 2`-hydroxyl of purine and pyrimidine ribonucle-
otides, catalyzed by the ribonucleotide reductase complex (Fig-
ure 33–7), forms deoxyribonucleoside diphosphates (dNDPs). 
The enzyme complex is functional only when cells are actively 
synthesizing DNA. Reduction requires thioredoxin, thioredoxin 
reductase, and NADPH. The immediate reductant, reduced thi-
oredoxin, is produced by NADPH:thioredoxin reductase (Figure 
33–7). Reduction of ribonucleoside diphosphates (NDPs) to de-
oxyribonucleoside diphosphates (dNDPs) is subject to complex 
regulatory controls that achieve balanced production of deoxyri-
bonucleotides for synthesis of DNA (Figure 33–8).
BIOSYNTHESIS OF PYRIMIDINE 
NUCLEOTIDES
Figure 33–9 illustrates the intermediates and enzymes of py-
rimidine nucleotide biosynthesis. The catalyst for the initial 
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On the other hand, pyrimidine nucleotides synthesis begins with the synthesis of uridine
monophosphate (UMP) from orotate and PRPP (Fig. 1.5). UMP is then phosphorylated to
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generate uridine diphosphate (UDP) and uridine triphosphate (UTP). UTP is then converted
to cytosine triphosphate (CTP).
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rise in intracellular PRPP results in purine overproduction. 
Mutations that decrease or abolish hypoxanthine-guanine 
phosphoribosyltransferase activity include deletions, frame-
shift mutations, base substitutions, and aberrant mRNA 
splicing.
von Gierke Disease
Purine overproduction and hyperuricemia in von Gierke dis-
ease (glucose-6-phosphatase deficiency) occurs secondary 
to enhanced generation of the PRPP precursor ribose 5-phos-
phate. An associated lactic acidosis elevates the renal thresh-
old for urate, elevating total body urates.
Hyperuricemias may be differentiated based on whether pa-
tients excrete normal or excessive quantities of total urates. 
Some hyperuricemias reflect specific enzyme defects. Others 
are secondary to diseases such as cancer or psoriasis that en-
hance tissue turnover.
Lesch–Nyhan Syndrome
Lesch–Nyhan syndrome, an overproduction hyperurice-
mia characterized by frequent episodes of uric acid lithiasis 
and a bizarre syndrome of self-mutilation, reflects a defect 
in hypoxanthine-guanine phosphoribosyl transferase, an 
enzyme of purine salvage (Figure 33–4). The accompanying 
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In addition to these de novo synthesis of nucleoside triphosphates (NTPs), cells also
are able t salvage intermediate molecules from degraded RNAs. Purine bases are sal-
vaged by phosphoribosyltransferases, which add PRPP to nucleobases to create nucleoside
monophosphates (NMPs). Adenine phosphoribosyltransferase (APRT) and hypoxanthine-
guanine phosphoribosyltransferase (HGPRT) are involved in adenine and guanine salvage,
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respectively. Although uracil phosphoribosyltransferase (UPRT) in bacteria is known to
salvage uracil to UMP (Pfefferkorn, 1978), mammalian UPRT does not bind to uracil, and
no enzymatic activity was detected (Cleary et al., 2005; Li et al., 2007). Instead, uridine
and cytidine are salvaged to UMP and cytidine monophosphate (CMP), respectively, by
uridine-cytidine kinases.
1.3.2 Transcription
The eukaryotic mRNA transcription consists of multiple steps (Fig. 1.6). When expression
of a gene is required, a pioneering transcription factor (TF) binds to a region proximal to
the core promoters to open up the chromatin. General transcription factors (GTFs) and
RNA polymerase II (Pol II) are recruited to the core promoters, which include several DNA
sequence motifs, to initiate transcription. Pol II joins NTPs in an order defined by the
template DNA sequence through the complementary base-pairing: A is paired to T, G to
C, and C to G. The only exception is U, which is paired to A instead of T. The transcribed
RNA undergoes the maturation processes, such as a cap addition and polyadenylation, and is
transferred to the cytoplasm for translation.
Pol II
BRE Inr DPE
–31 –26 –2 +4 +18 +32+28
GTFs
–37
Core promoter
TATA MTE
Co-regulator
Proximal sitesEnhancer region
Rate-limiting steps in transcription
The transcription cycle consists of at least eight distinct major steps at 
which transcription could be rate limiting and activators could poten-
tially act to increase the rate of transcription (Fig. 2). The transcrip-
tion cycle begins with Pol II gaining access to the promoter, which in 
some cases requires the promoter being cleared of nucleosomes that 
obscure access to Pol II and the GTFs (step 1). A PIC assembles on the 
core promoter (step 2). The DNA is then unwound, and Pol II initi-
ates transcription (step 3). Early-elongating Pol II gets a stable grip on 
both the DNA and the growing RNA chain, escapes/clears the core 
promoter and proceeds to the promoter-proximal pause region (step 4). 
The paused Pol II complex is then hyperphosphorylated and escapes 
from the pause region in an unknown manner, either terminating or 
entering productive elongation (step 5). If it has not terminated, Pol II 
must then productively elongate through the entire body of the gene 
(step 6). After this, Pol II undergoes termination (step 7), and it can 
reinitiate to start a new round of transcription (step 8).
Any of these major steps could, in principle, be rate limiting, and the 
distribution of Pol II across a gene can suggest which steps are rate limiting 
for that gene. The Pol II density across many genes has been determined in 
a plethora of individual gene studies4; moreover, a wealth of data has been 
obtained in recent genome-wide chromatin immunoprecipitation (ChIP) 
studies examining Pol II distribution ross the genom s of s veral org n-
isms: Saccharomyces cerevisiae5, Drosophila melanogaster6,7 and Homo 
sapiens8. In each organism, these studies have identified different classes 
of gene on the basis of th ir Pol II distr bution: no Pol II, Pol II evenly 
distributed and Pol II enrichment at the 5ʹ end. Genes without Pol II are 
in an ‘off ’ state, and are limited by the step at which the promoter is cleared 
of nucleosomes (step 1) or the step at which a PIC assembles (step 2). An 
even distribution of Pol II suggests that Pol II recruitment (step 2) is the 
rate-limiting step: none of the downstream steps leads to an accumula-
tion of Pol II in other regions of the gene9. An enrichment in Pol II at the 
5ʹ end suggests that steps down t eam of Pol II recruitme t (steps 3–5) 
are rate limiting. Because ChIP localization with a single Pol-II-specific 
antibody cannot distinguish between steps 3, 4 and 5, more experiments 
pinpointing the exact rate-limiting step need t  be performed. The tran-
sition between PIC formation (step 2) and promoter escape (step 4) is 
marked by the unwinding of DNA, formation of a transcription bubble 
with a stable RNA–DNA duplex and lengtheni g of t e nascent transcripts 
associated with Pol II. Transcription-bubble formation and RNA length 
can be distinguished by permanganate mapping of unpaired thymidines 
in the transcription bubble10 and run-on assays11,12, respectively. In addi-
tion, the transition between initiation and pausing (step 4) is marked by 
phosphorylation of the Pol II carboxy-terminal domain (CTD) repeats on 
Ser 5 by the kinase subunit of the GTF TFIIH (CDK7 in Drosophila), and 
productive elongation (step 6) is generally marked by phosphorylation of 
Pol II CTD repeats on Ser 2 by the kinase complex positive transcription 
elongation factor b (P-TEFb; CDK9−cyclin T in Drosophila). Therefore, 
using specific antibodies to examine these phosphorylation marks on 
genes with 5ʹ-end Pol II peaks can help distinguish the rate-limiting step 
for those genes13.
Regulating Pol II recruitment
Many genes regulated by the recruitment of Pol II have promoters cov-
ered with nucleosomes. Activators at these genes recruit nucleosome 
remodellers and nucleosome-modifying enzymes to allow GTFs and 
Pol II access to the promoter (Fig. 2, step 1) (see page 193 for details on 
nucleosome remodellers). PHO5 in S. cerevisiae is one of the best studied 
of the genes that are regulated in this manner (Box 1). In other examples, 
it has been shown that both human and yeast activators interact with the 
SWI/SNF remodelling complexes (Swi/Snf complex in yeast) and posi-
tively stimulate transcription from nucleosome-containing templates14. 
In addition, recruitment of histone-modifying enzymes (for example 
recruitment of the histone acetyltransferase Gcn5 to galactose-inducible 
genes by the yeast activator Gal4 (ref. 15)) provides another means by 
which activators influence and modulate the outcome of transcription 
by modifying promoter chromatin state.
In other genes, the promoter is free from nucleosomes, but Pol II 
recruitment is still rate limiting (step 2). During activated transcrip-
tion, recruited Pol II quickly progresses into productive elongation and 
becomes relatively uniformly distributed across the gene16. At these genes, 
PIC assembly must be upregulated by activators. Extensive in vitro studies 
have shown activators can interact with many GTFs: TATA-binding pro-
tein (TBP), TFIID, TFIIA and TFIIB17. Activators also recruit the coactiva-
tor Mediator, which can interact with GTFs and increase expression18,19. 
These interactions might increase the binding of GTFs to the promoter or 
stabilize the PIC, allowing more efficient recruitment of Pol II. Addition-
ally, activator-dependent recruitment of chromatin-modifying enzymes 
results in distinctive chromati  marks on promoters. Domains associated 
with GTFs can bind to these marks20,21, and these interactions can further 
aid in stabilizing PIC formation.
Regulating post-recruitment steps
In vivo Pol II distributions have also indicated that post-recruitment steps 
can be rate limiting. Enrichment in Pol II at the 5ʹ ends of genes suggests 
that steps between recruitment and productive elongation (steps 3–5) are 
Figure 1 | Transcription regulatory interactions. General transcription factors 
(GTFs) bind to specific sequence elements in the promoter. These elements 
(the B recognition element (BRE), the TATA box (TATA), the initiator (Inr), 
the motif ten element (MTE) and the downstream promoter element (DPE)) 
and their approximate locations relative to the transcription start site (TSS, 
black arrow) are shown2. Transcriptional regulators (orange oval and yellow 
diamond), which are either activators or repressors, bind to specific DNA 
sequences located near the core promoter of the gene or various distant 
regions, called enhancers. The regulators can interact (green arrows) with 
GTFs, such as TFIID (blue rectangle) and TATA-binding protein (TBP, 
blue horseshoe), and the Pol II complex (red ‘rocket’) to enhance or repress 
transcription. They also interact (green arrows) with co-regulators (green 
hexagon) that can interact (blue arrows) with the general transcription 
machinery or chromatin-modifying factors, such as histone modifiers or 
nucleosome remodellers. The co-regulators can also bind to nucleosomes 
(green) with various histone modifications, stabilizing the co-regulator 
binding to the gene. Activators can recruit, stabilize or stimulate these factors, 
and repressors can disrupt or inhibit these factors.
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Fig. 1.6 Sturcture and interactions of eukaryotic promoter
Pioneering TFs (orange and yellow) bind to either the loci near the promoter or the enhancer
region to make the chromatin accessible. Pol II and GTFs are rec uited to the accessibl core
promoter. Several consensus motifs are known to be present in the core promoter, such as
the B recognition element (BRE), the TATA box (TATA), the initiator (Inr), the motif ten
lement (MTE), and the downstream promoter element (DPE). Not all of these motifs may
be present within a promoter. The locations of the motifs relative to the transcription start
site (black arrow) are also shown. Known interactions are shown in green and blue arrows.
Figure taken from Fuda et al. (2009).
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1.4 Metabolic RNA labelling methods
To study the dynamics of RNA transcription, various nucleotide analogues or NTP analogues
have been employed to date. These analogues contribute to the cellular NTP pool and then
used to synthesise RNA, making the newly-synthesised RNA distinct from pre-existing
RNAs. Since U only exists in RNA but not in DNA, uridine or UTP analogues have often
been used to study RNA dynamics. Here, I review different analogues used so far and their
advantages and limitations.
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1.4.1 Radioautography
At the beginning of RNA labelling research, radioisotope-containing nucleotides, such as
[3H]-uridine (Uddin et al., 1984), were used. After exposing animals or cells to an analogue
for a limited time, the tissues or cells are examined by radioautography. One can visually
assay the abundance of newly synthesised RNA by quantifying the number of radioactive
granules detected, and which cells or subcellular compartments contain newly transcribed
RNAs. The major advantage of this method is that the radiolabelled nucleotide should
have little effects on the functions of RNA molecules, as there is no structural differences
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from the native nucleotides. However, most research institutes nowadays have very strict
regulations on radioactive agents, and thus conducting an experiment using radioactive
nucleotides is not straightforward. Also, since there is currently no established method to
isolate the radiolabelled RNA, the sequence of labelled RNA cannot be examined unless a
new sequencer that utilises single-molecule detectors will be improved to detect radiolabelled
nucleotides.
1.4.2 Antibody detection
5-Bromouridine (BrU) has become a more common labelling agent because of its easier
and more convenient usage. BrU can be detected by a specific antibody against it (Wansink
et al., 1993). Thus, RNA containing BrU can be visualised by immunostaining, and its
cellular/subcellular location can be studied. The abundance of newly transcribed RNA can
also be quantified based on the fluorescence intensity. The availability of anti-BrU antibody
enables specific pull-down of RNA containing BrU, and by combining with it either a low-
or high-throughput RNA quantification method, one can quantify the abundance of each
labelled RNA transcripts (Kageyama et al., 2004).
1.4.3 Click chemistry
As an alternative to the antibody-based detection of labelled nucleoside, 5-ethynyluridine
(EU) has been employed. EU can be visualised with fluorescent azides through a Sharp-
less–Meldal copper (I)-catalysed Huisgen cycloaddition reaction, which is also referred to as
“click” chemistry (Jao and Salic, 2008; Rostovtsev et al., 2002; Tornøe et al., 2002). Since
this reaction does not require cell permeabilisation, EU can also be used for whole-mount
staining (Jao and Salic, 2008), which cannot be achieved with BrU. Also, through click
chemistry with biotin, EU-labelled RNA can be pulled down with streptavidin beads, which
allows direct detection and quantification of the labelled transcripts just like the antibody
pull-down with BrU. A major limitation with EU is that the attachment of molecules with
click chemistry is irreversible. Hence, the isolated RNA is not suitable for cDNA synthesis,
and EU is not a suitable agent to be combined with next generation sequencing approaches.
1.4.4 Reversible disulfide chemistry
Recently, 4-thiouridine has been widely used to study the dynamics of RNA. Similar to EU,
4-thiouridine-containing RNA can be pulled-down with thiol-group specific biotinylation,
followed by streptavidin isolation of the biotinylated RNA (Cleary et al., 2005; Dölken et al.,
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2008). The major benefit of 4-thiouridine over EU is that the attached biotin can be removed
in the elution step by breaking the disulfide bond with a reducing agent, and thus the eluted
RNA can be used for high-throughput RNA sequencing (Kenzelmann et al., 2007). Different
methods that employ 4-thiouridine for metabolic labelling are further discussed in Chapter 3.
1.5 High-throughput RNA sequencing (RNA-seq)
In studying RNA biology, it is essential to quantify the amount of each RNA species in a
given sample accurately. Owing to the development of high-throughput DNA sequencing
(HTS) methods, accurate and simultaneous quantification of multiple RNA species has
become possible. Here, one of the most employed strategy for high-throughput sequencing,
the Illumina method, is summarised, and the benefits and limitations in RNA quantification
are discussed.
1.5.1 Illumina DNA sequencing
With the traditional DNA sequencing methods, the major limitation to its throughput is
that the reaction is carried out in each well of 96-well plates. To overcome this limitation,
massively-parallel DNA sequencing methods have been invented. Here, one of the most
frequently used methods, the Illumina method, is summarised (Bentley et al., 2008) (Fig. 1.8).
DNA fragments are first attached with short oligonucleotides called adapters and captured
on a flat reaction chamber that have a number of oligonucleotides that are complementary
to the adapter sequences on its surface. Then, libraries are amplified to form clusters that
are originated from the individual DNA molecule through bridge-PCR. The DNA templates
are sequenced by base-by-base incorporation of reversible terminators, 3′-O-azidomethyl
2′-deoxynucleoside triphosphates with the four bases (A, T, G, and C), which are labelled
with a different fluorophore. The sequencing can be performed from only one end (single-end
sequencing) or from both ends (paired-end sequencing).
1.5.2 Sequencing error
Although HTS is a powerful method in determining a sequence of nucleotides, it still has
inherent sequencing errors, as with other sequencing methods. Several potential sources
of errors have been suggested: misincorporation of nucleotides during PCR, preferential
incorporation of certain ddNTP (Schirmer et al., 2016), and insufficient removal of termina-
tors (Pfeiffer et al., 2018). As a result, Illumina Hiseq systems are shown to have an order of
0.1% of the misreading of bases.
16 Introduction
Fig. 1.8 Schematic of Illumina DNA sequencing
(a) Adapters (shown in blue and light blue) are ligated to fragmented DNA. (b) Denatured
DNA molecules are annealed to oligonucleotides on the flowcell surface that are complemen-
tary to the adapters. A new sequence (shown as dotted line) is synthesised from the original
sequence by extension. The synthesised strand is then annealed to another oligonucleotide
that is complementary to the other adapter on the other side by forming a bridge, and a new
strand is synthesised (dotted line). This series of amplification (bridge PCR) is repeated until
each cluster reaches 10 µm in diameter. (c) For sequencing, the amplified libraries are cleaved
at one adapter (asterisk) and linealised. Sequencing run is conducted by a sequencing primer
complementary to the adapter. For paired-end sequencing, the second strand is resynthesised
by bridge PCR, and the sequence is determined by a primer complementary to the other
adapter. Figure taken from Bentley et al. (2008).
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There are also methods to alleviate this error rate. Base-calling software assigns each
base a quality score called phred score to estimate the accuracy of base calling (Ewing and
Green, 1998; Ewing et al., 1998). Since the bases with a low phred score are more likely
called wrong, these bases can be removed for improved base-calling. Also, it is suggested to
add a short stretch of nucleotides to either 5′ or 3′ end of the target DNA (Fu et al., 2011;
Hug and Schuler, 2003). Since all the fragments originating from the same DNA molecule
will have the same "tag", PCR error can be mitigated by finding a consensus sequence among
the reads with the same tag. Moreover, paired-end sequencing can also be used to increase
the accuracy of base-calling. Since the same molecule is sequenced twice, the probability of
calling a base wrong would decrease significantly.
1.5.3 RNA-seq
Since RNA can be reverse transcribed into cDNA, HTS can also be used to determine
the sequence of RNA molecules (Wilhelm and Koopman, 2006). Furthermore, based on
the number of detected sequences for a given RNA species, relative quantification of each
transcript can be achieved.
One of the most frequent applications of RNA-seq is discovery of transcriptomic change
between two samples. Since the read count for each gene is only a relative measure of
transcript abundance in each sample, the normalisation method is the key to accurately
identify differentially expressed genes. A number of bioinformatic methods to normalise
read count have been invented and widely applied (Anders and Huber, 2010; Bray et al.,
2016; Trapnell et al., 2010). Also, instead of solely relying on an in silico approach, addition
of a small amount of RNA with distinct sequence from sample RNA prior to RNA-seq library
prep was also proposed (spike-in) (Zook et al., 2012). Since the ratio of spike-in RNA to
sample RNA is known for each sample, the number of reads for each gene can be adjusted to
the number of reads obtained from spike-in RNA. Another normalisation strategy is to add a
short stretch of DNA (UMI: unique molecular identifier) to cDNA before PCR amplification.
With this modification, the number of RNA molecules can be quantified by counting the
number of unique UMIs for each gene.
1.5.4 Single-cell RNA-seq (scRNA-seq)
Normally, RNA-seq was often performed using RNA extracted from a number of cultured
cells or a part of a tissue from an animal. Thus, the gene expression quantified from this
method is an average among the cells from which the RNA is extracted. To obtain the
transcriptional landscape of distinct individual cells, a more sensitive RNA-seq method that
18 Introduction
enables to prepare libraries from RNA extracted from single cells has been developed (Tang
et al., 2009). This scRNA-seq not only enables to obtain transcriptomic variance among
cells, but also to identify distinct cell populations within given animal tissues, or to differen-
tiation trajectories within an animal (La Manno et al., 2018). To interpret and cluster high
dimensional data of gene expression for each cell, it is often used to perform dimensionality
reduction methods. Principal component analysis (PCA) (Pearson, 1901) or t-distributed
neighbour embedding (t-SNE) (Maaten and Hinton, 2008) can project high-dimensional data
to lower dimensional space (e.g. 2D or 3D) to visualise cells with similar gene expression
patterns. By using known maker genes, one can orientate which cell type is represented by
a given cluster and can find unknown cell populations. However, great care must be taken
since the new clusters can sometimes arise from technical artefacts (O’Flanagan et al., 2019;
van den Brink et al., 2017). Studies have shown that cell dissociation methods can induce
differential gene expression in a part of cells, which was miscalled as a new cluster.
1.6 SLAMseq
Although RNA-seq is a powerful tool to quantify the number of RNA molecules existing in
the cell, it still lacks temporal information, and thus metabolic labelling has still been the best
way to study transcriptional dynamics. To overcome the drawbacks of biotin-streptavidin
isolation system, an alternative strategy for thio-labelled RNA discovery called thiol(SH)-
linked alkylation for the metabolic sequencing of RNA (SLAMseq) was developed (Herzog
et al., 2017). Instead of isolating the labelled RNA from a total RNA pool, an alkylating agent,
iodoacetamide (IAA), is used to attach a chemical residue to the thiol group specifically
(Fig. 1.9A). This alkylated 4-thiouracil induces mispairing of bases in the reverse transcription
(RT) step in RNA-seq library preparation: G is base-paired to this aklylated uracil instead of
A (Fig. 1.9B). Thus, after polymerase chain reaction (PCR) and high-throughput sequencing,
reads generated from the labelled RNA contains thymine-to-cytosine (T>C) conversions
at the positions where 4-thio-UTP was incorporated. T>C-aware read aligner, which was
specifically developed for SLAMseq analysis, aligns reads with T>C mismatches to the
genome for a sensitive discovery of T>C conversions.
1.6.1 SLAMseq data analysis
Since the reads obtained from SLAMseq contain more frequent T>C mismatches compared
with conventional RNA-seq methods, read aligner developed for standard RNA-seq cannot
map reads to the genome due to their high mismatch rate. Thus, SLAMseq requires an
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of thiol-specific alkylation in a ribose context confirmed these 
derivatization efficiencies (Fig. 1c and Supplementary Fig. 2). 
Because quantitative identification of s4U by sequencing presumes 
that reverse transcriptase (RT) passes alkylated s4U residues with-
out drop-off, we determined the effect of s4U alkylation on RT 
processivity in primer extension assays (Supplementary Fig. 3a). 
We did not observe a significant effect of s4U alkylation on RT 
processivity when compared with a non-s4U-containing oligo with 
identical sequence (P > 0.05; Supplementary Fig. 3b,c). To evalu-
ate the effect of s4U alkylation on RT-directed nucleotide incor-
poration, we isolated the full-length products of primer extension 
reactions, PCR amplified the cDNA and subjected the libraries to 
high-throughput sequencing (Fig. 1d and Supplementary Fig. 4). 
Although the presence of s4U prompted a constant 10–11%  
T > C conversions already in the absence of alkylation (presum-
ably as a result of base-pairing variations of s4U tautomeres), s4U 
alkylation increased T > C conversions by 8.5-fold, resulting in 
a >0.94 conversion rate (Fig. 1d). Notably, iodoacetamide-treat-
ment leaves conversion rates of any given non-thiol-containing 
nucleotide unaltered (Supplementary Fig. 4c).
SLAM-seq quantifies s4U-labeled transcripts in mESCs
We subjected mouse embryonic stem cells (mESCs) to 
100 MM s4U labeling, a concentration far below the EC50 toxicity 
value of s4U in mESCs (Fig. 2a and Supplementary Fig. 5). 
After metabolic RNA labeling for 24 h, we prepared total RNA 
followed by thiol-alkylation and 3`-end mRNA sequenc-
ing (Quant-seq). Quant-seq provides rapid and quantitative 
access to mRNA expression profiles by generating Illumina-
compatible libraries of the sequences close to the 3` end of 
polyadenylated RNA (Fig. 2b and Supplementary Fig. 6) 
(Moll, P., Ante, M., Seitz, A. & Reda, T., unpublished data). 
Hence, only one fragment per transcript is generated, which 
corresponds to polyadenylated mRNA 3`-end tags, rendering 
normalization of reads to gene length obsolete (Supplementary 
Fig. 6). Furthermore, 3`-end sequencing enables the cell-type-
specific re-evaluation of untranslated region (UTR) annota-
tions to conduct mRNA 3` isoform-specific expression analysis 
(Supplementary Fig. 7). Following generating SLAM seq librar-
ies through the Quant-seq protocol from mESCs 24 h after s4U 
metabolic labeling, we observed a strong accumulation of T > C 
conversions when compared with unlabeled conditions (Fig. 2b). 
Transcriptome-wide analyses confirmed this observation (Fig. 2c). 
In the absence of s4U metabolic labeling, we observed a median 
rate of a0.1% for any given conversion, consistent with Illumina-
reported sequencing error, whereas s4U-labeling resulted in a statis-
tically significant (P < 10−4, Mann–Whitney test), >50-fold increase 
in T > C conversion rates (Fig. 2c), which distributed evenly across 
the covered genomic regions (Fig. 2d, and Supplementary Fig. 8). 
Notably, non-T > C conversions remained below the expected 
sequencing error rates (Fig. 2c), and treatment of total RNA with 
iodoacetamide in the absence of metabolic labeling did not affect 
quantitative gene expression analysis (Supplementary Fig. 8d). 
s4U incorporation measured by mass spectrometry in poly- 
adenylated-enriched RNA was comparable with SLAM seq data 
(Supplementary Fig. 9).
Measuring the polyadenylated transcriptional output in mESCs
Next, we subjected mESCs to 45 min of s4U pulse labeling (final 
concentration of 100 MM s4U), followed by total RNA extraction, 
alkylation and mRNA 3`-end library preparation (Supplementary 
Fig. 10a). To identify newly made transcripts, we extracted back-
ground-error-subtracted T > C conversion-containing reads for 
individual transcripts (Supplementary Table 1). Indeed, initial 
inspection of selected transcripts with comparable steady-state 
abundance (~100 cpm) revealed transcript-specific differences in 
the number of recovered T > C reads (Fig. 3a). Although high lev-
els of T > C reads were recovered for the ESC-specific transcrip-
tion factor Sox2 and the inherently instable primary microRNA 
transcript from the miR-290-295 cluster, the house-keeping tran-
script Gapdh was associated with fewer T > C reads, presumably 
because its accumulation to high steady-state expression levels 
was achieved by high transcript stability (Fig. 3a).
Transcriptional output by RNA polymerase II is regulated 
by transcription factors that bind cis-acting regulatory 
elements known as enhancers16. In ESCs, the pluripotent state 
is largely governed by a small number of enhancer-associated 
master transcription factors, including Oct4, Sox2 and Nanog, 
which drive the expression of the target genes necessary to main-
tain the ESC state (Supplementary Fig. 10b)17. Transcriptional 
output measurements by SLAM seq revealed that well- 
established Oct4, Sox2 and Nanog (OSN) target genes produced 
overall a larger number of T > C conversion-containing reads in 
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Figure 1 | Detection of s4U by chemical derivatization and sequencing. 
(a) s4U reacts with the thiol-reactive compound iodoacetamide (IAA), 
attaching a carboxyamidomethyl group to the thiol group in s4U as a 
result of a nucleophilic substitution (SN2) reaction. (b) Absorption spectra 
of 4-thiouracil (s4Uracil) before and after treatment with IAA. Absorption 
maxima of educt (s4Uracil; Lmax y335 nm) and product (carboxyamido-
methylated 4-thiouracil, *s4Uracil; Lmax y297 nm) are indicated. Data 
represent mean (center line) o s.d. (whiskers) of independent experiments 
(untreated, n = 13; IAA treated, n = 3). (c) Normalized LC-MS extracted 
ion chromatograms of s4U (black) and alkylated s4U (red) at the indicated 
iodoacetamide concentrations. (d) Conversion rates for each position of 
a s4U-containing RNA before or after IAA treatment. Average conversion 
rates (center line) o s.d. (whiskers) of three independent experiments 
(points) are shown. The number of sequenced reads in each replicate 
(r1–3) are indicated. Nucleotide identity at s4U site (p9) is shown.
Fig. 1.9 SLAMseq biochemistry
(A) Alkylation reaction between IAA and the thiol group of 4-thiouridine is shown (taken
from Herzog et al. (2017)). A carboxyamidomethyl group is attached to the thiol group
of 4-thiouridine (s4U) through a nucleophilic substitution (SN2) reaction. (B) SLAMseq
workflow for thiol-containing and non-containing RNA is shown. The chemical residue
added thorough the alkylation reaction induces mispairing of G instead of A in the RT step
and leads to T>C base conversions in reads resulting from it.
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optimised strategy to align reads to the genome for an accurate estimation of gene expression
and T>C ratio. To achieve a better handling of reads containing frequent T>C mismatches,
Neumann et al. have developed a new software called SLAM-DUNK, which consists of four
consecutive steps: "map", "filter", "snp", and "count" (Fig. 1.10).
In the "map" step, reads are mapped to the genome allowing T>C mismatches. This is
achieved by modifying an existing aligner, NextGenMap (Sedlazeck et al., 2013), which
was originally developed for mapping reads to a genome that is highly polymorphic. In
determining where to align a read to the given genome, the native algorithm of NextGenMap
assigns a penalty score when there is a mismatch or a gap between the read and the mapped
genomic locus. SLAM-DUNK’s "map" step was configured not to penalise a mismatch
when it is a T>C mismatch in order to maintain reads mapped to the genome with high T>C
mismatches.
In the "filter" step, reads with a low mapping score and those that are ambiguously
mapped are removed. If a read cannot be assigned to a unique location, the software uses
supplied transcript annotation information to resolve this ambiguity. If a read is mapped to
multiple genomic loci, and only one of them overlaps with the annotation, only the location
in the annotation is assigned to the read. If a read is mapped to multiple genomic regions that
are included in the annotation, or does not overlap with any of the annotated loci, the read is
removed from the analysis.
Since the T>C mismatches found in the reads can also be derived from single-nucleotide
polymorphisms (SNPs), the "snp" step identifies T>Cs that are likely derived from SNPs. In
diploid cells, a SNP in the genome can in theory result in substantial transcripts containing
the SNP unless imprinted, whereas the intracellular concentration of 4-thiouridine can only
allow transcripts with <10% of 4-thiouridine incorporated for each T position. Thus, T
positions with a higher T>C conversion rate than the specified threshold (25% for diploid
cells) are considered to be derived from SNPs rather than 4-thiouridine incorporations and
are removed from the downstream T>C counting.
Finally, in the "count" step, the T>C mismatches that were not filtered out in the previous
"filter" step are counted for each gene in the annotation file. A table summarising T>C
conversion rate for each gene is also generated as an output. Since sequencing errors can also
generate low-rate T>C conversions that are not removed in the previous step, T>C containing
bases with a Phred quality score higher than the threshold are included for this count.
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Fig. 1.10 Comparison of read mapping strategies with and without SLAM-DUNK soft-
ware
Four analysis steps in SLAM-DUNK are shown to illustrate how the software can better
handle reads with T>C mismatches compared with when only a standard read aligner is used
(naive) (taken from Neumann et al. (2019)). (a) In the "map" step, SLAM-DUNK maintains
reads with T>C mismatches that are filtered out in a naive aligner (shaded reads in the left
pane). (b) In the "filter" step, when a read is mapped to a unique locus in the genomic region
that is included in the annotation file provided, the read is mapped there even though it is
mapped to other genomic loci that are not in the annotation. Such reads could be discarded
with a naive mapper (R2, R6). (c) In the "snp" step, if the frequency of T>C mismatch in a
given locus is higher than a threshold, this locus is removed from T>C counting. This step is
efficient in removing T>C mismatches that are derived from SNPs. (d) In the counting step,
T>C mismatches that were not filtered in the previous step are counted. When compared
with a naive strategy, SLAM-DUNK detects T>Cs more sensitively and accurately.
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1.7 Outline and aims of this thesis
RNA has been known as a key biological molecule, and it exists in all known living cells.
Although, since its discovery in the 1960s, numerous research projects have been conducted
to assess its significance in cellular processes, and molecular machineries producing RNA
have been discovered, the complete picture of RNA dynamics is still elusive.
Metabolic RNA labelling has been a powerful tool to study RNA dynamics. Although
different nucleotide analogues have been used so far, 4-thiouracil and 4-thiouridine have
become one of the most commonly used analogues due to their convenience, minimal
structural difference from the native nucleotides, and availability of efficient detection
methods. During my PhD, I have developed a novel in vivo metabolic RNA labelling method
through the collaboration with a group in Austria and used the method to answer various
biological questions. Below, I summarise the aims I achieved during my PhD.
• To establish a novel metabolic RNA labelling method in a specific type of cells in vivo
(SLAM-ITseq).
• To test if there are any endogenous RNAs that are mobile between different types of
cells in M. musculus using SLAM-ITseq.
• To identify transcripts synthesised from zygotic genome using metabolic labelling.
In Chapter 3, the development of SLAM-ITseq is shown. By labelling RNAs in well-
studied cell types, sensitivity and specificity of the method in multiple cell types are analysed.
Using this novel in vivo RNA labelling method, intercellular mobility of RNA is assayed in
Chapter 4. By generating multiple mouse strains with RNA labelled in different cell types,
RNA mobility between different cell types as well as RNA released into circulation are
comprehensively assayed. In Chapter 5, using the same detection method, transcriptional
dynamics in early mouse preimplantation embryos are studied. Stage-specific exposure
of embryos to 4-thiouridine enables to identify genes and transposable elements actively
synthesised in the embryo.
In summary, through the development and application of novel RNA labelling methods,
this thesis explores RNA dynamics in M. musculus: cell-type-specific transcriptome in
vivo, intercellular RNA transfer, and zygotic genome activation in the early preimplantation
embryo. Since these questions are all challenging to address with conventional RNA analysis
methods, this thesis not only proposes a new tool to tackle these questions, but also provides
first direct results addressing each problem.
Chapter 2
Materials and methods
2.1 M. musculus methods
2.1.1 Mouse husbandry
All mice were maintained in a specific-pathogen-free facility with sentinel monitoring at
standard temperature (19-23°C) and humidity (55 ± 10%), on a 12 h dark, 12 h light cycle
(lights on 7:30–19:00) and fed a standard rodent chow (9% crude fat content, 21% kcal as
fat, 0.276 ppm cholesterol, LabDiet). Both food and water were available ad libitum. The
mice were housed in groups of 3-4 mice per cage in individually ventilated caging receiving
60 air changes per hour. In addition to bedding substrate (Aspen), standard environmental
enrichment of a nestlet and a cardboard tunnel were provided. All animals were regularly
monitored for health and welfare concerns, and were additionally checked prior to and after
procedures. The care and use of mice in the study was carried out in accordance with UK
Home Office regulations, UK Animals (Scientific Procedures) Act of 1986 under a UK Home
Office license that approved this work (PF8733E07), which was reviewed regularly by the
Wellcome Sanger Institute Animal Welfare and Ethical Review Body.
2.1.2 Genetic crosses
All imported mice used were crossed with C57BL/6NTac at least once before used for further
crosses. The detailed information about the transgenic mice used in this study is shown in
Table 2.1. Homozygous UPRT mice (uprt/uprt) were crossed with hemizygous Cre mice
(cre/cre). In the F1 generation, an approximate 50:50 ratio of the Cre+ mice (uprt/0; cre/0)
and Cre- mice (uprt/0; +/+) were obtained. When mice reached the 10-day age, ear clips
were obtained by an ear puncher by Sanger Institute Research Support Facility (RSF) staffs
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for animal identification and genotyping. Collected ear clips were stored at -20°C until DNA
was extracted as described in a section below.
2.1.3 Tamoxifen administration
Spink8tm1(EGFP/Cre/ERT2)Wtsi transgene generates Cre-ERT2, which is a fusion protein of Cre
recombinase and a mutated ligand binding domain of the human estrogen receptor (ER) (Feil
et al., 1997). Cre-ERT2 requires 4-hydroxy-tamoxifen (OHT) or tamoxifen to induce Cre
recombinase activity (Indra et al., 1999). 20 mg/ml tamoxifen (Sigma-Aldrich) solution in
corn oil was made by dissolving tamoxifen in corn oil (Santa Cruz Biotechnology), and the
solution was placed in a 37°C incubator overnight with continuous mixing. Both Spink8-Cre+
and Spink8-Cre- mice received 20 mg/ml tamoxifen at 3.75 µl/g body weight dose by i.p.
injections for 5 consecutive days with 24 h intervals. These mice were used for 4-thiouracil
injections 2 weeks after the last tamoxifen injection.
2.1.4 Administration of RNA labelling agents
4-thiouridine (Sigma-Aldrich) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich)
at 400 mg/ml concentration and further diluted in corn oil (Santa Cruz Biotechnology) in a
1:4 ratio (100 mg/ml final 4-thiouridine concentration). Either the 4-thiouridine solution or
DMSO control solution was then i.p. injected into wild-type C57BL/6NTac mice at a dose of
8 µl/g body weight three times every 24 h.
4-thiouracil (Sigma-Aldrich) was dissolved in DMSO at 200 mg/ml concentration and
further diluted in corn oil in a 1:4 ratio (50 mg/ml final 4-thiouridine concentration). The
4-thiouracil solution was then injected to both Cre+ and Cre- mice at a dose of 8 µl/g body
weight three times every 24 h. The mice were culled, and blood and tissues of interest were
collected as described below.
2.1.5 Serum collection by cardiac puncture
The mice were anaesthetised with isoflurane 6 h after the last injection and blood was
collected by cardiac puncture using a 25G x 5/8" needle (Terumo) and a 1-ml syringe.
Cervical dislocation was performed to confirm their death. The collected blood was incubated
at room temperature for 30 min and subsequently at 4°C for 30 min. The coagulated blood
was then centrifuged at 2,000g for 10 min at 4°C. The supernatant was dispensed into a
new 1.5-ml tube, centrifuged at 2,000g for 10 min at 4°C, and the resulting supernatant was
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recovered again to completely remove blood cells. The obtained serum was stored at -80°C
until used for downstream RNA extraction.
2.1.6 Solid tissue collection
Solid tissues (brain, eWAT, intestine, and epididymis) were cut into pieces less than 5 mm in
thickness and submerged in 1-ml RNAlater (Sigma-Aldrich) for storage at -20°C. Details of
the collection method of each tissue is summarised below.
Brain
The mouse skull was cracked open with surgical scissors, and the whole brain including
cerebellum was collected. In order not to exceed the upper limit of RNA concentration
that the acid guanidinium thiocyanate reagent, TRIsure (Bioline), can dissolve, only the left
hemisphere was used for RNA extraction. The weight of the tissues that TRIsure reagent can
dissolve is shown in the manufacturer’s instructions. Further details about RNA extraction
are described in the next section.
Intestine
Duodenum was collected by incising at the junction of the intestine and stomach, and the 20
mm distal part of it. The luminal side of the duodenum was washed with phosphate-buffered
saline (PBS) before submerged in RNAlater.
Epididymal white adipose tissue (eWAT)
Only the right eWAT was collected. The junction with the testis was identified and eWAT
was excised at this point.
Epididymis
The caudal and caput parts of the epididymis were collected (Fig. 2.1). Since cauda was also
used to isolate sperm, it was stored for RNA extraction after being incubated in M2 medium
for sperm collection (details described below).
2.1.7 Sperm and epididymosome isolation
Sperm and epididymosomes were isolated from cauda epididymides as previously described
with minor modifications (Sharma et al., 2016). 4 ml M2 medium (Sigma-Aldrich) was
2.1 M. musculus methods 27
Fig. 2.1 Schematic representation of mouse epidiymal segments
The caput and cauda epididymis were collected based on this scheme (taken from Johnston
et al. (2005)).
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aliquoted in 5-ml round-bottom polystyrene tubes (Corning) and pre-warmed in a 37°C water
bath. Cauda epididymides collected from mice were submerged in the pre-warmed medium
after a few incisions were made and incubated at 37°C for 30 min. Epididymides were
preserved in 1 ml RNAlater for RNA isolation, and 3 ml supernatant was collected in 1.5-ml
tubes and centrifuged at 2,000g for 2 min. The resulting supernatant was dispensed into new
1.5-ml tubes for epididymosome isolation, and the pellet was used for sperm isolation.
Sperm purification
The sperm pellet was washed with 500 µl PBS. The sperm suspension was centrifuged at
2,000g for 2 min, and the supernatant was discarded. The pellet was then resuspended with
somatic cell lysis buffer (0.1% SDS and 0.5% Triton-X (Sigma-Aldrich) in nuclease-free
water), and incubated on ice for 10 min. The solution was centrifuged at 2,000g for 2 min,
and supernatant was discarded. The pellet was washed with 500 µl PBS again followed by
centrifugation, and the resulting sperm pellet was stored at -80°C until used for downstream
RNA isolation.
Epididymosome isolation
Epididymosomes were isolated using a method that was previously described elsewhere (Sharma
et al., 2016). Epididymosome-containing supernatant was centrifuged at 120,000g at 4°C
for 2 h, washed with ice cold PBS, and centrifuged again at 120,000g at 4°C for 2 h. The
supernatant was discarded, and the epididymosome pellet was used for downstream RNA
isolation.
2.1.8 Superovulation and embryo collection
Superovulation and embryo collection were performed following the protocol described
elsewhere (Doe et al., 2018) with the support of Evelyn Grau at RSF. 4-6 weeks old female
mice were i.p. injected with pregnant mare serum gonadotropin (PMSG; 5 IU, Intervet) and,
48 h later, with human chorionic gonadotropin (hCG; 5 IU, Intervet). After the hCG injection,
the female mice were housed with stud male mice overnight for mating. After confirming a
copulation plug, female mice were euthanised, and cumulus complex mass was collected
from their ampulla. One vial of hyaluronidase (Sigma-Aldrich) was added to the cumulus
complex on a dish, and the dish was swirled to disperse the cumulus cells. The embryos
were washed with flushing holding medium (AMS Biotechnology), and the fertilised zygotes
with two pronuclei were placed into potassium-supplemented simplex optimised medium
(KSOM; AMS Biotechnology) that was pre-warmed at 37°C.
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2.1.9 Embryo culture
In each dish, 40-60 embryos were cultured in 1 ml KSOM medium at 37°C. 100 µl of 50
mM 4-thiourdine stock solution in PBS or 100 µl of PBS was added to each dish, and the
dishes were returned to the incubator. The medium with either 4-thiouridine or PBS was
exchanged every 2 h. 4 h after the start of the exposure, KSOM medium was removed, and
1 ml of TRIsure was added to the embryos to extract RNA. The RNA extraction method is
described in the following section.
2.2 Molecular biology methods
2.2.1 Mouse genotyping
DNA from mouse ear-clips was isolated using the Sample-to-SNP kit (Life Technologies),
and the DNA products were amplified using a ViiA7 real-time PCR machine (Life Technolo-
gies) with TaqMan assay kit (Life Technologies) and oligonucleotides listed in Table 2.2.
Genotyping was performed with the support of the Sanger Institute RSF.
Table 2.2 Oligonucleotides used in this thesis
Target gene Sequence (5′ > 3′) Assay type
UPRT-forward ATTCCAAGATCTGTGGCGTC TaqMan
UPRT-reverse CTTCTCGTAGATCAGCTTAGGC TaqMan
UPRT-probe (VIC) CCGCATCGGGAAAATCCTCATCCA TaqMan
Cre-forward ACGTACTGACGGTGGGAGAA TaqMan
Cre-reverse GTGCTAACCAGCGTTTTCGTT TaqMan
Cre-probe (VIC) CTGCCAATATGGATTAACA TaqMan
UPRT-forward CCCGATATTCGACAAACGAC SYBR Green
UPRT-reverse GCTTCATGAGCACCACATTG SYBR Green
Hprt-forward GCCTAAGATGAGCGCAAGTTG SYBR Green
Hprt-reverse TACTAGGCAGATGGCCACAGG SYBR Green
2.2.2 In vitro RNA synthesis
In vitro RNA synthesis reaction was performed with MAXIscript T7 Kit (Thermo Fisher)
following the manufacturer’s instructions. RNA Century-Plus Marker Templates (Thermo
Fisher) was used as a DNA template. Two separate reactions were performed with and
without 4-thio-UTP (Jena Bioscience). For the reaction with 4-thio-UTP, UTP and 4-thio-
UTP were mixed at a 6:4 ratio. The reaction mix tubes were incubated at 37°C for 1 h and
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were DNase-treated for 15 min to digest the template DNA. RNA was precipitated by adding
1/10 volume of 3 M sodium acetate, 20 µg of glycogen, and 3 volumes of 100% ethanol,
and incubated at -20°C overnight. The resulting pellet was washed with 80% ethanol and
resuspended with nuclease-free water.
2.2.3 Biotinylation of thiolated RNA
MTSEA biotin-XX (Biotium) was dissolved in N,N-dimethylformamide (DMF; Sigma-
Aldrich) to prepare 0.1 mg/ml solution. Reaction mix was prepared by mixing 10 µl MTSEA
biotin-XX solution, 15 µl 10X biotinylation buffer (100 mM HEPES, 10 mM EDTA; pH
7.5), and 105 µl nuclease-free water. 10 µl RNA was added to the reaction mix and incubated
at room temperature for 2 h on a rotator with aluminium foil for protection from light. The
RNA was cleaned up with the phenol:chloroform isolation method and was dissolved in
nuclease-free water.
2.2.4 Isolation of biotinylated RNA with streptavidin beads
Biotinylated RNA was isolated with µMACS Streptavidin Starting Kit (Miltenyl Biotech). 25
µl of the biotinylated RNA was mixed with 100 µl µMACS streptavidin beads and incubated
with rotation at room temperature for 15 min with aluminium foil. µColumns were placed
in the magnetic field of the µMACS separator and equilibrated with 2 x 100 µl nucleic acid
equilibration buffer supplied with the beads. The mixture of RNA and beads was applied to
the equilibrated columns, and the flow-through was collected in a microfuge tube. µCoumns
were washed twice with 500 µl of high salt wash buffer (100 mM Tris-HCl, 10 mM EDTA,
1 M NaCl, 0.1% Tween-20). RNA bound to the beads was recovered with 2 x 100 µl of
100 mM DTT. RNA in the flow-through and the eluent fractions was recovered with the
phenol:chloroform isolation method.
2.2.5 RNA extraction from murine tissues
RNA was extracted with an acid guanidinium thiocyanate-phenol-chloroform extraction
method (Chomczynski and Sacchi, 1987) with either TRIsure (Bioline) or TRIzol LS (Thermo
Fisher) following the manufacturer’s instructions. Tissue homogenisation was performed
with different methods optimised for each tissue type.
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Solid tissues
A piece of tissue was taken out of RNAlater, and residual RNAlater was removed from the
sample with a Kimwipe (Kimberly-Clerk). The tissue was cut into a smaller piece that was
around 30 mg in weight and placed in a 2-ml tube. A 7-mm stainless steel bead (Qiagen) and
1-ml TRIsure (Bioline) were added on top of it, and homogenisation with a TissueLyser LT
(Qiagen) was performed until no visible debris was observed (2-3 min).
Serum
750 µl of TRIzol LS (Thermo Fisher) was added to 250 µl of serum and was pipetted up and
down 10 times to ensure homogenisation.
Sperm
1 ml of TRIsure was added to a sperm pellet, and the solution was passed through a 25G
needle attached to a 1-ml syringe multiple times until the solution became homogeneous,
and no visible pellet remained.
After homogenisation, the solution was left still at room temperature for 3 min. 200 µl of
chloroform-isoamyl alcohol mix (Sigma-Aldrich) was added, and the solution was mixed
vigorously for 15 s followed by 3 min incubation at room temperature. The mixture was
then centrifuged at 12,000g for 15 min at 4°C. The upper aqueous phase was transferred
to a new 1.5-ml tube. To perform RNA precipitation without oxidising the thiol group, 1
µl 100 mM dithiothreitol (DTT; Promega), 1 µl 20 mg/ml glycogen (Thermo Fisher), and
500 µl 2-propanol (VWR) were added to the solution, and the mixture was stored at -20°C
overnight after vigorous mixing with a vortex. RNA pellet obtained by centrifugation was
washed with 80% ethanol and was resuspended in nuclease-free water.
2.2.6 RNA quantification and quality check
The concentration of RNA was quantified with a fluorescence-based quantification method
specific to RNA using either Qubit RNA BR Assay kit or Qubit RNA HS Assay kit (Thermo
Fisher), depending on the expected RNA concentration of samples. Quantification was
performed following the manufacturer’s instructions, and fluorescence was detected with
Qubit fluorometer 2.0 (Thermo Fisher).
To confirm integrity of the RNA isolated from the tissues, the length distribution of the
isolated RNA was assayed with Bioanalyzer (Agilent). It performs electrophoresis on a small
chip, and the lengths of RNA are determined based on the migration pattern. Since rRNA is
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known to show a specific pattern in degraded RNA samples, a RNA integrity number (RIN)
is automatically determined based on the pattern of rRNA peaks by Bioanalyzer software. A
value of 1 to 10 is assigned, with 10 being the least degraded. Below, a representative RNA
profile of a sample with a high RIN is shown (Fig. 2.2).
Fragment table for sample 5  :  v5
Name Start Size [nt] End Size [nt] Area % of total Area
18S 1,662 2,227 16.3 20.5
28S 3,455 4,270 16.0 20.1
v5
Overall Results for sample 5  :  v5
RNA Area: 79.6 
RNA Concentration: 99 ng/µl
rRNA Ratio [28s / 18s]: 1.0 
RNA Integrity Number (RIN): 9.2   (B.02.09) 
Result Flagging Color:
Result Flagging Label: RIN: 9.20 
2100 Expert (B.02.09.SI725) © Copyright 2003 - 2017 Agilent Technologies, Inc. Printed: 07/12/2017 16:52:39
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Fig. 2.2 Representative Bioanalyzer profile of high-quality RNA
Bioanalyzer software detects rRNA peaks based on RNA length profile. The rRNA peaks
(shown as "18S" and "28S") are used to calculate an RIN. This sample has a RIN of 8.9, and
the electropherogram shows a typical high-quality RNA profile. The 25-nt peak corresponds
to the lower marker included in the assay buffer; FU, fluorescence unit.
2.2.7 RT-qPCR
Residual DNA was removed from RNA samples by a deoxyribonuclease (DNase) reaction
using TURBO DNA-free kit (Thermo Fisher) following the manufacturer’s instructions.
DNase-treated RNA was then cleaned up with RNA Clean & Concentrator-5 (Zymo Research)
following the manufacturer’s instructions.
The abundance of UPRT and Hprt cDNA was quantified with PowerUp SYBR Green
reagent (Thermo Fisher) and the primers listed in Table 2.2. Real-time polymerase chain
reaction (PCR) was performed with the “Fast” mode on StepOnePlus real-time PCR machine
(Thermo Fisher), which consists of an initial denaturation step at 95°C for 20 s, and then 40
cycles of 95°C for 3 s, followed by 60°C for 30 s for amplification and detection. Expression
of UPRT in different samples was compared by the ∆∆Ct method using Hprt as an internal
control.
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2.2.8 SLAMseq
Alkylation reaction was performed by preparing a 50-µl reaction mix (5-10 µg RNA, 10 mM
IAA, 50 mM pH8 sodium phosphate, and 50% DMSO) followed by incubation at 50°C for
15 min. The reaction was stopped by adding 1 µl 1 M DTT. To precipitate the alkylated
RNA, 1 µl glycogen (20 mg/ml), 5 µl NaOAc (3M, pH 5.2; Thermo Fisher), and 125 µl
100% ethanol were added, and the solution was incubated at -20°C overnight prior to RNA
precipitation.
The alkylated RNA was used as an input for RNA sequencing library preparation. For
polyA RNA-seq, QuantSeq 3′ mRNA-Seq Library Prep Kit for Illumina (Lexogen) was used
for the library preparation. After confirming library profile with Bioanalyzer high sensitivity
DNA assay kit (Agilent) (Fig. 2.3), a single-end 100 bp run was performed on Illumina HiSeq
1500.
For small RNA-seq, NEXTflex Small RNA-seq Kit V.3 (Bioo Scientific) was used for
library preparation. PCR-amplified libraries were loaded on a 6% TBE (tris-borate-EDTA)
gel (Thermo Fisher) and electrophorased at 200 V for 30 min. The gel was submerged in
SYBR gold (Thermo Fisher) dissolved in TE buffer for 20 min to stain the DNA. Using a
non-UV transilluminator, pieces of the gel containing DNA bands corresponding to libraries
between 130-200 bp in length were cut out, and the libraries were recovered from the gel
following the manufacturer’s instructions. After confirming length profile of the resulting
libraries with Bioanalyzer high sensitivity DNA analysis kit (Agilent) (Fig. 2.3), a single-end
50 bp run was performed on Illumina HiSeq 1500.
For embryo RNA analysis, RNA extracted from approximately 40-60 embryos per
biological replicate was used for each library construction. TruSeq Stranded Total RNA
Library Prep Gold Kit (Illumina) was used to capture rRNA-depleted total RNA. After
confirming library profile with Bioanalyzer high sensitivity DNA assay kit (Agilent), a
single-end 100 bp run was performed on Illumina HiSeq 1500.
2.2.9 Confirmation of alkylation reaction with a spectrophotometer
To confirm that the alkylation reaction was properly performed, a control reaction with
4-thiouracil was performed in parallel, using the same reagents and experimental conditions.
A shift in absorption peak of 4-thiouracil solution was measured as a readout of successful
alkylation. 1 µl of 10 mM 4-thiouracil solution was added to a 9-µl reaction mix (50%
DMSO, 1 µl 100 mM IAA, 50 mM sodium phosphate; all final concentration), and the mix
was incubated at 50°C for 15 min. After the reaction, the solution was diluted in 1:10, and 2
µl of it was used for UV-Vis analysis on NanoDrop spectrophotometer.
34 Materials and methods
A
B
Fig. 2.3 Representative Bioanalyzer profile of successful RNA-seq libraries
(A) Library prepared with QuantSeq. A single peak is observed in the 200-300 bp region.
(B) Library prepared with NEXTflex. A single sharp peak was observed in the 150-200 bp
region. Both libraries do not show visible peaks at either the 100 bp or the >1000 bp regions,
suggesting that little adapter dimers and PCR bubbles were generated. The 35- and 10380-bp
peaks correspond to the lower and upper markers included in the assay reagent, respectively.
FU, fluorescence unit.
2.3 Computational methods 35
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2.3.1 Quality check of high-throughput sequencing
For all the RNA-seq runs, the demutiplexed reads were first analysed with FastQC1 for a
quality check. To ensure that a successful sequencing run was performed, it was confirmed
that high base-calling quality was achieved along reads. The number of reads obtained for
the libraries and the sequence quality are summarised in Appendix A. Also, libraries were
checked to confirm that no overrepresented sequences are present, which may happen as a
result of contamination.
2.3.2 SLAMseq analyses
PolyA RNA-seq
The reads were aligned to the M. musculus primary genome assembly (GRCm38) obtained
from ensembl2 by SLAM-DUNK (v0.3.3) (Herzog et al., 2017; Neumann et al., 2019) with
options "-t 5 -5 12 -n 100 -m -mv 0.2 -c 2 -rl 100" (see Table 2.3 and SLAM-
DUNK website3 for further details). 3′ UTR annotation was constructed by merging all the
3′ UTR regions of Refseq genes obtained from UCSC Table Browser4 (assembly: GRCm38)
and Ensembl genes obtained from BioMart5 (Ensembl Genes 87). This 3′ UTR data was
used to resolve the ambiguity of multimapping reads and to measure read count and T>C
rate. This analysis outputs T>C conversion rate detected for each gene, and this table was
further analysed to identify genes with significantly higher T>C rate in Cre+ mice compared
with Cre- mice using an R package ibb (Pham et al., 2010). Procedures and R script used to
perform ibb analysis are shown in Appendix B.
Small RNA-seq
The adapter sequence (TGGAATTCTCGGGTGCCAAGG) was removed from the demultiplexed
reads with cutadapt software (Martin, 2011). Since RNAs that are too short cannot be assigned
to a single genomic locus, and reads originated from small RNA (20-30 nt) should contain the
3′ adapter sequence in a 50 bp sequencing run, reads shorter than 20 bp after trimming and
reads containing no adapter sequence were removed ("-m 20 --discard-untrimmed").
1https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
2http://www.ensembl.org/
3http://t-neumann.github.io/slamdunk/docs.html
4https://genome.ucsc.edu/cgi-bin/hgTables
5https://www.ensembl.org/biomart/martview
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Table 2.3 Description of arguments used in SLAM-DUNK
Argument Description
-t Number of threads to use
-e Use an end-to-end alignment algorithm for mapping
-5 Length (bp) to remove from the 5′ end of all reads
-a Maximum length (bp) of polyA allowed at the 3′ end of reads
-n Maximum number of alignments to report per read
-m Use reference to resolve multimappers
-mv Minimum variant fraction to call SNPs
-mi Minimum alignment identity to retain reads at the filter step
-c Minimum coverage to call SNPs
-rl Maximum read length (bp) in the supplied BAM file
Since the 5′ and 3′ adapters included in NEXTflex kit have 4 random bases at their ligating end,
the first and last 4 bases were further removed from the adapter-trimmed reads using cutadapt
with "-u 4 -u -4" options. The processed reads were aligned to the M. musculus genome
(GRCm38) by SLAM-DUNK (v0.3.3) with options "-mv 0.2 -rl 50 -a 50 -5 0 -mi 1
-e -m -n 5000". Labelled transcripts were discovered with ibb software as described in
Appendix B.
Total RNA-seq
The adapter sequence (AGATCGGAAGAGCACACGTCTGAACTCCAGT) was removed from the de-
multiplexed reads with cutadapt software. The processed reads were aligned to the M. mus-
culus genome (GRCm38) by SLAM-DUNK (v0.3.3) with options "-mv 0.2 -rl 50 -5 0
-mq 0". TE annotation was obtained from Repbase6 (v20140131). Labelled transcripts
were discovered with ibb software as described in Appendix B. For labelled TE discovery,
duplicate-level T>C count and read count were first summarised at gene level, and then an
ibb analysis was performed.
2.3.3 Reanalysis of the published FACS dataset
To construct lists of genes that are expressed in endothelial cells and other brain cells in
mice, the data table containing FPKM (fragments per kilobase of transcript per million
mapped reads) value for each gene in multiple cell types isolated from mouse brain was
used (Zhang et al., 2014). FPKM >0.1 was used as a conservative threshold to determine
6https://www.girinst.org/
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the expressed genes (>99% confidence). Also, in this dataset, FPKM values smaller than
0.1 were rounded up to 0.1 to avoid inflated values when calculating ratios. Thus, the genes
detected in the sorted endothelial cells were determined by filtering genes that have FPKM
>0.1 in endothelial cells; the genes expressed only in non-endothelial cells were identified by
choosing the genes with a mean FPKM >0.1 among non-endothelial cells and FPKM = 0.1
in endothelial cells.
2.3.4 Gene ontology (GO) term enrichment analysis
The list of all the annotated genes was sorted by P-values obtained from the beta-binomial test
in ascending order and then used as input for PANTHER 13.17 (Mi et al., 2017) to perform
the "Statistical enrichment test" with full biological processes GO terms. The enriched GO
terms obtained were further analysed using REVIGO8 (Supek et al., 2011) with allowed
similarity = 0.4 to better visualise the results with less redundancy of GO terms.
2.3.5 Motif enrichment analysis
HOMER9 (Heinz et al., 2010) was used to discover the enrichment of known TF-binding
motifs upstream of labelled genes in the 2-cell embryos. The script findMotif.pl was run
on the list of labelled genes selected at FDR <0.1 using the default parameters.
7http://pantherdb.org/
8http://revigo.irb.hr/
9http://homer.ucsd.edu/homer/

Chapter 3
Development of in vivo cell type-specific
RNA labelling
3.1 Background
Multicellular organisms are supported by a number of organs that further consist of numerous
highly specialised cells, which have distinct gene regulatory networks. Thus, it is essential to
accurately monitor gene expression in each type of specialised cells to better understand the
functions of each tissue and animal physiology.
Cell-type-specific gene expression analysis has commonly been achieved through iso-
lation of cells of interest prior to either a low- or high-throughput gene expression assay.
Laser capture microdissection (LCM) was developed to dissect cells of interest out of a
cryosectioned tissue through a microscope (Emmert-Buck et al., 1996). Although the notable
benefit with this method is that the cells can be histologically oriented, maintaining the
intact tissue structure, LCM is relatively low-throughput and was shown to be noise-prone
compared to other cell isolation methods (Okaty et al., 2011). This is because it is not always
possible to distinguish different types of cells through their appearances, and contamination
from neighbouring cells can occur.
One of the most commonly employed methods to isolate cells is fluorescence-activated
cell sorting (FACS) (Julius et al., 1972). Cells of interest are labelled through either by
generating transgenic animals expressing a fluorescent marker under a cell type-specific
promoter or by tagging cells with fluorescently-labelled antibody against a cell-specific
antigen. The cells are dissociated into single cell level and are sorted by a flow cytometer,
which not only measures fluorescent intensity, but also estimates the cell diameter to better
achieve isolation of a particular cell population. Although FACS is a very robust method and
40 Development of in vivo cell type-specific RNA labelling
has been applied in wide-ranged research fields in biology, one of the major drawbacks of the
method is that it requires dissociation of an animal/tissue so that singlet cells can be obtained.
It sometimes needs extensive optimisation to achieve optimal dissociation maintaining cell
viability, and, even after such optimisations, this isolation step itself could potentially affect
the gene expression of the cells (Richardson et al., 2015).
Recent advance in RNA-seq methods even enables to sequence RNA obtained from
single cells (scRNA-seq: single-cell RNA-seq) (Tang et al., 2009). Dimensionality reduction
analyses, combined with prior knowledge about marker genes, enable studying transcriptome
of each single cell without sorting them. This approach is also promising in identifying
previously-unknown cell types or subpopulations within a known cell type by finding cells
that do not cluster with other known cell types. However, there are a few reports stating that
the difference in tissue dissociation methods affect the transcriptome of the cells, and some
unique cell clusters discovered with scRNA-seq could be due to artefacts induced from a
tissue dissociation method employed (O’Flanagan et al., 2019; van den Brink et al., 2017).
Alternative approaches to study cell-type-specific RNA that do not depend on cell isola-
tion have also been developed. Instead of isolating cells prior to an analysis, molecules are
“tagged” in a cell-type-specific manner, and the tagged molecules are assayed after isolating
the molecules from the entire tissue (Fig. 3.1). One of such method, TU tagging, is reviewed
below.
3.1.1 TU tagging
TU tagging uses a uracil analogue, 4-thiouracil, to label RNA in a cell-type-specific man-
ner (Cleary et al., 2005; Gay et al., 2013). Uracil phosphoribosyltransferase (UPRT) from
Toxoplasma gondii (T. gondii) converts 4-thiouracil to 4-thiouridine monophosphate (4-
thio-UMP), which is further converted to 4-thiouridine triphosphate (4-thio-UTP) to be
incorporated into the newly synthesised RNA. Although the mammalian genome encodes a
UPRT gene, it was shown to have little enzymatic activity, and thus wild-type mammalian
cells cannot salvage 4-thiouracil to incorporate it into newly synthesised RNA (Cleary et al.,
2005; Li et al., 2007). By generating mice expressing T. gondii UPRT in a specific type
of cells, cell-type-specific RNA labelling can be achieved through systemic 4-thiouracil
administration. For the remainder of this thesis, “UPRT” refers to T. gondii UPRT unless
otherwise stated.
To achieve cell-type-specific UPRT expression in mice, Gay et al. developed a transgene
that expresses UPRT in a Cre recombinase (Cre)-inducible manner. The transgene consists
of a chicken beta-actin (CA) promoter followed by a green fluorescent protein (GFP)-coding
cassette, which is flanked by the locus of X-over P1 (loxP) sequences, and a UPRT-coding
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Fig. 3.1 Comparison of different cell-type-specific transcriptomics methods
Schematics of experimental approaches of FACS, TU tagging, and SLAM-ITseq are shown
(taken from Matsushima et al. (2018)). With FACS, cells of interest are physically isolated,
and RNA-seq is performed on RNA extracted from the isolated cells. On the other hand,
the other two methods metabolically label RNA in a cell-type-specific manner, and the
RNA is extracted from the entire tissue/animal of interest without cell sorting. TU tagging
identifies the labelled RNA through thiol-specific biotinylation followed by streptavidin
pull-down, while SLAM-ITseq identifies the labelled U through thiol-specific alkylation,
which introduces T>C base conversions at the thiolated uridine positions.
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sequence (Fig. 3.6). Since the GFP cassette includes SV40 polyadenylation sequences, this
transgene only expresses GFP where no Cre is expressed, whereas, in Cre-expressing cells,
the GFP cassette is removed, resulting in UPRT expression. Thus, by crossing mice with this
UPRT transgene (UPRT mice) with mice bearing Cre transgene under a cell-type-specific
promoter (Cre mice), double-transgenic mice that express UPRT only in the Cre-expressing
cells are obtained.
To detect the 4-thiouracil-labelled RNA, biotinylation of the thiol group followed by
streptavidin pull down is performed to first isolate the labelled RNA. The abundance of RNA
in the pulled-down fraction as well as the input RNA is measured by RNA-seq, and the
thiolated RNA is identified by finding RNAs that are enriched in the pulled-down fraction
(Fig. 3.1).
Although this TU tagging has been applied in a few research projects (Chatzi et al., 2016;
Erickson and Nicolson, 2015; Gay et al., 2013), this method has some limitations mostly due
to its use of a biochemical method to isolate the labelled RNA.
First, the biochemical isolation methods of RNA are noise- and bias-prone (Duffy et al.,
2015). The bead-based isolation methods have some false-positive signals that are due to
the unspecific binding of RNA to the beads. RNA with longer lengths were shown to be
preferentially pulled down than shorter ones. Also, potentially due to its repetitive washing
step as well as inefficient elution step, its recovery rate is not always high, which may lead to
lower sensitivity. Although an improved biotinylation method has been developed (Duffy
et al., 2015), and it improved the pull-down efficiency, it still does not eliminate the need of
an isolation step with beads.
Second, identification of the labelled RNA from a comparison between the eluted and
input fractions is challenging. Since only newly synthesised transcripts are labelled and
pulled-down, the compositions of each RNA species in the pulled-down and input fractions
are completely different, which makes normalisation as well as identification of enriched
transcripts challenging. Most frequently used software for differential gene expression
analysis use statistical models that assume more or less similar proportions of each RNA
species across samples for normalisation (Anders and Huber, 2010; Robinson et al., 2010),
and thus these software are not appropriate to be employed for TU tagging analyses. One
solution to overcome this normalisation problem would be to include spike-in RNA in each
fraction; however, optimisation of the ratio between spike-in and total RNA is not always
straightforward. Too much or too little spike-in concentration in each library may lead to
over- or under-representation of spike-in-derived reads, respectively. Since it is not easy to
predict how much RNA is labelled in the tissue before performing an experiment, the spike-in
concentration must always be optimised for each experiment. Even though an appropriate
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amount of spike-in is used, unbiased discovery of actively transcribed genes might not be
achievable. Since TU tagging only measures the enrichment level of each transcript in the
eluent fraction compared to the flow-through fraction, a threshold of the enrichment level
to determine which transcripts are enriched needs to be set. Although the selection of such
a threshold greatly affects the results, there has not been enough data to conclude which
threshold yields the best sensitivity and specificity.
3.2 Aims of this chapter
To further improve the TU tagging method, I developed a new method, SLAMseq in tissue
(SLAM-ITseq), which combined the TU tagging with SLAMseq. Also, I redesigned the
mating strategy to obtain the transgenic animals in order to control for non-specific RNA
labelling. With these changes, the labelled RNA can be identified with little bias.
First, to analyse the recovery rate and detection bias with the conventional pull-down
method used in TU tagging, in vitro transcribed labelled RNA was used. Pull-down ex-
periments on the synthetic labelled RNAs revealed the detection bias introduced by the
method.
To test the performance of SLAM-ITseq in comparison to TU tagging, in vivo RNA
labelling was performed on endothelial cells in the mouse brain. Since the same transgenic
animals were also previously used for TU tagging experiments, direct comparison of the
sensitivity and specificity of these two methods were accomplished.
Next, to test its robustness, SLAM-ITseq was applied to two other tissues using different
transgenic strains. The labelled gene lists in each cell type validated the specificity and
sensitivity of the method.
3.3 Assessment of the pull-down method with in vitro syn-
thesised RNA
To assess how well the pull-down based method recovers thiolated RNA, thiol-RNA synthe-
sised in vitro was used as input for the pull-down method, and the recovery efficiency was
assayed. DNA Template mix with different lengths (100, 200, 300, 400, 500, 750, and 1,000
nt) was used to synthesise RNA with corresponding lengths, and in vitro RNA transcription
was performed with and without 4-thio-UTP (at the ratio of UTP:4-thio-UTP = 6:4) (Fig. 3.2).
The synthesised RNA was biotinylated with methanethiosulfonate ethylammonium-biotin
(MTSEA-biotin), which was shown to be an efficient thiol-specific biotinylating agent (Duffy
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et al., 2015). The biotinylated RNA was then isolated with streptavidin beads, and both eluent
and flow-through fractions were recovered. The abundance as well as length distribution of
the RNA were assayed with Bioanalyzer.
Fig. 3.2 Schematic of the pull-down assay with in vitro synthesised RNA
In vitro synthesised RNA with and without 4-thio-UTP was biotinylated, and then the labelled
RNA was isolated with streptavidin beads. RNA bound to the beads was eluted and collected
as the eluent fraction (E), and RNA that did not bind to the beads was also recovered as the
flow-through fraction (FT). Both fractions were assayed with Bionalayzer for length and
abundance profiling.
Bioanalyzer results show that little RNA is obtained in the eluent fraction from RNA
synthesised without 4-thio-UTP in the eluent, which suggests that this method has a low
false-positive rate (Fig. 3.3, 3.4). On the other hand, only around 30% of the labelled RNA
was recovered in the eluent fraction, and 15% of the input appeared in the flow-through
fraction.
Since the labelled RNA was synthesised with the presence of normal UTP, not all the
RNA synthesised contains 4-thio-UTP. To better measure the recovery rate of the labelled
RNA, the RNA in the eluent fraction, which should consist solely of the labelled RNA, was
used for another round of biotinylation and streptavidin isolation steps.
3.3 Assessment of the pull-down method with in vitro synthesised RNA 45
Fig. 3.3 Bioanalyzer results of the pull-down assay
RNA profile obtained with Bioanalyzer is shown for the flow-through (FT) and eluent (E)
fractions of RNA synthesised with and without 4-thio-UTP. Note that the band intensity is
adjusted for each sample, and thus cannot be used to compare the relative abundance of RNA
among samples. L, ladder in nt.
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Fig. 3.4 Abundance of RNA obtained from different pull-down fractions
Relative abundance of RNA in the flow-through (FT) and eluent (E) fractions obtained from
the RNA synthesised with and without 4-thio-UTP is shown. Error bars represent standard
deviations among technical replicates (N = 2 each).
The recovery rate of the labelled RNA was revealed to be high (80-%) (Fig. 3.5B), and
only around 10% of the input was not captured and lost in the flow-through fraction. However,
the Bioanalyzer profile shows that the RNA that was lost in the flow-through fraction was
biased towards RNA with shorter lengths (Fig. 3.5A).
These results suggest that although thiol-RNA-specific recovery can be achieved with
the biotin-streptavidin isolation method, this approach may favour longer RNAs, potentially
because they contain more 4-thio-UTPs per molecule.
3.4 Development of SLAM-ITseq
3.4.1 Design of SLAM-ITseq
To better achieve cell-type-specific RNA labelling in vivo, I have redesigned TU tagging
and adapted SLAMseq to detect labelled RNA. For simplicity, I name this new method as
SLAM-ITseq (SLAMseq in tissue) (Matsushima et al., 2018, 2019) (Fig. 3.6).
There are a few potential sources of false-positive signal with the use of 4-thiouracil and
UPRT transgene for cell-type-specific analysis. First, although mammalian UPRT has been
reported to be inactive, this claim was made based on a chemoluminescence assay (Cleary
et al., 2005), which may not be the most sensitive method, and thus mammalian UPRT
could potentially have a very minimal enzymatic activity. Also, mammalian cells may
have another metabolic pathway to convert 4-thiouracil to 4-thio-UTP. Second, although 3
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Fig. 3.5 Recovery rate of labelled RNA
The pulled-down labelled RNA was treated with another round of an isolation step to assay
the length profile and concentration of recovered RNA. (A) Bioanalyzer results showing the
RNA profile of the flow-through (FT) and eluent (E) fractions. Band intensity is adjusted
for each sample and thus cannot be compared among samples. L, ladder in nt. (B) Relative
abundance of RNA obtained in FT and E is summarised as a bar graph. Error bars represent
standard errors among technical replicates (N = 2 each).
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consecutive SV40 polyadenylation sequences are placed between GFP-coding sequence and
UPRT-coding sequence for an efficient termination of transcription, there may be a low-level
read-though of the termination signals by Pol II.
To control for the UPRT-independent 4-thiouracil incorporation and Cre-independent
UPRT expression, I decided to include a control mice that only have the UPRT transgene.
To obtain this transgenic strain with maximum genetic background similarity, homozygous
UPRT mice (uprt/uprt) and hemizygous Cre mice (cre/0) were crossed so the double trans-
genic mice (uprt/0; cre/0) and hemizygous UPRT mice (uprt/0; +/+) were obtained in a
50:50 ratio in F1 (Fig. 3.6A). For simplicity, I refer the double transgenic mice as Cre+ and
the hemizygous UPRT mice as Cre-. To identify the significantly labelled transcripts in
Cre+ mice compared to Cre- mice, the beta-binomial regression was employed to test if
the observed difference of conversion rates between Cre+ and Cre- is significant based on
variance among biological replicates in each genotype (Pham et al., 2010).
3.4.2 Confirmation of Cre-inducible UPRT expression
To confirm if SLAM-ITseq can be applied for a cell-type-specific transcriptome analysis, I
used Tie2:Cre mice, which express Cre only in endothelial cells (Kisanuki et al., 2001), to
generate Cre+ mice. The same Cre strain was also used in TU tagging paper, so the sensitivity
and specificity of these two methods can be compared directly (Gay et al., 2013). Cre+
and Cre- mice generated as described in the previous section received intraperitoneal (i.p.)
4-thiouracil injection and, the tissues were collected 4 h after the injection.
First, to confirm if Cre-inducible UPRT expression was achieved, RNA from an entire
mouse brain was collected, and reverse transcription followed by quantitative polymerase
chain reaction (RT-qPCR) against UPRT was performed (Fig. 3.7). Significantly higher
UPRT expression was observed in Cre+ brain compared to Cre-, which suggests that UPRT
was expressed in a Cre-inducible manner.
3.4.3 Quality-check of the alkylating reaction
Since it is known that 4-thiouracil with and without a carboxyamidomethyl group has
different absorption spectra, ultraviolet-visible (UV-Vis) spectrophotometry was performed
on 4-thiouracil after an alkylation reaction to validate that the alkylation reaction was
successfully performed (Fig. 3.8). The absorption spectra show that an absorption peak was
observed around 330-340 nm in control 4-thiouracil solution, while the peak is shifted to 300
nm in the 4-thiouracil reacted with IAA. This result indicates that successful alkylation was
performed using the reagent and the incubation condition used.
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Fig. 3.6 Schematic representation of the SLAM-ITseq design
(A) Cross design for a SLAM-ITseq experiment is shown. Cre+ and Cre- mice are generated
by crossing homozygous UPRT mice and hemizygous Cre mice. (B) Both Cre+ and Cre- mice
are exposed to 4-thiouracil intraperitoneally. In the Cre-expressing cells, the GFP-coding
cassette is removed by Cre, resulting in UPRT expression. 4-thiouracil is incorporated into
newly-synthesised RNA only in the Cre-expressing cells. RNA extracted from a tissue that
contains the Cre-expressing cells is analysed with SLAMseq, and RNA synthesised in the
Cre-expressing cells is identified by finding higher T>C mismatches induced by 4-thiouracil
incorporations. Taken from Matsushima et al. (2018).
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Fig. 3.7 UPRT expression in Cre+ and Cre- mice
qRT-PCR was performed against UPRT in the brains of Cre+ and Cre- mice. Relative
expression of UPRT to Hprt is plotted, and each point represents a biological replicate (N =
3 for Cre- and N = 4 for Cre+). Red horizontal lines represent the mean and 95% confidence
intervals. Taken from Matsushima et al. (2018).
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Fig. 3.8 Absorption spectra of 4-thiouracil with and without IAA treatment
UV-Vis spectrophotometry was performed on 4-thiouracil solution with and without the
alkylation reaction with IAA. Taken from Matsushima et al. (2019).
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3.4.4 Higher overall labelling level was observed in Cre+ brain
RNA isolated from the brains of Cre+ and Cre- mice were treated with IAA and used to
prepare RNA-seq library. High-throughput sequencing was performed on the IAA-treated
RNA, and the obtained reads were analysed with SLAM-DUNK software, which was
designed for SLAMseq analyses (Herzog et al., 2017; Neumann et al., 2019).
Next, to confirm successful 4-thiouracil incorporation in Cre+ mice, T>C rate in the two
strains were compared (Fig. 3.9). As expected, significantly higher T>C conversions were
observed in Cre+ brain compared to Cre- brain.
0.0
0.1
0.2
0.3
0.4
0.5
0.6
T>
C 
pe
r g
en
e 
(%
)
Cre-Cre+
p < 2.2 x 10-13
Fig. 3.9 T>C rate comparison between Tie2-Cre+ and Tie2-Cre- brain
Distributions of T>C rate for each gene in Cre+ and Cre- are shown as boxplots (taken from
Matsushima et al. (2018)). The lower and upper hinges correspond to the first and third
quartiles, the middle hinges indicate the median, and the whiskers extend to 1.5 interquartile
range from the upper hinges. Outliers are not shown. Two-tailed Mann–Whitney U-test was
used to calculate the P-value indicated.
3.4.5 Labelled transcripts were identified by beta-binomial test
SLAMseq followed by SLAM-DUNK analysis outputs the number of Ts sequenced and
T>C conversions for each transcript, and for each biological replicate. To best identify the
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transcripts with a higher T>C rate in Cre+ compared to Cre- considering variance among
biological replicates, the beta-binomial regression was employed. In each sample, events of
T>C conversions follow the binomial distribution, and the ratio of T>Cs to all Ts sequenced
follow the beta distribution among the replicates. This model has been used to identify
differentially methylated regions from bisulfite sequencing data (Dolzhenko and Smith, 2014;
Feng et al., 2014; Sun et al., 2014), where non-methylated Cs are converted to Gs after the
bisulfite treatment, while methylated Cs are protected from the conversion.
Using the beta-binomial model, the probability density function Pr can be shown as
below:
Pr(M = m|n,α,β ) =
(
n
m
)
B(m+α,n−m+β )
B(α,β )
where the number of 4-thio-UTPs incorporated m and the total number of Ts sequenced n. B
is the beta function and p∼ B(α,β ) (shape parameters α ≥ 0, β ≥ 0) is assumed.
The beta-binomial test was performed using an R package, ibb (Pham et al., 2010), and,
at the threshold of Benjamini-Hochberg FDR (false discovery rate) <0.05, 5,427 genes were
significantly labelled (Fig. 3.10A). Also, to confirm if the presence of Cre or UPRT in the
tissue induced any aberrant transcription, the abundance of RNA between Cre+ and Cre- was
compared (Fig. 3.10B). The abundance of RNA in the two genotypes is highly and positively
correlated, suggesting that the presence and effect of the Cre transgene has little effect on the
transcriptome of the tissue.
Interestingly, the labelled gene list not only includes endothelial-specific genes, but also
genes expressed globally, the so-called “house-keeping” genes (Fig. 3.11). This result is
important in assessing the sensitivity of SLAM-ITseq. The proportion of endothelial cells in
all the cells that consist mouse brain is thought to be approximately <5% (Gay et al., 2013).
Since the house-keeping genes are expressed in all the cell types, the labelled house-keeping
transcripts synthesised in endothelial cells are diluted in >95% of the unlabelled transcripts
when SLAM-ITseq was performed on the mouse brain. This result suggests that SLAM-
ITseq is sensitive enough to detect labelled RNA that consists less than 5% of the total pool
of the particular transcript.
Since 4-thio-UTPs are incorporated at the positions of Ts in each gene, the number of Ts
in each gene could potentially introduce a bias in identifying labelled transcripts. To assess
this potential bias, the distributions of the number of Ts in the labelled and total transcripts
are compared (Fig. 3.12). The plot revealed that the labelled transcripts tend to contain more
Ts compared with all the transcripts detected. This could be due to the fact that transcripts
with more Ts can incorporate the analogue with higher probability.
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Fig. 3.10 Labelled genes identified by SLAM-ITseq
(A) T>C levels of RNA in Tie2-Cre+ and Tie2-Cre- brain are compared. Each plot represents
the mean value among the biological replicates in each genotype (N = 4 for Cre+ and N =3
for Cre-). Red points show the significantly labelled (FDR <0.05, beta-binomial test) genes,
and the known endothelial genes are marked with a label. A constant value of 10-5 is added
to each value when plotting. (B) The abundance of each transcript is compared between
the genotypes. A high correlation (Pearson’s correlation coefficient = 0.99) was observed
between the two. A constant value of 10-3 was added to each value when plotting. Taken
from Matsushima et al. (2018).
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Fig. 3.11 Labelling levels of globally expressed genes
T>C conversion rates of three globally expressed genes are compared between Cre+ and Cre-.
Each point represents a value for a biological replicate, and red bars represent the mean and
95% confidence intervals among the replicates in each genotype. FDR (Benjamini-Hochberg
procedure) obtained from the beta-binomial test is also shown. Taken from Matsushima et al.
(2018).
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Fig. 3.12 Comparison of the number of Ts between labelled and total transcripts
Empirical cumulative distribution function plot summarises the distribution of the number
of Ts in labelled transcripts and all the detected transcripts (total). Two-sided Kormogorov-
Smirnov (KS) test was applied to assess the difference of the distributions, and the P-value
from the test is shown.
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To compare the sensitivity of SLAM-ITseq with that of TU tagging, a set of known
endothelial genes that was used as the positive control in TU tagging was used (Gay et al.,
2013). Among 13 known endothelial genes, 11 of them were labelled with SLAM-ITseq
(Fig. 3.10A), which is comparable to the sensitivity of TU tagging. To perform a more
comprehensive analysis on the sensitivity and specificity of SLAM-ITseq, a previously
published dataset that identified the transcriptome of different types of cells in mouse brain
by FACS was used (Zhang et al., 2014). Importantly, the endothelial cells in this study were
fluorescently-labelled and isolated using a GFP transgene under the same promoter, Tie2.
The SLAM-ITseq-labelled genes overlap with the FACS-identified endothelial genes, but its
overlap with non-endothelial genes was less than 5%, suggesting that endothelial-specific
RNA labelling was achieved with SLAM-ITseq (Fig. 3.13).
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Fig. 3.13 Euler diagram comparing the genes identified with SLAM-ITseq and FACS
The genes labelled in Tie2-Cre+ mice by SLAM-ITseq (red circle) are compared with the
genes identified by FACS (Zhang et al., 2014). The genes that were expressed in the FACS-
sorted endothelial cells are shown as a white “Endothelial” circle, while the genes that were
not detected in endothelial cells but expressed in other cell types in mouse brain are shown
as a grey “Non-endothelial” circle. Taken from Matsushima et al. (2018).
Further, to comprehensively analyse what types of genes were labelled with SLAM-
ITseq, gene ontology (GO) term enrichment analysis was performed on the labelled gene
list (Fig. 3.14). GO terms that are known to be linked to endothelial functions, such as
“cardiovascular system development”, are enriched. This further confirms that endothelial-
related genes are selectively labelled with SLAM-ITseq.
3.5 SLAM-ITseq application in two other murine tissues
To test the robustness of SLAM-ITseq, two other types of cells were additionally analysed:
epithelial cells in intestine and adipocytes in white adipose tissue (WAT). For both cell
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Fig. 3.14 GO term enrichment analysis performed on the labelled genes in Tie2-Cre+
GO term enrichment analysis was performed on the labelled gene list obtained from Tie2-Cre
mice using PANTHER (Mi et al., 2017), and similar GO terms were visualised as two-
dimensional clusters, semantic scape X/Y, by REVIGO (Supek et al., 2011) (taken from
Matsushima et al. (2018)).
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types, well-characterised specific Cre lines are available: Vil-Cre (Madison et al., 2002) and
Adipoq-Cre (Eguchi et al., 2011) (Fig. 3.17), and these lines were crossed with UPRT mice
to generate double-transgenic lines.
3.5.1 UPRT expression was confirmed in Vil-Cre+ and Adipoq-Cre+
First, to confirm Cre-inducible UPRT expression was achieved in each tissue, RNA was
extracted from duodenum of Vil-Cre mice and epididymal white adipose tissue (eWAT) of
Adipoq-Cre mice and used for RT-qPCR analyses (Fig. 3.15). Significantly higher UPRT
expression was observed in Cre+ mice compared with Cre- mice in both strains, suggesting
that UPRT is expressed in a Cre-inducible manner in these tissues.
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Fig. 3.15 UPRT expression analysis in Vil-Cre+ and Adipoq-Cre+ mice
RT-qPCR analysis was performed against UPRT in mice with (A) Vil-Cre and (B) Adipoq-Cre.
Relative expression of UPRT to Hprt is quantified, and points representing a value for each
biological replicate are shown. Red horizontal lines represent the mean of the values and
95% confidence intervals. Taken from Matsushima et al. (2018).
3.5.2 In vivo RNA labelling was achieved without transcriptome per-
turbation
Next, SLAMseq was performed on Vil-Cre mice and Adipoq-Cre mice, and an order of 1,000
genes with significantly higher T>C conversions were identified in each strain (Fig. 3.16).
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Also, to assess if the UPRT or Cre expression had any effect on the transcriptome of the
tissues assayed, the abundance of each transcript was compared between Cre+ and Cre- mice.
In both strains, a high positive correlation between the genotypes was observed, suggesting
that Cre or UPRT expression did not induce aberrant transcription.
A
B
Fig. 3.16 T>C rate and abundance of each transcript in Cre+ and Cre-
T>C ratio (left panes) and RNA abundance (right panes) in Cre+ and Cre- are compared in
(A) Vil-Cre and (B) Adipoq-Cre. Red points represent the genes with a significantly higher
T>C rate (FDR <0.05) in Cre+ mice compared to Cre- mice. Each point shows the mean
value among the biological replicates. A constant value of 10-5 and 10-3 were added to T>C
fraction and read count (cpm), respectively. Pearson’s correlation coefficient r is shown.
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3.5.3 RNA labelling is specific to the Cre-expressing cells
Since both tissues from which RNA was extracted consist of heterogeneous cell types, the
labelling levels of a few known marker genes for each cell type were compared to confirm
the specificity of the labelling with SLAM-ITseq (Fig. 3.17A). While intestine consists of
various types of cells such as epithelial cells, interstitial cells, smooth muscle cells, and
endothelial cells, Vil-Cre is known to be only expressed in epithelial cells (Madison et al.,
2002) (Fig. 3.17). In Vil-Cre+ mice, while known epithelial genes such as Vil, Muc4, and
Lyz1 were significantly labelled, non-epithelial genes such as Kit (interstitial), Acta2 (smooth
muscle), and Pecam1 (endothelial) were not labelled.
WAT consists of adipocytes and endothelial cells. Some marker genes for each cell type
were similarly tested in Adipoq-Cre+ mice to confirm the labelling specificity (Fig. 3.17B).
Adipose marker genes (Adipoq, Fabp4, and Pparg) were confirmed to be significantly labelled,
whereas endothelial genes (Esam, Pecam1, and Thsd1) were not labelled, suggesting that
adipose-specific RNA labelling was achieved.
Second, to comprehensively assay what types of genes are labelled in each Cre line,
GO term enrichment analysis was performed on the labelled gene lists (Fig. 3.18). In the
Adipoq-Cre data (Fig. 3.18A), the analysis revealed that some adipose-related GO terms
such as “fat cell differentiation” were enriched, while no enrichment of endothelial-related
terms was found. This result suggests that the labelled gene list contains a high number of
adipose-related genes. However, in the Vil-Cre+ data, no cluster linked to specific cellular
functions was found (Fig. 3.18B). This may be due to the fact that Vil-Cre+ cells in intestine
consist of various types of cells (e.g. enterocytes, Paneth cells, and intestinal stem cells), and
thus no significant enrichment for particular GO terms was obtained.
These data suggest that SLAM-ITseq can achieve RNA labelling in wide-ranged Cre
strains without labelling RNA in surrounding cells.
3.6 Discussion
In this chapter, the development of a novel in vivo RNA labelling method, SLAM-ITseq, by
employing UPRT line and novel metabolic RNA labelling method, SLAMseq, was shown.
SLAM-ITseq utilises transgenes developed for TU tagging, but it is combined with a
newly developed detection method, SLAMseq. Another major improvement to TU tagging
was to use Cre- animals to control for background labelling, which may be introduced by
UPRT-independent 4-thiouracil incorporation, unfiltered SNPs, or sequencing errors. In fact,
our data showed the presence of noticeable background labelling in Cre- mice ranging from
an order of 10-5 to 10-1. Although it is unclear whether all the factors above are influential
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Fig. 3.17 T>C conversion rates of transcripts known to be expressed in Cre+ and Cre-
cells
A few marker genes for Cre+ and Cre- cells in (A) Vil-Cre and (B) Adipoq-Cre were chosen
to validate the specificity of SLAM-ITseq. On the left, histological schematics of the tissues
that RNA was extracted from are shown, and the cells expressing Cre as well as UPRT are
shown in yellow. On the right, genes shown in the top three panes are known marker genes for
the Cre-expressing cells, while the genes in the bottom three panes are known to be expressed
in the non-Cre-expressing cells of the tissues. Red horizontal bars represent mean T>C
fraction and 95% confidence intervals among biological replicates. Benjamini-Hochberg
FDR from the beta-binomial test is shown for each gene. Taken from Matsushima et al.
(2018).
62 Development of in vivo cell type-specific RNA labelling
metabolic process
ribonucleoprotein complex biogenesis
protein localization to organelle
ncRNA processing
cellular response to DNA damage stimulus
mitotic cell cycle process
methylation
chromosome segregation
cell division
response to ionizing radiation
cell cycle
−10
−5
0
5
10
−5 0 5
Semantic space X
Se
m
an
tic
 sp
ac
e 
Y
−300
−200
−100
0
log10 p−value
log10 GO term size
1.5
2.0
2.5
3.0
3.5
4.0
metabolic process
Golgi vesicle transport
localization
proteolysis involved in cellular protein catabolic process
cellular component organization or biogenesis
cardiovascular system development
regulation of organelle organization
actin filament−based process
regulation of autophagy
positive regulation of molecular function
negative regulation of intracellular signal transduction
regulation of molecular function
positive regulation of metabolic process
−10
−5
0
5
−5 0 5
Semantic space X
Se
m
an
tic
 sp
ac
e 
Y
−300
−200
−100
0
log10 p−value
log10 GO term size
2.5
3.0
3.5
4.0
A
B
Fig. 3.18 GO term enrichment analysis on the labelled transcripts in Vil-Cre+ and
Adipoq-Cre+
GO term enrichment analysis on the labelled gene list in (A) Vil-Cre and (B) Adipoq-Cre
using PANTHER (Mi et al., 2017). Related GO terms are shown together as clusters using
REVIGO (Supek et al., 2011). Taken from Matsushima et al. (2018).
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or just one of them is critical, our data suggests the importance of using a control mice to
control for this background labelling.
Cell-type-specific RNA labelling was confirmed to be achieved in the three different cell
types: endothelial cells, intestinal epithelial cells, and adipocytes. It is important to note that
ratios of Cre-expressing cells in these tissue are varied: endothelial cells account for only 5%
of all cells in brain, whereas epithelial cells in duodenum and adipocytes in WAT comprise
much higher proportions. Also, these three tissues exist in anatomically different locations of
the mouse body, and thus these cells may have different availability of 4-thiouracil from the
circulation. These facts suggest that SLAM-ITseq can achieve robust cell-type-specific RNA
labelling regardless of a Cre-line used, a ratio of Cre-expressing to non-Cre-expressing cells,
and anatomical locations of tissues analysed.
3.6.1 Comparison with other methods
SLAM-ITseq achieves cell-specific transcriptome analysis without physically isolating cells
of interest. A clear advantage of this strategy over existing methods that require cell isolation
is that it does not involve tissue or animal dissociation into single cells. Tissue dissociation
methods often require a long time to find an optimal condition to isolate cells of interest,
maintaining cell viability. Even if such a condition is found, there is no guarantee that the
isolated cells still retain the native transcriptome before the cell isolation step. Also, cell
isolation methods are generally time-intensive and require expensive equipment to perform.
There are other cell-isolation-independent, yet pull-down-dependent methods to study
RNA in a cell-specific manner. Transgenic expression of a tagged RNA-binding protein in
specific cells followed by co-purification of the protein and RNA bound to it, enables to isolate
RNAs involved in a particular biological process in a specific cell type. Methods that employ
tagged ribosomal protein (Hupe et al., 2014) and polyA-binding protein (PABP) (Hwang
et al., 2017) have been established, and each method can be used to study mRNA being
translated and alternative polyadenylation events, respectively. As these methods neither
directly address the transcriptional rate nor capture the transcriptome, these methods and
SLAM-ITseq are complementary to each other and can study cell-specific RNA dynamics
from different perspectives.
Around the same time SLAMseq was developed, two alternative methods for identify-
ing 4-thiouridine incorporations were reported: thiouridine-to-cytidine sequencing (TUC-
seq) (Riml et al., 2017) and TimeLapse-seq (Schofield et al., 2018). Unlike SLAMseq,
which introduces T>C base conversions in cDNA at the reverse transcription step, these
two methods directly introduce uracil-to-cytosine (U>C) conversions at the positions of
4-thiouracil in RNA using osmium tetroxide (OsO4) and ammonium in TUC-seq, and
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2,2,2-trifluoroethylamine (TFEA) and sodium periodate (NaIO4) in TimeLapse-seq. Direct
introduction of base conversions on RNA could potentially be beneficial when using an RNA-
seq method that is independent of reverse transcription (e.g. Nanopore direct RNA-seq). The
conversion efficiencies of SLAMseq and TUC-seq were both confirmed to be equally high
(>90% conversion rate), while TimeLapse-seq has about an 80% conversion rate based on a
restriction digestion assay. A thorough comparison with the same starting material is needed
to conclude which method is the most sensitive and specific method to detect 4-thio-UTP
incorporations.
3.6.2 Limitations of SLAM-ITseq
Sensitivity
Unlike the conventional RNA-seq methods, which identify differential gene expression based
on the number of reads obtained for each gene, SLAM-ITseq needs to detect the difference
in base conversion rates between samples. Although, as shown in the experiments using
Tie2-Cre, SLAM-ITseq was confirmed to label housekeeping genes in endothelial cells that
account only for <5% of the tissue, it is unknown if this method is sensitive enough to detect
the difference in labelling levels of transcripts in even more minor types of cells in a tissue.
Also, metabolic RNA labelling level in a given exposure time is critically affected by two
factors: (i) intracellular concentration of the analogue and (ii) transcriptional rate of each
transcript. Hence, SLAM-ITseq might not be able to sensitively capture transcripts in cells
that have less access to blood (e.g. neurons) or transcripts that have extremely long turnover
times (e.g. rRNA).
A potential solution to capture transcripts with a low level of 4-thio-UTP incorporation
would be to perform an enrichment step of the labelled transcripts prior to SLAMseq. Thiol-
specific biotinylation followed by a streptavidin pull-down would allow us to perform deeper
sequencing of the labelled transcripts without wasting sequencing power on reads from the
majority of unlabelled transcripts. Also, its combination with SLAMseq would identify
truly labelled transcripts from the unlabelled RNAs that are pulled-down non-specifically.
Although the combination of streptavidin pull-down and SLAMseq has not yet been tested,
TimeLapse-seq has employed this strategy and obtained more reads from nascent transcripts
(e.g. pre-mRNA) (Schofield et al., 2018). However, this strategy has not yet been tested for
its recovery rate (i.e. how much labelled transcripts are retained after the purification), and
thus needs an extensive comparison to conclude if this is an appropriate method to increase
the sensitivity.
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Another limitation in sensitivity with SLAMseq is that its reliance on T>C conversions
to discover labelled transcripts. As summarised in Chapter 1, RNA-seq inherently introduces
errors in base calling at an order of 0.1% frequency. Thus, in theory, if the T>C conversions
introduced by the incorporation of U analogues occur less frequently, this signal could be
masked by the background error induced by the sequencing error. A simple solution to this
issue is to use a long read paired-end sequencing. Since the same base is read twice, the
probability of having the same T>C mismatch from the sequencing error should be less than
once in 106 bases. This approach, however, will not account for the errors introduced during
library preparation. Another solution would be to introduce unique molecular identifiers
(UMIs) at the end of reads. Although this approach requires to redesign the library preparation
method, it will find T>C mismatches introduced during PCR amplification by finding a
consensus sequence among the reads with the same UMI.
Effects on RNA metabolism
Since our knowledge about effects of RNA modifications on RNA metabolism is still limited,
it is still unknown if the 4-thiouracil-containing RNA retains the same biological properties
in comparison to the native RNA. A study addressed this issue by culturing cells with the
presence of different concentrations of 4-thiouridine and assessed cellular phenotypes and
transcriptional changes (Burger et al., 2013). This study discovered that high concentrations
of 4-thiouridine inhibit the synthesis of rRNA and decreases cell viability. Although, the
in vivo concentration of 4-thiouracil we use in SLAM-ITseq is much lower than that was
used in this in vitro experiment, the biochemical properties of RNA obtained from metabolic
labelling experiments should be viewed with care.
Cre promoter specificity
As the cell-type-specificity of this method is dependent on the specificity of a promoter
that drives Cre expression, labelling specificity with SLAM-ITseq is dependent on the Cre
promoter expression specificity. This limitation applies to all methods that employ a Cre
promoter to achieve cell-specificity and is not limited to SLAM-ITseq. Since some promoters
are less cell-specific and sometimes even stochastic (Heffner et al., 2012), it is critical to
choose a well-studied and reliable Cre promoter to achieve specific RNA labelling when
performing SLAM-ITseq.
Also, if cells of interest cannot be selected with a single promoter (e.g. immune cells),
FACS could still be an advantageous option as it can sort the cells with multiple markers.

Chapter 4
Analysis of mobile RNA in M. musculus
with SLAM-ITseq
4.1 Background
Since the discovery of RNA as an essential biological molecule in the cell, studies have been
conducted focusing on cell-autonomous RNA functions. However, in the past few decades,
some compelling lines of evidence suggesting the mobility, and non-cell-autonomous roles
of RNA in animals and plants have been shown. In this chapter, previous publications
suggestive of RNA mobility are summarised, and the mobility of RNA in mouse is assessed
with SLAM-ITseq.
4.1.1 Mobile RNA in nematodes
One of the most compelling lines of evidence that support the mobility of RNA was presented
in 2001. A newly established model organism at that time, Caenorhabditis elegans (C.
elegans) (Brenner, 1974), was shown to be effective in studying gene functions through
transcriptional perturbation by short RNA targeting it, which is called RNA interference
(RNAi) (Fire et al., 1991, 1998). Fire and colleagues showed that this RNAi can be induced
not only through an injection of RNA but also through feeding bacteria that produce double-
stranded RNA (dsRNA) (Timmons et al., 2001). Surprisingly, although dsRNA is taken up
by intestinal cells, RNAi is induced systemically, and also in subsequent generations through
germline. This result strongly suggests the spread of RNAi signal from intestinal cells to
other cells including germ cells.
Genes involved in this systemic RNAi process have been identified through forward
genetic screens. C. elegans expressing GFP only in body wall muscles and dsRNA targeting
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GFP only in pharynx was generated, and the systemic RNA interference deficient (sid)
phenotype was assessed. Forward genetic screens have identified SID genes involved in
the sid phenotype (Winston et al., 2002). Among them, SID-1 and SID-2 have been well
described. A transmembrane protein SID-1 has been suggested to be a dsRNA transporter
across the cell membrane, and overexpression of SID-1 in Drosophila S2 cells increased
the efficiency of dsRNA uptake by the cells (Feinberg and Hunter, 2003). SID-2, on the
other hand, is highly expressed in intestinal epithelium and involved in environmental RNA
uptake (Winston et al., 2007). Unlike SID-1, however, SID-2 is not involved in the spread of
RNAi among different cells.
Although SID-1 is conserved across different animal kingdoms including mammals, it
is important to note that the existence of SID-1 or SID-2 homologues in the genome is not
sufficient for RNA mobility. For example, Caenorhabditis briggsae (C. briggsae) possesses
both SID-1 and SID-2 in the genome, but is not able to induce systemic RNAi (Winston
et al., 2007). Similarly, other Caenorhabditis nematodes have been tested for their ability of
systemic RNAi through ingestion and injection (Nuez and Félix, 2012). The study revealed
that both the uptake and spread of RNAi signal in Caenorhabditis genus are under rapid
evolution, and only a subset of them shows such phenomena despite the high conservation of
SID genes.
4.1.2 Mobile RNA in plants
An elegant experiment in plants also showed the mobility of RNA between different parts
of a plant. It has been known that the transgenic tabacco line homozygous for 35S-Nia2
transgene exhibits silencing of both the host and transgenic Nia2 (Palauqui et al., 1996). Also,
this co-suppression of the genes is observed in a constant fraction of homozygous progeny.
Thus, using this system, isogenic plants with or without the silencing effect can be obtained,
and each state is called as S (silenced) and NS (non-silenced), respectively. By grafting NS
scion on S stocks, silencing of Nia2 in the grafted NS scion was observed, suggesting that the
silencing signal spreads from the stock to the scion (Palauqui et al., 1997) (Fig. 4.1). Also,
this spread of the silencing signal was discovered to be phloem-dependent.
The short-distance spread of transgene silencing signal has also been discovered in
Nicotiana benthamiana (Voinnet and Baulcombe, 1997). By delivering a full-length GFP
transgene by Agrobacterium tumefaciens to a part of a plant bearing a promoter-less GFP
transgene, gradual silencing in the inoculated part was induced, suggesting that the GFP
silencing signal spread from neighbouring parts of the plant (Voinnet et al., 1998).
Both long- and short-range spread of transgene silencing revealed to involve small
RNA species (Dunoyer et al., 2007). Northern blot analyses discovered two classes of
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Fig. 4.1 The graft experiment that showed the spread of gene silencing signal in plants
Schematic of the design of the experiment that showed the intercellular silencing signal in
plants (taken from Palauqui et al. (1997)). Non-silenced (NS) scion was grafted on silenced
(S) stocks, and the gene expression in the graft and the host was assayed. Both plants were
kept and observed to carefully exclude the possibility that the transgene silencing was induced
by time.
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siRNA, 21-22 nt and 25 nt long, that silence a transgene. The mobile siRNA research
in plants has experienced a shocking news that reported that two groups have admitted
image manipulations, following retractions of several key publications in the field. However,
the mobility of siRNA has been confirmed by independent groups (Molnar et al., 2010),
suggesting that the scientific claims made in the retracted publications may still be valid.
Several miRNA species were also suggested to be mobile between different parts of
plants similar to siRNA. Still, for both siRNA and miRNA, the detailed mechanisms of action
need to be explored. Also, more importantly, functional consequences of the small RNA
mobility is still elusive.
4.1.3 Extracellular RNA in mammals
In mammals, the studies on RNA mobility began with the discovery of extracellular RNA.
Scientists started to analyse extracellular nucleic acid concentration as early as 1931 (Javillier
and Fabrykant, 1931), when functions of DNA and RNA were not yet known. These studies
were conducted in the context of studies on how different metabolites are exchanged between
cells and plasma. Concentration of DNA and RNA in human plasma was determined with
rapid inhibition of ribonuclease (RNase) (Kamm and Smith, 1972) in order to prevent
degradation of the nucleic acids.
Extracellular RNA research has became a hot topic when tumour-derived RNA was
detected in human plasma (Kopreski et al., 1999; Lo et al., 1999), as it promised discovery
of novel diagnostic markers. A characterisation of circulating RNA in the plasma revealed
that the majority of the serum RNA is of low molecular weight. Deep sequencing of small
RNA in plasma revealed that abundant miRNA is stably present in the plasma (Mitchell et al.,
2008).
The big remaining question is how the extracellular RNA is protected from degradation.
Since RNase exists in extracellular space, any naked RNA in the circulation will be degraded
rapidly. To test if the circulating RNA is associated with any particles that protect RNA
from degradation, RNA concentration was measured after filtering with different sizes of
pores (Ng et al., 2002). This experiment indeed suggested the possible existence of RNA
that is associated with particles. Also, though extracellular RNA is stable for at least a few
hours in plasma at room temperature, an addition of detergent to plasma induced a rapid
degradation of the RNA, suggesting that extracellular RNA is protected by either lipid bilayer
or protein (El-Hefnawy et al., 2004).
An experiment identified that small (50-90 nm) extracellular vesicles called exosomes
are present in the serum and small RNAs were discovered in these vesicles. Since then, the
vesicle has become a strong candidate that keeps RNA intact in the extracellular space (Valadi
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et al., 2007). On the other hand, RNA-binding proteins have also been proposed to protect
RNA from degradation (Arroyo et al., 2011). In this report, an assay was performed to
identify the protective factor of RNA by exposing extracellular fluid to different treatments,
detergent or protease, and RNA abundance in the fluid after the treatment was compared.
While the protease treatment significantly reduced the concentration of extracellular RNA,
the detergent treatment did not, which suggests that the majority of RNA is bound by RNA-
binding proteins and thereby remains stable in the extracellular space. A miRNA-binding
protein, Ago2 pull-down experiment in plasma identified abundant miRNAs bound to Ago2.
Yet, since no biological functions have been discovered for extracellular RNAs, there is no
consensus on which mode of protection is more biologically relevant.
4.1.4 Mobile RNA in mammals
As the research on extracellular RNA grew, some started to hypothesise that these extracellular
RNAs are mobile between different cells and function as an intercellular signal. A number of
experiments were performed to test this hypothesis by transferring purified exosomes from a
dish of cultured cells to another, and mRNAs derived from the donor cells were observed in
the recipient cells (Valadi et al., 2007). Although some of these experiments are suggestive of
RNA transfer through exosomes, it is hard to conclude that the same is true in vivo, as these
experiments were mostly performed using immortalised cells, and the exosome concentration
introduced in the medium was presumably much higher than the physiological concentration.
An elegant approach was invented to study the mobility of transgene-derived mRNA in
vivo by using mice with a Cre-inducible LacZ transgene and a Cre transgene under a cell-type-
specific promoter. With this approach, the mobility of Cre mRNA can be tested: if there is
mobile Cre mRNA to a non-Cre-expressing cell, the recipient cell will be detectable through
the LacZ positive signal. Ridder et al. generated mice expressing Cre in the haematopoietic
lineage, and, surprisingly, detected LacZ-positive neurons in the brain. They carefully
excluded the possibility that this was caused due to cell fusions through immunofluorescence
assays. Hence, this suggests the mobility of Cre mRNA from haematopoietic cells to neurons.
However, since this experiment does not show the mobility of endogenous transcripts, and the
number of LacZ-positive neurons detected was quite low, it is hard to link this phenomenon
to any physiological processes. Also, it could just be an ectopic expression of the Cre in the
neurons.
Below, some experiments that attempted to show the mobility of endogenous RNA are
summarised.
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necessary to unveil how miRNAs are sorted into exo-
somes and whether there is a pathway in which specific 
miRNAs are chosen to be incorporated into exosomes.
Growing evidence indicates that exosomal miRNA 
packaging occurs non-randomly based on differential 
expression of exosomal miRNA compared to that of donor 
cells.92 Indeed, studies have demonstrated that nearly 30% 
of the released miRNAs in vitro and in vivo do not reflect 
the expression profile found in donor cells, suggesting that 
specific miRNAs are selected to be intracellularly retained 
or released by exosomes.105 Taken together, these studies 
indicate that the secretion of miRNAs by tumor cells is 
associated with their ability to influence the surround-
ing microenvironment for their own benefit. After being 
transcribed in the nucleus and exported to the cytoplasm 
in donor cells, pre-miRNA molecules can bind to specific 
proteins responsible for their stability and association 
with MVBs and exosomes. After fusion with the plasma 
membrane, MVBs are able to release exosomes into the 
circulating compartments and bloodstream. These exo-
somes can donate their miRNAs to the recipient cells by 
the process of endocytosis. Exosomal miRNAs are pro-
cessed by the same machinery used in miRNA biogenesis 
and thus promote widespread consequences within the 
cell and lead to an alteration in the physiologic state of the 
cell. Recently, another mechanism potentially involving 
the nSMase2 pathway was discovered showing that high-
density lipoprotein (HDL) transports circulating miRNAs 
and can alter gene expression by transferring miRNAs to 
recipient cells (Figure 3).106 This is an exciting finding, but 
further study is necessary to determine the mechanism by 
which selective miRNAs are taken up from recipient cells 
and how they are released.
Although the presence of miRNAs in exosomes or 
HDL could explain their stability in serum, other pos-
sibilities include protection by chemical modifications 
or association with protein complexes. In this regard, 
recent findings showed that the RNA-binding protein 
nucleophosmin 1 (NPM1) may have a role in the expor-
tation, packaging, and protection of extracellular miRNAs 
(Figure 3).107 Furthermore, recent studies demonstrated 
that potentially 90% of the plasma and serum miRNAs 
are not encapsulated by vesicles, but cofractionated with 
protein complexes. The results indicated that the associ-
ation of Argonaute2 (Ago2; the effector of target mRNA 
silencing by miRNAs) with plasma and serum miRNAs 
influences their stability. Whether the Ago2–miRNA 
complex in plasma is capable of regulating the expression 
of recipient cells is not clear; however, these findings may 
be useful in the near future for establishing circulating 
miRNA as biomarkers.108
It was demonstrated that the cell-free miRNAs were 
probably derived from normal and/or tumor-lysed cells 
in body fluids.71,109 Therefore, in order to use miRNAs as 
biomarkers in cancer, it is important to determine the 
source of the tumor-specific miRNAs in body fluids and 
establish a signature capable of differentiating diseased 
from healthy states. Also, it is necessary to clarify whether 
the differential expression between tumor and normal 
tissues is related solely to the tumor or is a response 
mediated by the affected organ or system. There is evi-
dence that circulating miRNAs in body fluids and extra-
cellular fluid compartments have hormone-like effects, 
leading to widespread consequences within the cells at 
a distance from the ‘secreting’ cell (Box 1). Nonetheless, 
additional studies are necessary to elucidate the mecha-
nism by which miRNAs reach the bloodstream and 
Figure 3 | Biogenesis and mechanism of action of circulating miRNAs. After being 
transcribed in the nucleus, pre-miRNA molecules can be processed further by Dicer 
in the cytoplasm. In addition, based on recent findings,92,104–108 there are at least two 
ways that pre-miRNAs can be packaged and transported using exosomes and MVBs 
or other (not fully explored) pathways together with RNA-binding proteins. After fusion 
with the plasma membrane, MVBs release exosomes into the circulating 
compartments and bloodstream. Likewise, pre-miRNA inside the donor cell can be 
stably exported in conjunction with RNA-binding proteins, such as NPM1,107 and 
Ago2,108 or by HDL.106 Circulating miRNAs enter the bloodstream and are taken up by 
the recipient cells by endocytosis or, hypothetically, by binding to receptors present 
at the recipient cellular membrane capable of recognizing RNA-binding proteins. 
More studies are necessary to elucidate how miRNAs are loaded into exosomes and 
how they can be internalized by recipient cells. Exosomal miRNAs are processed by 
the same machinery used in miRNA biogenesis and thus have widespread 
consequences within the cell by inhibiting the expression of target protein-coding 
genes. For processing machinery see Figure 1. Abbreviations: MVBs, multivesicular 
bodies; NPM1, nucleophosmin 1; Ago2, Argonaute2; HDL, high-density lipoprotein.
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Fig. 4.2 Working hypotheses of miRNA mobility in m mmals
Schematic summary of potential pathways, in which miRNAs are transferred from one cell
to another. Pre-miRNAs synthesised in a donor cell are released into the circulation and
are transferred to a recipient cell contained in exosomes or by pr tei s bound t them. The
pre-miRNAs delivered to the recipient cel r further process d by Dicer to generate mature
miRNAs and regulate gene expression in the recipient cell. Taken from Maria Angelica et al.
(2011).
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Adipose-to-liver RNA transfer
A series of experiments have been performed to test if adipose-derived miRNAs are released
into the circulation and if they are delivered to liver (Thomou et al., 2017). First, adipose-
specific Dicer knock-out mice (ADicerKO) were generated, and the abundance of circulating
miRNA was compared with wild-type mice. The overall abundance of circulating miRNA
was significantly lower in the ADicerKO, which suggests that adipocytes are the major
contributer to the circulating miRNA pool. Next, the study assessed the intercellular mobility
of miRNAs in vivo. They injected adenovirus bearing a human pre-miR302f directly into
brown adipose tissue (BAT), and, four days later, another adenovirus bearing a luciferase
reporter attached to the 3′ UTR sequence that miR302f binds to was introduced intraveneously
so that it was delivered to liver. The luciferase reporter expression in the liver was lower
in the pre-miRNA-injected mice compared to control, suggesting that the miR302f was
transferred from BAT to liver and suppressed the expression of the reporter. Although this
direct assessment of mobility in vivo paves the way to understanding miRNA mobility in
mice, this particular experimental result could be just because the adenovirus bearing pre-
miRNA was delivered to liver. Also, even if this particular miRNA is mobile as stated, this
study raised new questions: how general is this phenomenon among different species of RNA
and cell types? What is the physiological significance of this RNA mobility?
Gut-to-liver RNA transfer
A potential communication between intestine and liver was also shown (Deng et al., 2013).
Intestinal epithelial cells are known to secrete extracellular vesicles. Deng et al. collected the
extracellular vesicles from intestine, labelled them with infrared dye, and administered the
labelled vesicles to another mice orally. They showed that fluorescent signal was detected in
the intestine and liver of the recipient mice, which shows the mobility of the administered
vesicle from intestine to liver. Although this experiment proves neither the mobility of
vesicles synthesised in intestinal cells nor the uptake of the contents of the vesicles in liver,
the proposed hypothesis seems reasonable considering the fact that blood flows from intestine
to liver through the portal vein.
Epididymis-to-sperm RNA transfer
The majority of steps of spermatogenesis takes place in the testicular tubule, and when
the cells become elongating spermatids, they are released to another tubular organ called
epididymis attached to testis. The epididymis was once thought to just store sperm before
ejaculations, but it turned out to be important for sperm to get fully matured. The epididymis
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can anatomically be divided into three parts from the proximal part: caput, corpus, and cauda
epididymis. Sperm collected from the caput shows lower mobility and less efficient acrosome
reaction with oocytes compared to the ones collected from the cauda (Lakoski et al., 1988).
Studies have found that the epididymal epithelium releases extracellular vesicles named
epididymosomes, which contain various biological molecules that are thought to be important
for sperm maturation (Frenette et al., 2002). Co-incubation of sperm and epididymosomes
revealed that they can fuse together.
Recent studies have found that epididymosomes also contain small RNA species, and two
papers claim that RNA is transferred from the epididymis to sperm using epididymosome as
a cargo (Chen et al., 2016; Sharma et al., 2016). More surprisingly, the transferred RNA was
suggested to regulate the transcriptional network in the mouse embryo and, in turn, affects
phenotypes of the offspring. Mechanisms of the transfer and mode of actions of the small
RNA in embryos still need further investigations.
Also, the same group reported that this RNA transfer is even essential for mouse develop-
ment (Conine et al., 2018). They showed that the sperm collected from the caput epididymis
is not only incapable of fertilisation but also incapable of progressing development. The
lower developmental potential observed from the caput sperm-derived embryos was rescued
by exposing the sperm to epididymosomes prior to fertilisation, suggesting that the molecules
contained in epididymosomes are critical for the embryonic development. However, recently,
another group sent a letter to the journal claiming that they successfully generated mice from
caput sperm, and thus epididymosomal transfer is not essential for mouse development (Zhou
et al., 2019). Also, in human, in vitro fertilisation (IVF) is routinely performed using sperm
obtained from epididymis, and even the testicular sperm is also capable of progressing devel-
opment. Thus, it does not seem to be reasonable that murine sperm loses the developmental
potency only while they are in the caput epididymis.
4.1.5 Mammalian SID-1 orthologs
Since SID-1 is suggested to be an RNA transporter in C. elegans, a number of studies have
analysed the functions of its orthologs, called Sidt1 and Sidt2. Based on the RNA expression
atlas1, both genes show a general expression pattern across mammalian tissues, but Sidt2 has
higher expression compared to Sidt1 in many tissues.
A number of in vitro studies have addressed the functions of Sidt1. One study has
reported that the overexpression of Sidt1 in mammalian cells enhances the cellular ability to
uptake RNA and thus is useful for RNAi experiments (Wolfrum et al., 2007). The functional
1https://www.proteinatlas.org
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significance of Sidt1 in vivo has also been assessed through generating KO mice. The
KO mouse database shows that Sidt1 KO mice had been generated and their phenotypes
were assessed, but no clear phenotypes were observed2. Independent of this large-scale KO
project, a group also generated Sidt1 KO mice and assessed the ability of RNA transfer in
immune cells (Nguyen et al., 2019). They identified that Sidt1 localises to the endosomal
and lysosomal membrane and is involved in releasing dsRNA to the cytosol through direct
interaction with the RNA.
Involvement of Sidt2 in RNA uptake has also been studied, and a group reported that
the overexpression and knock down of Sidt2 led to increased and decreased uptake of
single-stranded oligonucleotides, respectively (Takahashi et al., 2017). Sidt2 KO mice have
also been generated, and several KO-associated phenotypes have been reported. Metabolic
alterations including glucose intolerance and changes in liver histology were observed in the
KO mice, suggesting the link between Sidt2 and liver functions (Chen et al., 2018; Gao et al.,
2013, 2016), though the molecular mechanisms that cause these phenotypes are unclear.
Also, another group assessed the significance of Sidt2 in immune cells, where relatively
higher expression of Sidt2 is observed (Nguyen et al., 2017). They showed that the cellular
ability of dsRNA uptake was unchanged between KO and wild-type (WT), and that dsRNA
was mostly confined in the endosomes in the KO mice, whereas it was diffused in the cytosol
in WT. These observations suggest that Sidt2 is not involved in the dsRNA uptake but is
important for dsRNA release from the endosomes. Further, the KO mice were fed with
human sarcoma virus (HSV), which is an RNA virus, and lower survival was observed in the
KO mice compared with WT. Thus, these results show for the first time that transmembrane
RNA mobility in immune cells are important for antiviral immunity.
However, there is also a contradictory report about human SIDT1 and SIDT2. Valdes
et al. discovered a gene involved in cholesterol transport in C. elegans and named it CUP-1.
Surprisingly, their in silico sequence analysis revealed that human SIDT1 and SIDT2 are
closer homologues to CUP-1 than SID-1. Also, they found that the expression of neither
SIDT1 nor SIDT2 is linked with the cellular ability of dsRNA uptake in vitro, but, instead,
that SIDT1 overexpression increased cholesterol uptake. Interestingly, when dsRNA was
provided with cholesterol, the overexpression of SIDT1 increased dsRNA uptake. Since the
previous papers reporting the significance of SIDT1 and SIDT2 in RNA uptake were shown
using lipophilic RNAs, the authors speculate that mammalian SIDTs are just involved in
cholesterol transport but not RNA transport. Also, this hypothesis fits well with the metabolic
phenotypes observed in the Sidt2 KO mice, though it does not explain the RNA release from
endosomes observed in the immune cells.
2https://www.mousephenotype.org/data/genes/MGI:2443155
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4.1.6 Mobile RNA and intergenerational epigenetic inheritance
The mobile RNA phenomenon is particularly fascinating when it is viewed in the context of
information transmission from soma to germline.
Whether parental experiences affect offspring has been a great question since the 19th cen-
tury. The theory about inheritance of acquired phenotypes proposed by Lamarck (Lamarck,
1809) has become unrecognised after being backlashed by Weismann both theoretically and
experimentally (Weismann, 1892). Recently, however, some neatly designed experiments
have shown that some phenotypic differences were observed when parents are exposed to
certain stimuli (Ng et al., 2010). To best focus on the inheritance through germline, a number
of experiments have been designed to expose male animals to stimuli, and the phenotypic
changes in the offspring were assessed. Genome-wide epigenetic analyses on spermatozoa
revealed that a wide range of molecular states in the spermatozoa was altered in response to
the stimuli, which includes changes in DNA methylation (Carone et al., 2010; Radford et al.,
2014) and abundance of RNA species (Gapp et al., 2014). Some research groups reported
that differential RNA expression in sperm is sufficient to induce the phenotypic changes
observed by showing the reproduction of the phenotypes through injecting RNA obtained
from the sperm of males that were exposed to the stimuli to zygotes (Chen et al., 2016; Gapp
et al., 2014; Sharma et al., 2016).
A common working hypothesis in the field is that somatic cells exposed to a certain
stimulant release RNA that is later taken up by germ cells, which in turn alters the phenotypes
of offspring derived from the germ cells. This hypothesis is surprisingly similar to the
conceptual substance called “gemmules” proposed by Charles Darwin (Darwin, 2010),
although, unlike the hypothetical gemmules, extracellular RNA or exosomes will not form
germ cells themself.
4.2 Aims of this chapter
Although a number of studies have been conducted to assess the mobility of RNA between
mammalian cells, it has been challenging to directly assess the mobility of RNA in vivo.
Most of the studies have utilised in vitro systems, in which medium or extracellular vesicles
collected from cells were transferred to another. Although a few in vivo experiments have
been performed, they mostly showed the mobility of transgene-derived RNA, and thus it is
still unclear if there is any endogenous mobile RNA in mammals.
To directly and comprehensively assess the intercellular mobility of endogenous RNA in
mice, I employed SLAM-ITseq. By generating mice expressing UPRT in a specific cell type,
potential “donor” cells, I tested if the labelled RNA is mobile to any other tissues by detecting
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the labelled RNA in non-UPRT-expressing cells, potential “recipient cells” (Fig. 4.3). Tissues
for the analyses were chosen based on previous publications suggesting mobile RNA and the
availability of well-studied Cre lines.
To optimise the RNA labelling time in vivo, 4-thiouridine exposure to WT mice was
first performed instead of the transgenic mice. After determining the exposure time that is
sufficient to label small RNAs, the same exposure time was used for mobile RNA assays
with cell-type-specific RNA labelling animals.
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Fig. 4.3 Schematic representation of the experimental design to detect mobile RNA in
vivo
Transgenic mice expressing UPRT in a specific cell type (i.e. donor cells) is generated and
exposed to 4-thiouracil to label RNA synthesised in the cells. RNA collected from the serum
and non-UPRT-expressing tissues (i.e. recipient tissue) was analysed with SLAM-ITseq
to see if the RNA labelled in the donor cells are detectable. Wavy line, RNA; red circle,
incorporated 4-thiouracil; Pdonor, a promoter specific to the donor cell.
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4.3 Confirmation of extracellular small RNA labelling with
4-thiouridine
In order to achieve in vivo metabolic labelling to detect mobile RNA in mice, I first performed
4-thiouridine injections to WT mice to find an optimal dosing condition for the experiment.
Since 4-thiouridine is incorporated into RNA independent of UPRT, all the cells exposed to
4-thiouridine should synthesise the labelled RNA. The thiol-labelling level of the circulating
miRNA is used as a readout to assess if a given exposure method to an analogue is sufficient
to observe mobile RNA. As 4-thiouracil and 4-thiouridine can both be administered in the
same way, they presumably have similar physiological dynamics in vivo.
Considering many miRNA species have a half-life of 24 h or longer (Duffy et al., 2015),
an exposure time of 54 h was used to maximise the labelling level. Three injections were
performed with 24 h intervals, and tissues were collected 6 h after the last injection (Fig. 4.4).
This shorter interval of 6 h between the last injection and tissue collection was chosen in
order to capture miRNAs with a shorter half-life before they were degraded. WT mice were
exposed to either 4-thiouridine or DMSO control, and RNA was extracted from the serum.
To capture both exosomal and non-exosomal miRNAs, RNA was isolated from the serum
without any fractionation. The alkylation reaction with IAA was performed as described
before, and SLAMseq was performed on the IAA-treated small RNA.
24 h 24 h 6 h
4-thiouridine or DMSO
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Serum
collection
WT
Fig. 4.4 4-thiouridine injection scheme to label circulating miRNA
WT mice were i.p. injected with 4-thiouridine or DMSO (N = 3 each). Two additional
injections were performed at 24 h intervals, and the serum was collected 6 h after the last
injection.
To identify circulating miRNAs that were labelled by the 4-thiouridine injections, miRNA
species with higher T>C conversions in 4-thiouridine serum were determined by comparing
the T>C conversion rates between 4-thiouridine and DMSO mice (Fig. 4.5A). The miRNA
expression level was also compared between 4-thiouridine and DMSO mice, and a high
positive correlation of the abundance of miRNAs was confirmed, suggesting that 4-thiouridine
incorporation did not have a significant impact on serum miRNA abundance (Fig. 4.5B).
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Although a higher proportion of highly expressed miRNAs were labelled, lowly expressed
miRNAs were also labelled (Fig. 4.5C), suggesting that wide-ranged circulating miRNAs
were labelled.
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Fig. 4.5 Circulating miRNAs labelled by 4-thiouridine injections
(A) T>C conversion rate of the serum miRNAs comparing 4-thiouridine and DMSO mice.
miRNAs with significantly higher T>C rate in the 4-thiouridine-exposed serum are shown
in red (beta-binomial test FDR <0.1; N = 3 for each condition). A constant value of 10-5
was added when plotting. (B) Serum miRNA expression in 4-thiouridine and DMSO mice
is compared. Spearman’s correlation coefficient between the two conditions is shown. A
constant value of 10-2 was added when plotting. (C) miRNAs that were detected in all
samples are sorted by their mean expression among all samples (N = 6). Significantly
labelled miRNAs are shown in red. Each point represents the mean expression of miRNA
among all samples, and the vertical lines show 95% confidence intervals.
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Since 4-thiouridine can only be incorporated into genomic T positions of miRNAs, the T
content of labelled and total miRNA was compared to test if miRNAs with high T content
were enriched in the labelled fraction (Fig. 4.6). However, distributions of the labelled and
total miRNAs with different genomic T content do not differ significantly, which suggests
that labelled circulating miRNAs identified with SLAMseq did not enrich for miRNAs with
higher T content.
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Fig. 4.6 Cumulative distribution of the number of Ts in labelled and total miRNAs
Empirical cumulative distribution function plot of the number of Ts in labelled and total
circulating miRNAs. The P-value obtained from the two-tailed KS-test is shown.
Circulating miRNAs are thought to be originated from multiple tissues in a body. To
confirm if the 4-thiouridine injections labelled circulating miRNAs released from specific
tissues with bias, a list of the labelled miRNAs by 4-thiouridine is obtained, and their
expression patterns in different tissues were assessed using a published miRNA expression
atlas (de Rie et al., 2017). A heat map of the cellular expression pattern for the labelled
miRNA shows that some labelled miRNAs have a broad expression pattern across cell types,
while others have a highly specific expression pattern. However, no obvious cluster in any
specific cell types was found, and thus it suggests that the systemic 4-thiouridine injection
labelled the circulating miRNAs with little bias towards any miRNAs originated from specific
tissues.
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4.4 Mobile RNA assay with SLAM-ITseq
Now that this 3-time injection of 4-thiouridine was confirmed to label circulating miRNAs
with little bias, the same protocol was applied to the SLAM-ITseq method to study the
mobility of miRNA synthesised in particular cell types.
Both Cre+ and Cre- mice were exposed to 4-thiouracil by i.p. injections, and RNA
from the tissue containing UPRT-expressing cells, serum, and a non-UPRT-expressing tissue
was collected. SLAMseq was performed on the isolated RNA, and labelled miRNAs were
determined based on the T>C rate difference between Cre+ and Cre-.
Based on the previous studies that showed the intercellular mobility of transgene-derived
RNA or exosomes, three pairs of tissues were chosen for the analyses: WAT to liver (Thomou
et al., 2017), intestine to liver (Deng et al., 2013), and epididymis to sperm (Chen et al.,
2016; Sharma et al., 2016, 2018). To achieve this goal, three different Cre mice were used to
generate both Cre+ and Cre- mice: Adipoq-Cre (adipocyte specific), Vil-Cre (gut epithelium
specific), and Spink8-Cre (epididymal epithelium specific). The specificity of the expression
of these promoters have previously been extensively tested, and in vivo labelling specificity
using 4-thiouracil with Adipoq-Cre+ and Vil-Cre+ mice were confirmed in Chapter 3.
4.4.1 Adipose-to-liver RNA transfer was not detected
Adipoq-Cre was used to test if adipocyte-derived RNA is mobile. Epididymal white adipose
tissue (eWAT) was chosen as a representative adipose tissue and was used to confirm if
miRNA labelling in the donor cells was achieved. Adipoq-Cre should be expressed in both
WAT and brown adipose tissue (BAT). SLAM-ITseq was performed on the small RNA
extracted from eWAT, serum, and liver, and T>C rate for miRNAs was compared between
Adipoq-Cre+ and Adipoq-Cre-.
Significantly labelled miRNAs were found in eWAT, which suggests that successful small
RNA labelling was achieved in the donor tissue (Fig. 4.8A). To confirm the abundance of
labelled and unlabelled miRNAs, the expression level of all the sequenced miRNAs are
plotted (Fig. 4.8B). Strikingly, the majority of the highly abundant miRNAs were labelled,
and some of the miRNAs with mid-low expression level were also labelled.
However, when the beta-binomial test was performed on the labelling level of miRNAs
detected in the serum and liver, none of them reached FDR <0.1 (Fig. 4.8A). To compare
the miRNA species sequenced from different tissues, an Euler digram summarising all the
sequenced miRNAs in eWAT, serum, and liver was generated (Fig. 4.8C). Since there is a
significant overlap of the detected miRNAs among these three tissues, non-detection of the
4.4 Mobile RNA assay with SLAM-ITseq 83
Serum Liver
eWAT
Serum
Liver
6
210
2
209
142
8
60
eWAT
10−5
10−4
10−3
10−2
10−1
100
10−5 10−4 10−3 10−2 10−1 100
Cre− T>C fraction
C
re
+ 
T>
C
 fr
ac
tio
n
10−5
10−4
10−3
10−2
10−1
100
10−5 10−4 10−3 10−2 10−1 100
Cre− T>C fraction
C
re
+ 
T>
C
 fr
ac
tio
n
10−5
10−4
10−3
10−2
10−1
100
10−5 10−4 10−3 10−2 10−1 100
Cre− T>C fraction
C
re
+ 
T>
C
 fr
ac
tio
n
B
C
102
103
104
105
M
ea
n 
ex
pr
es
si
on
 (c
pm
)
Labelled Unlabelled
A
Fig. 4.8 Mobile RNA assay between eWAT and liver
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labelled miRNAs are shown in red. A constant value of 10-5 was added when plotting. (B)
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labelled miRNAs in serum and liver is not because the labelled miRNAs were not sequenced
in these tissues.
4.4.2 Intestine-to-liver RNA transfer was not detected
Exosomes taken up from intestine are known to be transferred to liver, and intestinal epithe-
lium has the capacity to release extracellular vesicles containing RNA through in vivo and
organoid studies (Deng et al., 2013; Szvicsek et al., 2019). To test if the RNA contained in
these exosomes was released from the intestinal epithelium, SLAM-ITseq was used to label
RNA in the intestinal epithelium and to test if the labelled RNA was found outside intestine.
Villin is known to be expressed in all types of the intestinal epithelial cells (Madison et al.,
2002), and thus Vil-Cre+ mice were used to label RNAs in all the intestinal epithelium cells
to see if any RNA generated in the cells is mobile to the serum or liver.
Similar to the experiment using Adipoq-Cre, Vil-Cre+ and Vil-Cre- mice were exposed to
4-thiouracil for three times, and duodenum, serum, and liver were collected. RNA extracted
from these tissues was used for SLAM-ITseq analyses to find labelled miRNAs. Significantly
labelled miRNAs in Vil-Cre+ mice were found by comparing the T>C ratio (Fig. 4.9). A plot
summarising the expression level of miRNAs confirmed that most of the abundant miRNAs
were significantly labelled (Fig. 4.9B).
However, similar to the previous experiment, no labelled miRNAs were found in the
serum and liver. To confirm the similarity of the repertoires of miRNAs detected in these
three tissues analysed, an Euler diagram comparing detected miRNAs in these tissues was
generated (Fig. 4.9C). A considerable overlap is seen among the detected miRNAs in these
tissues, suggesting that the labelled miRNAs in intestine were also sequenced in the serum
and liver, and that non-detection of miRNAs in the serum and liver was not due to failure in
RNA sequencing.
4.4.3 Epididymis-specific RNA labelling was achieved with Spink8-Cre
Although specific Spink8 expression in the epididymal epithelium has been reported (Jalkanen
et al., 2006), the specificity of Cre expression in Spink8-Cre+ mice has not been confirmed.
To test the specificity of RNA labelling with this transgene, SLAM-ITseq was performed
on the polyA RNA extracted from the cauda epididymis. The beta-binomial test identified
genes with a significantly higher T>C rate in Spink8+ mice (Fig. 4.10A). To confirm whether
cell-type-specific RNA labelling was achieved, a few marker genes of epididymis as well as
sperm were chosen as positive and negative controls, respectively (Fig. 4.10B). As expected,
while known epididymal genes (Spink8, Spink10, and Wfdc10) were significantly labelled,
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Fig. 4.9 RNA mobility assay between intestinal epithelium and liver
(A) T>C rate of miRNA in Vil-Cre+and Vil-Cre- is compared in intestine, serum, and liver.
Significantly labelled miRNAs are shown in red (beta-binomial test; FDR <0.1). A constant
value of 10-5 was added when plotting. (B) Mean expression of the miRNAs detected in all
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sperm genes (Prm1, Prm2, and Tnp2) were not labelled, suggesting that epididymal-specific
RNA labelling was achieved.
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4.4.4 Epididymis-to-sperm RNA transfer was not detected
Since a few reports suggest that small RNAs, namely miRNAs and tRFs, synthesised in the
epididymal epithelium are packaged into epididymosomes and are delivered to sperm (Chen
et al., 2016; Sharma et al., 2016, 2018), this hypothesis was tested with Spink8-Cre+ mice
that label RNA in the epididymal epithelium.
First, small RNA labelled by 4-thiouracil in the epididymis was confirmed by comparing
the labelling level of each small RNA in Spink8-Cre+ and Spink8-Cre-. Since the previous
studies suggest that both miRNAs and tRFs may be mobile, the labelling level of these
two small RNA species was assayed. Surprisingly, although a few tRFs are labelled, no
significantly labelled miRNAs were detected in the epididymis (Fig. 4.11A, B). Since similar
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sets of small RNA were detected in these samples, and the epididymal mRNA was confirmed
to be successfully labelled in the previous chapter, this could be due to the low synthesis rate
of miRNA in the epididymis. Also, no detectable labelling of both miRNA and tRF in the
serum and sperm was observed.
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Fig. 4.11 Small RNA mobility from epididymis to sperm was analysed
(A, B) Mean T>C rate among biological replicates (N = 3 each) is compared between Spink8-
Cre+ and Spink8-Cre- in epididymis, epididymosomes, and sperm is shown for (A) miRNAs
and (B) tRFs. A constant value of 10-5 was added when plotting. Red points represent the
small RNAs that were significantly labelled in Spink8-Cre+ mice. (C, D) Euler diagrams
showing overlaps of the detected small RNAs among the epididymis, epididymosomes, and
sperm for (C) miRNAs and (D) tRFs.
Next, to compare the RNAs detected in three different tissues, Euler diagrams summaris-
ing overlaps of the detected small RNAs in these tissues were made (Fig. 4.11C, D). Since
the labelled small RNAs were detected in all the samples, the non-detection of the labelled
small RNA in epididymosomes and sperm might not be due to the failure in capturing the
labelled small RNA species in the small RNA-seq library preparation.
4.5 Discussion
An increasing number of papers have reported mobile RNA in mammalian tissues in the past
few decades, due to its promise to develop new diagnostic markers that can be used for an
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early detection of various types of diseases based on a signature of extracellular RNA. Also,
it has been discussed in the context of epigenetic memory across generations. Similar to the
systemic and multigenerational RNAi in C. elegans, some reports claim that small RNAs
are also mobile from somatic cells to germ cells in M. musculus. This field is potentially
a very exciting new avenue since if the abundance of RNA delivered from somatic cells
to gametes affects the development of embryos derived from it, this could actively relay
parental experience to their offspring, which adds another layer of the transgenerational flow
of information in addition to the stable DNA sequence.
However, it has been challenging to show the mobility of endogenous RNA directly. Since
many identical RNA molecules are synthesised in different cells, it is essential to employ
a strategy to distinguish RNAs that are exogenously delivered from those that are natively
synthesised to prove the mobility of RNA. In this study, a cell-type-specific metabolic RNA
labelling method, SLAM-ITseq, was employed in order to test the intercellular mobility
of RNA in three different pairs of tissues, which were chosen based on previous reports
showing the mobility of either transgene-derived RNA or extracellular vesicles. However,
our analyses with SLAM-ITseq did not detect any small RNA mobility reported in these
publications.
Since the absence of evidence is not the evidence of absence, it is not possible to conclude
that there is no mobile RNA based on the non-detection of mobile RNA in this study. It
could be just due to a lack of detection power: although it was confirmed that this method
is sensitive enough to detect 5% of labelled RNA that is diluted in 95% of unlabelled RNA
based on the Tie2-Cre experiment in brain (Chapter 3), mobile RNA delivered to a recipient
cell could be much less abundant than this. Another possibility is that mobile RNA could be
very unstable. Our experiment was designed to capture both stable and unstable transcripts,
and this is why the mice were culled 6 h after the last injection. However, it is possible that
mobile RNA was already degraded within this 6 h. Finally, in this experiment, although the
majority of highly expressed RNAs were labelled in the donor cells, not all the donor RNAs
were labelled. Thus, the less abundant unlabelled host RNAs may have escaped the detection
even though they were mobile.
Nevertheless, this study provides new insights into the nature of endogenous mobile RNA
in mammals. As even the most abundant and highly labelled RNAs were not detected in
both serum and recipient tissues, RNA release from a cell must be highly selective or very
miniature. This is considerably different from the results that were previously reported in
experiments using cell lines, where highly expressed miRNAs in the cell lines were also
observed in extracellular space. This signifies the importance of performing an experiment in
4.5 Discussion 89
vivo with an appropriate RNA labelling method to assess the significance of various mobile
RNA phenomena.

Chapter 5
Detection of zygotic transcription with
SLAMseq
5.1 Background
Animal development begins with fertilisation. A haploid sperm and an oocyte fuse together
to form a diploid zygote. Just at the time of fertilisation, the majority of RNA contained in
zygote is of oocyte-origin because of a massive difference in the cell size between the oocyte
(60-70 µm diameter in mouse) and sperm head (6-8 µm length in mouse). After fertilisation,
however, this maternally deposited RNA undergoes extensive degradation, and, in turn, the
zygotic genome starts to synthesise its own transcripts to shape the transcriptome required for
animal development, which is termed zygotic genome activation (ZGA). Although zygotic
transcription is known to be essential for development and some key regulators have been
discovered, the complete picture about zygotic genome activation is not yet known. Here,
literature on mouse preimplantation development and zygotic transcriptional dynamics is
summarised.
5.1.1 Preimplantation development of M. musculus
After fertilisation, mouse embryos undergo a number of cell divisions, and when they
reach the late blastocyst stage, embryos come out from the outer layer, zona pellucida, and
implant themselves onto the internal wall of uterus for further development. Embryonic
development before the implantation is referred to as “preimplantation development” and
has been studied to understand how terminally differentiated germ cells are reprogrammed to
become totipotent embryos. Until the 8-cell stage, an embryo undergoes symmetric cleavages
and remains totipotent: any one of the cells can give rise to a viable offspring (Chazaud and
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Yamanaka, 2016) (Fig. 5.1). In the next cleavage, the cells are asymmetrically divided to
generate outer cells and inner cells, which later become trophectoderm and inner cell mass
(ICM) cells, respectively. At the blastocyst stage, ICM cells further differentiate into epiblast,
which generates fetal cells, and primitive endoderm. The primitive endoderm later produces
extra-embryonic tissues such as placenta.
Fig. 5.1 Mouse preimplantation development
Preimplantation development of the mouse embryo is summarised. Figure taken from
Chazaud and Yamanaka (2016).
5.1.2 Maternal RNA in preimplantation embryo
Some maternally deposited RNAs are essential for zygotic development. This type of
maternal RNA is also called “dormant” RNA since they are not translated in the oocyte
but are recruited for translation after fertilisation. This time-specific regulation is achieved
through polyA stretching induced later in the developing zygote. This process was shown
to be essential for preimplantation development, since the inhibition of polyadenylation
by 3′-deoxyadenosine (3′-dA) inhibited genome activation (Aoki et al., 2003). One of the
examples of dormant mRNA is the one encoding ORC6L, which is a critical component for
DNA replication complex (Murai et al., 2010). Since oocytes between metaphase I (MI) and
metaphase II (MII) do not undergo DNA replication but need to replicate after fertilisation to
initiate cleavage into 2-cell (2C) embryos, Orc6l mRNA is not translated in oocytes but is
recruited after fertilisation in embryo.
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At the same time, timely degradation of maternal RNA is also critical for proper preim-
plantation development. A few mechanisms have been proposed to explain how an embryo
achieves maternal-specific RNA degradation. Below, the proposed mechanisms are sum-
marised.
miRNA
Although mature oocytes contain little miRNA, late preimplantation embryos contain abun-
dant miRNA, suggesting miRNA is synthesised in the early preimplantation stages. In
zebrafish and frog zygotes, miRNAs are shown to target maternal mRNA and accelerate
their degradation (Giraldez et al., 2006; Lund et al., 2009). Importantly, the miRNAs that
are thought to be involved in the process, namely miR-430 family, are conserved among
vertebrates and are expressed in preimplantation embryos.
However, although the same miRNA family is conserved in mice, miRNA does not seem
to be essential in mouse preimplantation development. When a miRNA biogenesis factor,
Dgcr8, is knocked-out in oocytes, they can still generate viable offspring (Suh et al., 2010).
Further, even if both the oocyte and sperm lack Dgcr8, they can still generate viable offspring.
These results suggest that the miRNA pathway is dispensable in mammalian development.
siRNA
Compared with the little phenotypic change observed in Dgcr8 KO, which is deficient of
miRNA maturation, embryos generated from Dicer KO oocytes exhibit a dramatic tran-
scriptional change, mitotic defect, and developmental arrest. Since Dicer is involved in
both siRNA and miRNA processing, these results collectively suggest that endogenous
siRNA (endo-siRNA) is essential for preimplantation mouse development, while miRNA is
dispensable for the process.
There are a few important properties in mammalian oocytes that allow a robust siRNA
machinery. Normally, if dsRNA is present in a mammalian cell, it can induce an inflamma-
tory response through interferon (Kang et al., 2002; Yoneyama et al., 2004). However, the
mammalian oocyte lacks an interferon response and induces RNAi through dsRNA injec-
tion (Stein et al., 2005). Also, M. musculus possesses the oocyte- and Muridae-specific Dicer
isoform called DicerO (Flemr et al., 2013). The expression of DicerO is driven by an intronic
insertion of a transposon-like element called MT, and the removal of MT phenocopies Dicer
KO and Ago KO. This suggests that the loss of DicerO-derived endo-siRNA is responsible
for the meiotic defect observed in the Dicer KO oocyte.
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PolyA tail shortening
Upon fertilisation, some mRNAs undergo polyA tail shortening and are rapidly degraded (Au-
dic et al., 1997). CCR4-NOT complex has been shown to be important in this deadenylation
process in the preimplantation embryo (Mishima and Tomari, 2016). Although this process
was shown to occur in various cell types and organisms (Subtelny et al., 2014), how such
selective mRNA deadenylation is regulated is still unclear.
3′ end uridylation
Recently, non-templated addition of uridine was discovered at the 3′ end of mRNAs targeted
by miRNA in various organisms from Arabidopsis to mice (Shen and Goodman, 2004). Later
studies discovered that terminal uridyltransferases called TUT4 and TUT7 are involved in this
non-templated addition of uridine at the 3′ end of RNA (Lim et al., 2014). Analyses of the 3′
end of RNA in the preimplantation embryo revealed that maternal RNA is often uridylated,
and the 3′ end uridylation is more frequently observed after shorter polyA tails (Morgan
et al., 2017). TUT4/7 knock-down by morpholinos resulted in embryonic defects in Xenopus
laevis. This suggests that maternal RNAs with short polyA are uridylated by TUT4/7 for
degradation, which is important for embryonic development.
5.1.3 Zygotic genome activation (ZGA)
In addition to maternal RNA clearance, transcription from the zygotic genome is also essential
for embryonic development. Different organisms seem to employ different machineries to
achieve ZGA.
Fly
In Drosophila, the key transcription factor that induces ZGA, called Zelda, has been identi-
fied (Liang et al., 2008). This zinc-finger protein binds to a cis-regulatory heptamer motif,
CAGGTAG, which is shared among the majority of zygotic genes. Zelda-lacking embryos
cannot induce zygotic genome activation and are defective in development. Thus, Zelda con-
trols the expression of these zygotic genes, which are essential for embryonic development.
Mammals
Nascent transcription labelling assay with BrU revealed that zygotic transcription happens as
early as the late 1-cell stage (Bouniol et al., 1995). Since the most transcripts in this stage
are not properly spliced (Abe et al., 2015), it was questioned if the transcripts synthesised
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in the 1-cell zygote are functional. However, inhibition of these early transcripts led to 2C
arrests, suggesting that this transcription is essential for development (Abe et al., 2018). The
highest rate of zygotic transcription was observed in the 2C embryos, and transcriptional
inhibition in this stage led to developmental arrest, suggesting that transcription at the 2C
stage is necessary for embryonic development. However, the transcriptional cascade that
governs zygotic genome activation in mammals is still poorly understood.
Three papers claiming that a transcription factor, Dux, governs zygotic genome activation
in human and mouse embryos were published in the same issue of Nature Genetics (De Iaco
et al., 2017; Hendrickson et al., 2017; Whiddon et al., 2017). However, unlike Zelda in
Drosophila, following works reported that Dux-lacking mouse embryo can develop in term
and generates viable mice (Chen and Zhang, 2019; De Iaco et al., 2019), though lower
developmental potential was observed. These studies suggest that Dux is an important factor
affecting a significant proportion of mammalian zygotic transcripts but not essential for
development.
5.1.4 Reactivation of transposable elements during ZGA
Another notable phenomenon during ZGA is that a number of different classes of transposable
elements (TEs) are derepressed. TEs are selfish genetic elements that exist in various
organisms and account for more than 30% of the mouse genome. There are various types
of TEs, and each has a distinct mobilisation machinery (Fig. 5.2). To maintain the genomic
integrity, their expression is tightly regulated by multiple molecular machineries such as DNA
methylation, PIWI-interacting RNA (piRNA) (Aravin et al., 2007), and KRAB-zinc finger
proteins (Imbeault et al., 2017). In mammalian embryos, however, it is known that transcripts
derived from a number of different TEs are detected in multiple stages of embryos (Evsikov
et al., 2004; Kigami et al., 2003; Peaston et al., 2004). Especially, abundant transcripts derived
from endogenous retrovirus (ERV) are observed in 2C mouse embryo and, notably, MuERV-L
(murine endogenous retrovirus with leucine tRNA primer) is well-known to be expressed
only during the 2C stage (Kigami et al., 2003). Surprisingly, many 2C-activated genes were
discovered to have a MuERV-L-derived promoter (Macfarlan et al., 2012), suggesting that
TE integrations into intergenic regions contribute to forming the 2C transcriptional network.
Also, there is a subpopulation of ES cells that expresses MuERV-L, and this population
exhibits 2C-like transcriptome, suggesting that MuERV-L expression is linked with the 2C
gene regulatory network (Macfarlan et al., 2012).
In addition to these co-opted roles of TE-derived sequences in the genome, it is also spec-
ulated that transposon-derived RNA itself may have biological roles in the host cell. LINE-1
RNA was shown to recruit Kap1 and Nucleolin to rDNA and Dux-encoding loci, resulting in
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Figure 1 | The diverse mechanisms of transposon mobilization. a | DNA transposons. Many DNA transposons are 
flanked by terminal inverted repeats (TIRs; black arrows), encode a transposase (purple circles), and mobilize by a 
‘cut and paste’ mechanism (represented by the scissors). The transposase binds at or near the TIRs, excises the 
transposon from its existing genomic location (light grey bar) and pastes it into a new genomic location (dark grey 
bar). The cleavages of the two strands at the target site are staggered, resulting in a target-site duplication (TSD) 
typically of 4–8 bp (short horizontal black lines flanking the transposable element (TE)) as specified by the 
transposase. Retrotransposons (b and c) mobilize by replicative mechanisms that require the reverse transcription 
of an RNA intermediate. b | LTR retrotransposons contain two long terminal repeats (LTRs; black arrows) and 
encode Gag, protease, reverse transcriptase and integrase activities, all of which are crucial for retrotransposition. 
The 5′ LTR contains a promoter that is recognized by the host RNA polymerase II and produces the mRNA of the  
TE (the start-site of transcription is indicated by the right-angled arrow). In the first step of the reaction,  
Gag proteins (small pink circles) assemble into virus-like particles that contain TE mRNA (light blue), reverse 
transcriptase (orange shape) and integrase. The reverse transcriptase copies the TE mRNA into a full-length dsDNA. 
In the second step, integrase (purple circles) inserts the cDNA (shown by the wide, dark blue arc) into the new 
target site. Similarly to the transposases of DNA transposons, retrotransposon integrases create staggered cuts at 
the target sites, resulting in TSDs. c | Non-LTR retrotransposons lack LTRs and encode either one or two ORFs. As for 
LTR retrotransposons, the transcription of non-LTR retrotransposons generates a full-length mRNA (wavy, light blue 
line). However, these elements mobilize by target-site-primed reverse transcription (TPRT). In this mechanism, an 
element-encoded endonuclease generates a single-stranded ‘nick’ in the genomic DNA, liberating a 3′-OH that is 
used to prime reverse transcription of the RNA. The proteins that are encoded by autonomous non-LTR 
retrotransposons can also mobilize non-autonomous retrotransposon RNAs, as well as other cellular RNAs (see the 
main text). The TPRT mechanism of a long interspersed element 1 (L1) is depicted in the figure; the new element 
(dark blue rectangle) is 5′ truncated and is retrotransposition-defective. Some non-LTR retrotransposons lack 
poly(A) tails at their 3′ ends. The integration of non-LTR retrotransposons can lead to TSDs or small deletions  
at the target site in genomic DNA. For example, L1s are generally flanked by 7–20 bp TSDs.
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Fig. 5.2 Mobilisation mechan sms of different TE families
(a) DNA transposons excise th ir own sequence using transposase encoded and integrate
into a new genomic locus. Retrotransposons (b, c) employ a “copy and paste” mechanism
through generating RNA intermediate. (b) RNA synthesised from an LTR transposon is first
transferred to the cytoplasm and rev se-transcribed to yn hesise cDNA in a virus-like capsid
made of Gag proteins (pink circle). The cDNA is then transferred back to the nucleus and
integrated into a new genetic locus. (c) Non-LTR transposons use an endonuclease to induce
a single-stranded nick at an integration site of th genomic DNA an reverse transcribe the
TE tra scri t at the integration s te for integration. Taken from Levi and M ran (2011).
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the repression of Dux and induction of rRNA synthesis in the mouse blastocyst (Percharde
et al., 2018). Although the precise mechanisms of how LINE-1 RNA targets different genetic
loci and induces the opposite transcriptional responses are still unknown, this study shows
that retrotransposon-derived RNA could function as a regulatory RNA.
5.1.5 Experimental approaches to study ZGA
Since first discovered in 1964 (Mintz, 1964), transcriptional activity in the early preimplanta-
tion embryos has been widely studied using various methods. Here, different approaches to
study zygotic transcription are summarised.
Metabolic labelling with uridine analogues
Radiolabelled uridine, namely [3H]-uridine was the first tool to dissect ZGA. Embryos at dif-
ferent stages were exposed to the analogue, and the RNA synthesis rate was measured (Mintz,
1964). It is surprising that this first experiment even revealed that the RNA synthesised
in the 2C embryo mostly remains in the nucleus. Also, combined with size fractionation
with electrophoresis and polyA selection, it was discovered that polyA RNA is also actively
synthesised in the 2C embryos (Clegg and Pikó, 1983a; Ellem and Gwatkin, 1968). It is par-
ticularly worth noting that RNA synthesis at the 1-cell stage (i.e. zygote) was detected with
the metabolic labelling method (Clegg and Pikó, 1983b). Also, extensive polyadenylation for
new RNA synthesis and pre-existing RNA degradation were observed.
As an alternative to the radiolabelling methods, 5-bromouridine-5′-triphosphate (BrUTP)
was used to capture the first wave of ZGA with higher sensitivity (Bouniol et al., 1995). They
not only unambiguously determined that the first ZGA occurs at the late 1-cell stage, but also
identified that the first transcripts are synthesised in the paternal pronucleus.
Transcriptional perturbation
Another key strategy in studying ZGA is to block the transcription by stalling polymerases.
The most frequently used agent is α-amanitin, which specifically binds to Pol II and stalls it.
Pol II-dependent transcription in the 2C embryo was shown with decreased expression of
[3H]-uridine labelled RNA in α-amanitin-treated embryos (Warner and Versteegh, 1974).
While the transcriptional inhibition by α-amanitin is irreversible, inhibition with 5,6-
dichloro-1-β -D-ribofuranosyl-benzimidazol (DRB) is reversible (Tamm et al., 1976), and
thus DRB has been used to study the significance of transcripts synthesised at a particular
stage of embryo by assessing developmental progression after a stage-specific treatment (Abe
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et al., 2018). This study identified that the minor transcription observed in the late 1-cell
stage is essential for later zygotic development.
Comparison of RNA abundance
Since the methods above do not provide information about abundance of particular RNA
molecules, other experimental approaches that provide transcript-level information have
also been used to study the transcriptional dynamics of particular genes. Northern blot and
RT-qPCR have been widely used to achieve low-throughput quantification of transcripts in
different stages of embryos. Especially, by comparing the embryonic transcriptome with
that of oocytes, transcripts synthesised in the zygote can be identified. Inventions of high-
throughput methods, such as microarray or RNA-seq, enabled to simultaneously study the
dynamics of a diverse set of transcripts during ZGA (Hamatani et al., 2004; Tang et al.,
2009).
Also, these quantitative methods have been combined with the above two methods.
Labelled RNA from 4-thiouridine-exposed embryos was isolated with biotinylation combined
with the streptavidin beads pull-down, and the pulled-down RNA was quantified to identify
transcripts synthesised in the embryo (Heyn et al., 2014). Hamatani et al. combined α-
amantin treatment with microarrays and identified genes actively synthesised in different
stages of embryos.
SNP assay
Since RNA-seq determines the exact sequence of each transcript, single-nucleotide poly-
morphism (SNP) in each transcript can also be detected. Considering that the abundance of
sperm-deposited RNA is negligible, the zygotic transcriptome just after fertilisation contains
SNPs only from the maternal allele. Thus, by identifying transcripts with paternal SNPs
after ZGA, zygotic transcripts can be identified (Harvey et al., 2013; Lee et al., 2013). Also,
with the development of single-cell RNA-seq method (Tang et al., 2009), this strategy can
also be applied to analyse SNP using non-inbred animals including humans (Xue et al.,
2013). However, this method is not exhaustive in identifying all the zygotic transcripts
because informative SNPs to differentiate the alleles are present up to 20% of all the detected
transcripts, and many genes exhibit the maternal monoallelic expression pattern. Still, it is a
useful method to study ZGA in genetically diverse samples and to study the allelic expression
patterns.
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5.2 Aims of this chapter
The most simple strategy to study ZGA is to compare the transcriptome between the oocyte
and the zygote/2C embryos. Although this method has been widely used and has successfully
identified a number of transcripts synthesised in the 2C embryos (Hamatani et al., 2004), this
approach has some limitations. First, since this method just focuses on the abundance of
transcripts for each stage of embryos, it is difficult to identify transcripts that are synthesised
both in the oocyte and the embryo. It is also very challenging to compare the abundance of
RNA between different stages of embryos since most RNA-seq pipelines are optimised to
compare cells with more or less similar abundance of total RNA and proportions of RNA
species (Anders and Huber, 2010; Robinson et al., 2010). In the oocyte-to-embryo transition
process, however, maternal RNA degradation and ZGA alter both the proportion of RNA
species and the total abundance of RNA. Although one possible solution is to include a
spike-in, it is also difficult to find the right sample-to-spike-in ratio.
With metabolic RNA labelling, these problems can be solved. By culturing embryos in
nucleotide analogue-containing medium, only RNA synthesised in embryos incorporates
the analogue. Also, by restricting the exposure time so that embryos at a particular stage
are labelled, RNA synthesised in that particular stage can specifically be labelled, which is
powerful in studying stage-specific active gene expression, as opposed to RNA abundance in
each embryonic stage.
In this chapter, mouse 2C transcriptome is studied with SLAMseq. Mouse 2C embryos
were cultured in vitro in medium containing 4-thiouridine, and the RNA isolated from the
embryos was analysed to find actively synthesised transcripts in the 2C embryo.
5.3 Optimisation of RNA labelling condition
Since 4-thiouridine exposure has been reported to inhibit cell proliferation through block-
ing rRNA synthesis (Burger et al., 2013), we first confirmed the highest concentration of
4-thiouridine that can be used to culture the mouse embryos without affecting the preim-
plantation development. WT embryos were cultured in medium with different 4-thiouridine
concentrations. As shown in Table 5.1, the embryos cultured with 0, 1, and 5 mM of 4-
thiouridine developed to the blastocyst stage at almost identical rates, while none of the
embryos in 10 mM 4-thiouridine reached the blastocyst stage. Thus, in the subsequent
analyses, the embryos were cultured with 5 mM 4-thiouridine to achieve the labelling without
any developmental defects.
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Table 5.1 Proportions of the embryos that reached the blastocyst stage with different 4-
thiouridine concentrations
4-thiouridine conc. (mM) Number of starting zygotes Number of blastocysts obtained
10 15 0 (0%)
5 15 15 (100%)
1 15 14 (93%)
0 10 10 (100%)
5.4 Analysis of active transcription in the 2C embryo
5.4.1 Higher T>C was observed in 4-thiouridine-exposed embryos
To test if this method can label RNA synthesised during ZGA, the mouse embryos were
collected and in vitro cultured for 24 h until the embryos reached the 2C stage. The 2C
embryos were then transferred to medium containing 5 mM of 4-thiouridine or control
medium and were further incubated for 4 h. RNA was extracted from the embryos and
used as input for SLAMseq. By comparing the T>C rate between 4-thiouridine-exposed
embryos and control embryos, transcripts with a significantly higher T>C conversion rate
in 4-thiouridine embryos compared with control were identified (Fig. 5.3A). To see if 4-
thiouridine exposure affects the transcriptome of embryos, the abundance of RNA was
compared. As shown in Fig. 5.3B, a highly-positive correlation was observed between
the abundance of transcripts in control and 4-thiouridine embryos, which suggests that
4-thiouridine incorporation did not affect RNA expression levels in the embryos.
5.4.2 SLAMseq labelled the zygotic transcripts specifically
The labelled transcripts were further analysed for characterisation. To confirm that the
labelled transcripts are in agreement with the previously identified zygotic transcripts, the
obtained list of labelled genes was compared against the previously published 2C gene
list (Macfarlan et al., 2012) (Fig. 5.4). Although the number of genes in the two lists are
different, potentially due to SLAMseq being performed with only 4 h exposure, more than
40% of SLAMseq-identified genes overlap with the 2C genes in the dataset.
Also, to confirm the labelling level of the maternally-deposited RNA in the 2C embryo, a
list of genes that are highly expressed in metaphase II (MII) oocytes was obtained from a
previous literature (Tang et al., 2009), and this confirmed the labelling level of these genes
in the 2C (Fig. 5.5). As expected, although the oocyte-synthesised transcripts are of high
abundance in the 2C embryo, the majority of them are not labelled. It is interesting that there
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Fig. 5.3 SLAMseq identified genes actively transcribed in the 2C embryos
(A) Mean T>C conversion rates among biological replicates (N = 3 each) for each polyA
transcript in the control and 4-thiouridine embryos are shown. Genes with a significantly
(FDR <0.1, beta-binomial test) higher T>C rate in 4-thiouridine are shown in red. A constant
value of 10-5 was added to each value when plotting. (B) Mean gene expression in 4-
thiouridine and control embryos is shown. Spearmen’s correlation coefficient is shown. A
constant value of 1 was added to each value when plotting.
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Fig. 5.4 Venn diagram comparing the labelled genes and the 2C genes
Genes labelled with SLAMseq in the 2C embryos were compared with the genes identified to
be 2C-expressed in a previous report (Macfarlan et al., 2012) and shown as a Venn diagram.
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are several oocyte genes that are labelled, as this suggests that SLAMseq could potentially
be able to identify genes that are transcribed in both oocyte and zygote, which has been
challenging to achieve with conventional RNA-seq methods.
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Fig. 5.5 Abundance and labelling level of the transcripts detected in the 2C embryo
Read count and fold change of labelling level of the 4-thiouridine embryo divided by the
control embryo are shown. To highlight the maternally-deposited RNA, a list of genes that
are highly expressed in MII oocytes (oocyte genes) are obtained from Tang et al. (2009).
Unlabelled oocyte genes, blue; labelled oocyte genes, green; labelled non-oocyte genes, red.
5.4.3 No significantly enriched DNA motif was found upstream of the
labelled genes
To dissect the molecular mechanisms that govern the expression of genes in the early 2C
embryo, common DNA sequence motifs upstream of the labelled genes were sought using
HOMER (Heinz et al., 2010), and the enrichment levels of transcription factor (TF) binding
sites were quantified (Fig. 5.6). The analysis has revealed that a number of known TF-binding
motifs are enriched among the upstream of the labelled transcripts identified by SLAMseq;
however, all of them have a FDR >0.1, suggesting that no strong enrichment was observed.
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Fig. 5.6 Enriched sequence motifs upstream of the 2C-labelled genes
Common DNA sequence motifs from -300 to +50 relative to transcription start site (TSS) of
the genes labelled in the 2C embryo were sought with HOMER. Enrichment level of known
TF-binding sequences are summarised.
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5.5 Analyses of active TE transcription in the 2C embryo
5.5.1 Labelled TE transcripts were identified with SLAMseq
Since TE-derived transcripts are known to be expressed in the 2C mouse embryo, we further
analysed the SLAMseq data to see if TE transcripts were also labelled with 4-thiouridine
exposure. By comparing the T>C rate between the 4-thiouridine and control embryos,
significantly labelled TE transcripts were discovered. Since there are multiple identical
copies of each TE in the genome, it is often not possible to align a read to a single TE-
encoding genomic locus unambiguously. Thus, if a read cannot be aligned to a unique
genetic locus, the read is mapped to a locus randomly among all the candidate loci, and,
subsequently, the read count as well as T>C conversion events were summarised at the TE
gene level.
The beta-binomial test on the T>C count data for each TE gene identified the TE genes
that have higher T>C rates in the 4-thiouridine embryos than the control embryos (Fig. 5.7A).
Also, the abundance of each TE transcript was compared between 4-thiouridine and control
embryos, and a high positive correlation (Pearson’s correlation coefficient = 1.00) was ob-
served (Fig. 5.7B). These results suggest that the actively synthesised TE-derived transcripts
were labelled with the 4-thiouridine exposure, and the transcription of TEs was not affected
by 4-thiouridine incorporations.
To better characterise the labelled TE transcripts, all the expressed TEs were sorted by
expression and plotted (Fig. 5.8). The majority of highly abundant TE transcripts in the
early 2C embryo were confirmed to be labelled with SLAMseq. Also, these labelled TE
genes include the well-known 2C-synthesised TEs, such as MuERV-L. These results suggest
that the majority of highly abundant TE transcripts in the 2C embryo are synthesised in this
particular stage and not inherited from the oocyte.
5.5.2 Different classes of TE genes are active in the early 2C
Further, to summarise the labelled TEs by their classes, the number of labelled TE genes in
each TE class was compared between the labelled and unlabelled fractions (Fig. 5.9). Many
ERVs and LINE transposons are significantly labelled, which is in agreement with previous
reports (Fadloun et al., 2013; Macfarlan et al., 2012). Intriguingly, when compared to the
proportions of the unlabelled TE genes, SINEs are overrepresented in the labelled TE genes.
This result suggests that the majority of SINE-derived RNAs detected in the 2C embryos are
synthesised in the 2C stage.
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Fig. 5.7 Actively transcribed TE-derived RNAs were identified in the 2C embryos
(A) Mean T>C rate of each TE gene in the 4-thiouridine and control embryos (N =3 each).
TE genes with a significantly (FDR <0.1) higher T>C rate in the 4-thiouridine embryos
are shown in red. A constant value of 10-5 was added to each value when plotting. (B)
Expression of each TE-derived RNA in the 4-thiouridine and control embryos. Spearman’s
correlation coefficient is shown. A constant value of 1 was added to each value when plotting.
5.6 Discussion
Capturing active transcription is essential in studying the transcriptional network in the
cell. In this chapter, I showed that 4-thiouridine treatment followed by SLAMseq identifies
active transcription of polyA and TE-derived transcripts and distinguishes zygotic transcripts
from maternally-deposited RNA. The concentration of 4-thiouridine was first optimised to
maintain the viability and developmental potential of the embryos. Also, it was confirmed that
4-thiouridine exposure at this concentration did not affect the abundance of each transcript,
and thus it suggests that 4-thiouridine exposure itself has little effect on RNA metabolism in
embryos, and that the method captures the native transcriptional state of the embryo.
Conventionally, zygotic transcripts have been studied by comparing RNA-seq data ob-
tained from different stages of the embryos to identify transcripts that are significantly more
abundant in a particular stage than the previous stage. This approach has been successful in
identifying zygotic transcripts that are not synthesised in the oocytes. However, to understand
the transcriptional cascade that governs the ZGA, it is essential to unbiasedly capture genes
that are transcriptionally active at a particular stage of embryos. SLAMseq is the first method
that analyses transcriptional activity with the nucleoside incorporation rate at single-base
resolution. Application of this method at different stages of the embryos would reveal a
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Fig. 5.9 Proportions of the labelled TE classes in the 2C embryos
The fractions of different TE families in the labelled and unlabelled TE genes are summarised.
The numbers shown in each bar plot represent the number of TE genes.
complete transcriptional map at each stage of the embryos. Further, by combining molecular
perturbations (e.g. inhibition of a transcription factor), transcripts directly under control of
the particular factor can be studied.
SLAMseq also has a practical benefit compared to existing metabolic RNA labelling
methods. Conventionally, metabolically labelled transcripts are isolated from the pool of
RNA by a biochemical method, and the isolated RNA fraction as well as the input fraction are
sequenced separately. In addition to the analytical difficulties with this approach discussed
in Chapter 3, it requires abundant starting materials to obtain sufficient pulled-down RNA
for sequencing library construction, which is particularly difficult to achieve with embryo
experiments, as more mice would have to be used for superovulation. With SLAMseq,
labelled and unlabelled RNA are sequencing in the same library; therefore, the minimum
number of embryos sufficient for a library is needed for each biological replicate, though
more embryos may be needed if transcriptionally less active genes have to be captured.
In this study, SLAMseq was performed to label both cells of the 2C embryo, as these
two cells are considered to be identical. However, by generating mice expressing UPRT in a
particular cell population, SLAM-ITseq could be used to study transcriptional activity in a
specific subpopulation of cells in later embryos, where cells are differentiated and exhibit
different transcriptome (e.g. blastocyst).
Further experiments are needed to determine whether transcriptional activity in different
stages of the embryos can be studied with this metabolic RNA labelling method. Since we
only confirmed that SLAMseq labels RNA transcribed in the 2C stage, where the transcrip-
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tional activity is thought to be the highest during the preimplantation development, only
little RNA labelling may be achieved in other stages, in which transcriptional activity is less
strong.
Chapter 6
Final considerations and future
perspectives
Metabolic RNA labelling has led to key biological discoveries. Radiolabelled nucleoside
analogues allowed scientists observe short-lived mRNAs in nucleus for the first time (As-
trachan and Volkin, 1958; Hershey et al., 1953), which led to the discovery of the flow of
genetic information to protein synthesis. Zygotic genome activation as a phenomenon was
also first observed with RNA radiolabelling (Mintz, 1964).
Although metabolic labelling has become less common in studying RNA transcriptional
changes after the inventions of PCR and various high-throughput approaches, it is still an
important tool in interrogating transcriptional dynamics, and, indeed, has discovered miRNA
dynamics recently (Duffy et al., 2015).
In this thesis, I showed that SLAM-ITseq can be used to identify cell-type-specific
transcriptome without cell sorting. While this method is already a useful method in studying
native transcriptional states of particular cells without cell sorting, it would potentially be
able to observe new biological phenomena if this method is applied to analyse transcriptional
dynamics in vivo by combining it with a perturbation. For example, it would be interesting to
observe the transient transcriptional changes in gut epithelium after a virus challenge.
Also, SLAM-ITseq enabled to study the intercellular mobility of endogenous RNA for
the first time. Although no signs of mobility was detected in the three cell types tested in
this thesis, different cell types or cells under different conditions may release mobile RNA in
mammals, and SLAM-ITseq might be useful in directly proving the mobility of such RNAs.
SLAMseq was also shown to be useful to capture the active transcription in the mouse
2C embryo. Although various metabolic labelling methods have been used to study ZGA,
SLAMseq took the method to the next level. The pull-down-independent approach to identify
the labelled RNA allows an unbiased detection of the zygotic transcripts starting from a small
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number of embryos. Also, the labelling level is quantified at single-nucleotide resolution,
which enables a quantitative analysis of the transcriptional dynamics.
One of the biggest limitations of SLAM-ITseq is the potential sensitivity problem, as
the T>C conversion rate that can be achieved is still lower than what can be achieved with
4-thiouridine exposure. To further improve the method, it might be worth testing different
UPRTs from various species to discover UPRT with the highest enzymatic activity. With
this optimisation, more sensitive data could potentially be obtained from SLAM-ITseq
experiments. Also, sequencing strategy could be improved. Since the sequencing error rate
inherent to the illumina method could potentially be higher than the T>C rate induced by
the labelling, the use of paired-end sequencing or UMI might be effective in lowering the
background noise, leading to improving the sensitivity.
The development of SLAMseq and equivalent methods to identify 4-thiouridine incorpo-
rations by base-conversions has potential to make metabolic labelling to be applied in wider
research fields and to enable more detailed studies of RNA transcription, as opposed to just
comparing steady-state abundance of RNA. One of the most promising examples is a study
that combined SLAMseq with a transcription factor knock down and identified the genes
directly controlled under the transcription factor (Muhar et al., 2018). This clearly overcame
the problem in the conventional RNA-seq method that cannot differentiate direct and indirect
effects of transcription factor perturbation.
SLAMseq was also combined with a single-cell RNA sequencing (scRNA-seq) method
and captured transcriptional dynamics at single-cell level (Erhard et al., 2019). Hence,
SLAM-ITseq could potentially be combined with scRNA-seq to capture the heterogeneity
of transcriptional dynamics within the same cell type in vivo. Also, using F1 hybrid mice,
allelic expression analysis could also be performed. By finding transcripts that contain both
allele-specific SNPs and T>Cs, one can estimate the allele-level expression for each gene,
which would be powerful in studying genomic imprinting or random monoallelic expression.
Metabolic RNA methods would potentially shed light on the still enigmatic eukaryotic
transcriptional machinery.
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Appendix A
RNA-seq quality check
A.1 RNA-seq on Tie2-Cre mice
0 10 20 30 40 50 60 70
uptt1_1f_cr
uptt1_1g_wt
uptt3_1a_cr
uptt3_1b_cr
uptt3_1c_cr
uptt3_1d_wt
uptt3_1e_wt
M SEQ
Fig. A.1 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from Cre-
mice and "cr" ID are from Cre+ mice.
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Fig. A.2 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
A.2 RNA-seq on Vil-Cre mice
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Fig. A.3 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from Cre-
mice and "cr" ID are from Cre+ mice.
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Fig. A.4 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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0 5 10 15 20 25 30 35
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Fig. A.5 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.6 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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A.4 Small RNA-seq on WT mice
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Fig. A.7 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.8 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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A.5 Small RNA-seq on Vil-Cre mice
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Fig. A.9 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from Cre-
mice and "cr" ID are from Cre+ mice.
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Fig. A.10 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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A.6 Small RNA-seq on Adipoq-Cre mice
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Fig. A.11 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.12 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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A.7 RNA-seq on Spink8-Cre mice
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Fig. A.13 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.14 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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Fig. A.15 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.16 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
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Fig. A.17 Read count obtained for each library
The number of reads obtained in each library is shown. Samples with "wt" ID are from
Cre- mice and "cr" ID are from Cre+ mice. Note that the second and the third samples were
assigned two barcodes.
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Fig. A.18 Phred score across read for each library
Phred score for each position of read is summarised for each library. Samples with "wt" ID
are from Cre- mice and "cr" ID are from Cre+ mice.
Appendix B
SLAMseq analysis script
1. Install and load required packages.
install.packages(c("dplyr", "tidyr", "ibb"))
library("dplyr")
library("tidyr")
library("ibb")
2. Read all the count tables and combine them into one data table.
ls <- list.files(pattern = "_tcount.tsv")
df <- do.call(rbind, Map("cbind", lapply(ls, read.delim, skip = 2,
header = T), sample = gsub("//..*", "", ls)))
3. Reshape the data for ibb to perform the beta-binomial test.
dfsprd <- df %>%
select(sample, Name, CoverageOnTs, ConversionsOnTs) %>%
gather(variable, value, CoverageOnTs, ConversionsOnTs) %>%
unite(var, variable, sample) %>%
group_by(var) %>%
mutate(id = 1:n()) %>%
spread(var, value)
4. Remove genes with no T>C in any of the samples.
dfexp <- dfsprd[apply(dfsprd %>%
select(starts_with("CoverageOnTs")), 1, function(z) !any(z == 0)),]
144 SLAMseq analysis script
5. Specify sample groups as they appear in the "dfexp" columns.
dftc <- dfexp %>%
select(starts_with("ConversionsOnTs"))
dftotal <- dfexp %>%
select(starts_with("CoverageOnTs"))
group <- c("cr","wt","cr","cr","cr","wt","wt")
6. Run bb.test() function to perform the beta-binomial test.
bbtest <- bb.test(dftc, dftotal, group, n.threads = 0)
7. Write a table as a file with P-values and FDR (Benjamini-Hochberg’s procedure)
calculated by beta-binomial test.
dfexp$pval <- bbtest$p.value
adj <- dfexp %>%
mutate(BH = p.adjust(pval, method = "BH"))
write.table(adj, file = "ibb.txt", sep = "/t", quote = F)
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